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The! animal! nervous! system,! with! its! unparalleled! connectivity,! epitomizes! the!integration!of!divergent!elements!forming!complex!entities!in!nature.!At!the!heart!of!this! connectivity! lies! what! now! constitute! the! targets! of! drug! development,! first!theorized!by!physiologist! John!Langley! in!1905!as!a! “receptive!substance”! (Langley,!1905),! membrane! receptor! molecules! are! the! interfaces! that! transduce! specific!biological!signals!between!cells.!The!particular!subject!of!Langley’s! insights!was!the!same! effector! underlying! the! actions! of! the! poison! curare! speculated! by! Claude!Bernard! to! be! localized! at! the! junction!between!nerve! and!muscle! almost! 50! years!earlier,!now!known!as!the!nicotinic!acetylcholine!receptor!(nAChR).! It!was!not!until!1970!that!the!nAChR!was!characterized!biochemically!(Changeux!et!al.,!1970)!as!the!first!ligand!gated!ion!channel!(LGIC)!ever!to!be!identified.!The!nAChR!is!now!known!to!encompass!a!large!family!of!receptor!subtypes!with!diverse!functional!properties.!They! fulfil! a! range! of! physiological! roles,! many! of! which! follow! from! a! receptor!mediated! increase! in! intracellular! calcium! ions! (Ca2+),! central! to! a! tremendously!diverse! range! of! biological! signalling! events! in! a! multitude! of! different! cells! and!tissues.!As! such,! nAChRs! are! implicated! in! a! spectrum!of! diseases! and! it! intuitively!follows! that! nAChRs! present! worthy! targets! for! pharmaceutical! intervention! in!medicine.!This!introduction!will!discuss!the!current!state!of!knowledge!about!nAChRs!as!drug! targets! that!modulate!cellular!Ca2+! signalling,! covering! their!basic! structure!and!function,!physiological!roles,!clinical!significance,!and!relevance!to!this!thesis.!
1.1 Structure)and)Diversity)of)nAChRs)At!the!centre!of!complex!interactions!in!nature!that!give!rise!to!biology!are!proteins,!for!which!form!and!function!are!inextricably!linked.!Knowledge!and!understanding!of!the! structure! of! protein! molecules! like! nAChRs! can! help! us! to! pharmacologically!manipulate! their! function.! This! section!will! describe! the! structure! of! nAChRs,! their!diversity,! their! function! as! LGICs! and! their!modulation! by! a! variety! of! endogenous!and!exogenous!ligands.!























a.!nAChR!subunit!topology:!a!complex!folded!βXsheet!rich!extracellular!NXterminal!domain!contains!a! pair! of! disulphide! bonded! cysteine! residues! that! characterizes! the! cysXloop! LGIC! receptor!superfamily.!Four!amphipathic!transmembrane!αXhelical!domains!(M1XM4)!are!joined!by!intraX!or!extracellular! loops,! forming! a! variable! intracellular! domain! and! a! short! extracellular! CXterminal!domain.!b.!Five!nAChR!subunits!arrange!in!a!ring!spanning!the!membrane!forming!a!central!pore.!ACh!binding!sites!are!formed!at!subunit!interfaces.!Other!sites!for!alternative!ligands!exist!close!to!the!ACh!binding!site!and!within!the!transmembrane!domain.!Residues!of!the!M2!transmembrane!domain! line! the! lumen! of! the! pore,! which! selectively! allow! the! passage! of! monoX! and! divalent!cations.! The! central! pore! is! also! the! site! of! action! for! channel! blocking,! nonXcompetitive!antagonists.!
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properties! and! diverse! distribution! throughout! the! nervous! system! and! periphery!(Dani! and! Bertrand,! 2007;! Albuquerque! et! al.,! 2009;! Taly! et! al.,! 2009;! Changeux,!2012).!nAChRs!are!pentameric!LGICs,!allosteric!proteins!whose!structure!allows!the!transduction!of!ligand!binding!to!opening!of!the!intrinsic!ion!channel!leading!to!cation!flux.!Figure!1.1.1a!shows!the!basic!topology!of!a!single!nAChR!subunit,!comprised!of!a!large!complex,!folded!βXsheet!rich!extracellular!NXterminal!domain,!4!transmembrane!αXhelical!domains!(M1XM4)!joined!by!intracellular!or!extracellular!loops,!and!a!short!extracellular!CXterminal!end.!The!NXterminal!region!of!each!subunit!contains!a!pair!of!disulphideXbonded!cysteine!residues!separated!by!13!amino!acids,!known!as!the!‘cysXloop’,! a! signature! polypeptide! motif! which! defines! the! ‘cysXloop’! LGIC! receptor!superfamily,! to! which! GABAA,! glycine! and! 5XHT3! receptors! also! belong! (Dani! and!Bertrand,!2007;!Albuquerque!et!al.,!2009).!In!some!subunits,!part!of!the!extracellular!NXterminal!region!also!forms!half!of!an!ACh!binding!site!with!another!subunit.!Upon!pentameric!arrangement,!as!shown!in!Figure!1.1.1b,!the!membrane!spanning!regions!of!nAChR!subunits!form!a!central!pore,!which!is!lined!by!the!hydrophobic!residues!of!the! M2! segments! in! the! closed! conformation,! whilst! the! M4! segments! bare! the!outward!facing,!membraneXlipid!interface.!
1.1.2 The)ACh)binding)site)The!primary!endogenous! ligand!of! the!nAChR,! the!neurotransmitter!ACh!binds! to!a!region!on!the!extracellular!domain!referred!to!as!the!orthosteric!or!canonical!binding!site,!as!do!many!other!nonXendogenous!agonists!such!as!nicotine.!As!shown!in!Figure!1.1.1b,!other!sites!also!exist!on!nAChRs,!which!accommodate!a!wealth!of!alternative!ligands! that! affect! nAChR! function! in! various! ways! expanding! their! complexity!further!still!(see!section!1.1.5).!
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Much!of!our!knowledge!of!the!orthosteric!nAChR!binding!site!with!which!ACh!interacts! comes! from! xXray! crystallographic! structures! of! the! ACh! binding! protein!(AChBP)!expressed!by!the!aquatic!mollusks!Lymnaea'stagnalis!(Brejc!et!al.,!2001)!and!
Bulinus' truncatus! (Celie! et! al.,! 2005),! and! the! marine! mollusk! Aplysia' californica!(Hansen!et! al.,! 2005).!These!proteins! share!~20!%!sequence!homology!with! the!NXterminal!domain!of!nAChRs,! and!more! importantly! an! identical!ACh!binding! site! to!muscle! type! nAChRs,! represented! in! Figure! 1.1.2.! Select! combinations! of! nAChR!subunit! interfaces! form!ACh!binding! sites.! Subunits!α1,!α2,!α3,!α4!and!α6! form! the!principle! (+)! face,! with! polypeptide! loops! AXC,! which! generally! determine! ligand!selectivity,!whereas!subunits!δ,!ε,!γ,!β2!and!β4!can!form!the!complementary!(X)!face!with!polypeptide!loops!DXF,!and!generally!determine!ligand!affinity!(Albuquerque!et!al.,!2009).!A!minimum!of!two!binding!sites!is!required!for!full!receptor!function.!α7,!α8! (in! avian! species;! not! found! in!mammals),! α9! and! α10! subunits! are! capable! of!forming!ACh!binding!sites!with!both!(+)!and!(X)! faces,!and!can! therefore!arrange! to!
form!homomeric! nAChRs,!which! contain! five! binding! sites.! The! remaining! subunits!α5,!β1!and!β3!do!not!form!ACh!binding!sites,!but!instead!are!classified!as!accesssory!subunits! (Kuryatov! et! al.,! 2008);! they! are! not! classically! thought! to! contribute! to!
!




ligand!binding!but! still! affect! receptor! function,!and!as!described! in! section!1.1.5,! it!could!be!possible!that!these!subunits!harbour!alternative!ligand!binding!sites.!αXsubunits!are!defined!by!a!pair!of!adjacent!cysteine!residues!(CysX192,!CysX193;! Torpedo! numbering)! on! polypeptide! loop! C! of! the! NXterminal! extracellular!domain,! this! loop! also! contains! two! tyrosine! resides! (TyrX190,! TyrX198,! Torpedo'numbering),!which! along!with! a! tryptophanXtyrosine!pair! on!both! loops!A! (TrpX86,!TyrX93,! Torpedo! numbering)! and! B! (TrpX149,! TyrX151,! Torpedo! numbering)! are!responsible!for!binding!ligands!via!πXcation!interactions!(Celie!et!al.,!2004;!Changeux!and! Taly,! 2008).! When! an! agonist! ligand! binds,! loop! C! extends! round! the! ligandXbinding! pocket,! moving! 7.3! Å! towards! loop! F! of! the! adjacent! (X)! subunit! face! and!trapping! the! ligand! inside! (Figure! 1.1.3),! resulting! in! conformational! changes! that!open! the! receptor! ion! channel.! The! extent! of! this! conformational!movement! varies!depending!on!the!efficacy!of!the!agonist;!partial!agonists!with!weaker!efficacy!would!
cause! a! more! modest! rotation.! Competitive! antagonist! binding! on! the! contrary!extends! loop! C! in! the! other! direction! by! 4.3! Å,! preventing! receptor! ion! channel!opening!(Figure!1.1.3;!Hansen!et!al.,!2005).!
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!altered! desensitization! kinetics! (Gerzanich! et! al.,! 1998;! Kuryatov! et! al.,! 2008;!Wageman!et!al.,!2013;!see!1.1.4.3),!increased!sensitivity!to!ACh!and!nicotine!(Wang!et!al.,! 1996),! and! resistance! to! nicotine! induced!upregulation! (Wageman! et! al.,! 2013).!Recently! the! possibility! of! an! α4/α5! interface! binding! site! was! negated! in! a! siteXdirected!mutagenesis!study!(Marotta!et!al.,!2013),!but! interestingly! Jin!et!al.! (2013)!reported! that!α5! could! take! the!place!of! a! binding! site! forming!β2! subunit!with!no!effect! on! receptor! function.! Together,! the! assortment! of! nAChR! subunits! creates! a!range!of!unique!pentameric!blends!whose!characteristics!differ!on!many!levels!from!conformational!kinetics!and!ion!permeability!to!ligand!sensitivity.!
1.1.4 Gating)
1.1.4.1 From)ligand)binding)to)pore)opening)–)Allosteric)transitions)nAChRs! are! allosteric! proteins! that! exist! in! an! equilibrium! between! three! main!conformational! states! that!are!described!by! the!MonodXWymanXChangeux!model!as!
resting,!active!and!desensitized!(Figure!1.1.5;!Monod,!Wyman,!&!Changeux,!1965).!As!such,!nAChRs!exhibit!constitutive!activity!even!in!the!absence!of!agonists,!but!binding!
!
Figure'1.1.5:'Distinct'conformational'states'of'nAChRs'in'equilibrium'!nAChRs! exist! in! equilibrium!between! resting! (closed! channel),! active! (open! channel)! and!desensitized!(closed!channel)!conformational!states.!Transitions!between!these!states!are!influenced!by!the!binding!of!ligands.!The!desensitized!state!can!be!further!divided!into!fast!and!slow!onset.!
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of! agonists! lowers! the! energy!barrier! for! the! transition! from!resting! to!open! states!considerably,!as!it!does!also!for!transition!to!the!desensitized!state,!in!which!ligands!are!tightly!bound,!but!the!channel!remains!closed!(see!1.1.4.3).!The!desensitized!state!can!be! further! subdivided!between! fastX! and! slowXonset.!Antagonist! binding!on! the!other! hand! favours! the! resting! state,! raising! the! energy! barrier! for! activation! even!higher.! The! nAChR! therefore! can! be! viewed! as! a! dynamic! process! for! which! the!probability!of!transition!between!distinct!conformational!states!is!strongly!influenced!by!the!binding!of!various!ligands.!




1.1.4.3 nAChR)desensitization)A! prominent! feature! of! nAChR! behaviour! is! the! intrinsic! tendency! to! succumb! to!desensitization! in! the!presence! of! continued! agonist! stimulation! (Quick! and!Lester,!2002).! In! this! conformation!nAChRs!can!no! longer! induce!a!physiological! response,!although!it!should!be!noted!that!the!lack!of!a!physiological!response!in!a!certain!state!does!not!attribute!biological!redundancy,!which! is!easily! forgotten!when!it!presents!itself!as!an!experimental!nuisance.!Indeed,!it!has!been!proposed!that!the!desensitized!state! could! serve! as! a!mechanism! for! fine! tuning! a! response,! protecting! cells! from!overXexcitation! (from! Ca2+! especially,! see! 1.2.2),! providing! a! memory! of! recent!stimuli,! and!even!as! a!way!of! sequestering! ligands!or! “trapping”! (Quick!and!Lester,!2002;!Giniatullin!et!al.,!2005).!The!process!of!nAChR!desensitization,!although! intrinsic! to! the!receptor,!can!be!altered!by!many!factors!such!as!agonist!structure,!concentration!and!duration!of!exposure;! nAChR! subunit! composition! and! stoichiometry;! and! the! external!
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environment,! which! includes! experimental! expression! systems! (Giniatullin! et! al.,!2005).!For!example,!the!rate!at!which!α7!nAChRs!desensitize!in!the!presence!of!high!agonist! concentrations! is! notoriously! rapid,! on! the! scale! of! milliseconds;! whereas!α4β2*! and! α3β4*! nAChRs! desensitize! more! slowly,! within! seconds! (Fenster! et! al.,!1997).! Distinct! forms! of! desensitization! have! been! reported! to! exist,! classically!divided!between!fastX!and!slowXonset!(Figure!1.1.5),!although!more!recently!with!the!aid!of!highXresolution!electrophysiological!recordings!and!the!use!of!allosteric!ligands!and!receptor!mutations!that!modulate!desensitization,!extensions!have!been!made!to!the! original! categories! to! accommodate!more! exotic! states! (Williams! et! al.,! 2011c,!2012;!see!1.1.5.2).!FastXonset! desensitization! occurs! rapidly! in! the! presence! of! higher! agonist!concentrations! (μMXmM),! whereas! slowXonset! desensitization! as! its! name! suggests!occurs!more! gradually! on! the! scale! of! seconds! to!minutes! and! in! response! to! low!concentrations! of! agonists! (nM),! because! of! this! it! is! also! termed! “highXaffinity!desensitization”! (Giniatullin! et! al.,! 2005).! The! molecular! determinants! of! nAChR!desensitization! have! been! alluded! to! by! site! directed!mutagenesis! studies,! and! are!proposed! to! exist! in! the! M2! domain! and! the! extracellular! NXterminal! domain.! For!example,!mutation!of!S284L!in!the!α4!nAChR!subunit!M2!region!increases!the!speed!of! fastXonset! desensitization! (Matsushima! et! al.,! 2002),! whereas! ValX287! has! been!reported! to! underlie! the! faster! desensitization! kinetics! conveyed! by! the! β2! nAChR!subunit!when!combined!with!α4!(De!Fusco!et!al.,!2000),!and!the!M2!region!residue!LysX247!is!crucial!to!the!characteristic!rapid!desensitization!of!α7!nAChRs!(Revah!et!al.,! 1991).! The! inclusion! of! some! nAChRs! subunits! into! the! accessory! position! of!heteromeric!pentamers!has!been!shown!to!yield!consistent!effects!on!desensitization!such! as! the! desensitizationXenhancing! effect! of! an! α5! subunit! on! α3β2! and! α3β4!(Wang!et!al.,!1996;!Gerzanich!et!al.,!1998;!GrootXKormelink!et!al.,!2001),!although!a!recent! study! reported! α5! to! confer! HSXα42β23! nAChRs! greater! resistance! to!desensitization!(Wageman!et!al.,!2013).!The!inclusion!of!β2!subunits!has!been!shown!to! have! complimetary! effects! at! different! nAChR! subtypes,! increasing! the! rate! of!desensitization!of!α4β2!nAChRs!(Nelson!et!al.,!2003),!but!slowing!that!of!α7!nAChRs!expressed!in!X.'laevis!oocytes!(Khiroug!et!al.,!2002).!The! diversity! of! nAChR! subtypes! as! governed! by! their! subunit! composition!conveys! distinct! ion! permeability! and! desensitization! characteristics! due! to!
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differences! in! amino! acid! sequence! in! various! regions.! These! properties! directly!influence! the! downstream! cellular! and! physiological! effects! of! nAChR! activation,!which! will! be! the! concern! of! section! 1.2,! before! that! however! there! remains! an!additional!layer!of!modulatory!possibilities!to!be!described!that!continues!the!theme!of!allosteric!transitions!in!nAChRs.!
1.1.5 Allosteric)modulation)of)nAChRs)Additional!sites!at!which!ligand!binding!also!affects!the!conformational!equilibria!of!nAChRs,! known! as! allosteric! or! nonXcompetitive! binding! sites! exist! at! diverse!locations! such! as! the! NXterminal! extracellular! region,! the! nonXcanonical! subunit!interface!binding!sites,!sites!within!the!TM!domains!and!regions!at!the!proteinXlipid!interface!(Bertrand!and!Gopalakrishnan,!2007;!Arias,!2010;!Thomsen!and!Mikkelsen,!2012a).!Ligands!acting!in!this!way!are!categorized!according!to!their!overall!effect!on!nAChR! function,! although! it! should! be! noted! that! for! many! compounds! acting!allosterically! at! nAChRs,! these! effects! are! dependent! on! multiple! factors! such! as!concentration! of! the! ligand,! duration! of! exposure! to! ligand! and! nAChR! subunit!composition!and!stoichiometry.!Compounds!that!positively!affect!nAChR!function!are!termed! nonXcompetitive! agonists! or! positive! allosteric! modulators! (PAMs! –!previously!known!as!allosteric!potentiating!ligands;!APLs),!again!by!the!way!in!which!their!effects!are!achieved.!NonXcompetitive!agonists!promote!activation!via!allosteric!binding!sites,!whereas!PAMs!are!defined!by!their!lack!of!intrinsic!agonist!activity,!but!their! ability! to! enhance! agonist! induced! receptor! activation.! PAMs! can! be! further!subdivided!by!the!way!in!which!they!bring!about!enhanced!receptor!function:!those!that!increase!the!peak!current!of!a!response!(type!I!PAMs)!and!those!that!affect!the!time! course! of! a! response! (type! II! PAMs;! Figure! 1.1.7;! Grønlien! et! al.,! 2007).! Both!types! increase! the! potencies! of! agonists! and! increase! their! maximal! efficacies.!Conversely,! compounds! that! negatively! affect! nAChR! function! include! nonXcompetitive! antagonists! and! negative! allosteric! modulators! (NAMs),! also!differentiated! by! the! manner! in! which! their! effects! are! realized:! nonXcompetitive!antagonists! act! by! interacting! with! intraluminal! sites,! blocking! the! ion! channel,! a!phenomenon! that! also! becomes! prevalent! at! high! concentrations! of! nonXspecific!compounds.! NAMs! are! generally! considered! to! stabilize! inactive/nonXconducting!receptor!conformations!(Arias,!2010).!!
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1.1.5.1 Positive)allosteric)modulators)of)nAChRs)–)Type)I)NonXselective! nAChR! ligands! that! have! been! reported! to! enhance! the! peak! current!response! induced! by! agonist! stimulation! include! the! acetylcholinesterase! (AChE)!inhibitors! physostigmine! and! galantamine,! and! the! morphine! derivative! codeine,!(Storch! et! al.,! 1995;! Samochocki! et! al.,! 2003),! the! neurotransmitter! 5Xhydroxytryptamine! (5XHT)! (Schrattenholz! et! al.,! 1996),! the! plant! tropane! alkaloids!atropine!and!scopolamine!(Zwart!and!Vijverberg,!1997;!Smulders!et!al.,!2005),!the!CXterminus!of!AChE!(Greenfield!et!al.,!2004),!the!2XaminoX5Xketo!thiazole!analogue!LYX2087101!(Broad!et!al.,!2006)!and!the!GABAA!receptor!PAM!CCMI!(Ng!et!al.,!2007).!α7!nAChR!selective!type!I!PAMs!include!the!tryptophan!metabolite!5Xhydroxyindole!(5XHI),!(Zwart!et!al.,!2002;!ArnaizXCot!et!al.,!2008;!LópezXHernández!et!al.,!2009;!PérezXAlvarez! et! al.,! 2012),! albumin! derivatives! (Conroy! et! al.,! 2003),! the! naturally!occurring! isoflavone! and! tyrosine! kinase! inhibitor! genistein! (Bertrand! et! al.,! 2008;!Grønlien! et! al.,! 2010),! the! synthetic! anthelmintic! drugs! ivermectin! (Krause! et! al.,!
!
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1998;!Collins!et!al.,!2011),!morantel!(Seo!et!al.,!2009;!Cesa!et!al.,!2012;!Chrisman!et!al.,!2013),! pyrantel! and! oxantel! (Cesa! et! al.,! 2012),! the! 5XHT2B/C! receptor! antagonist!SBX206553!(Dunlop!et!al.,!2009),!and!the!urea!derivative!NSX1738!(Timmermann!et!al.,! 2007;! Bertrand! et! al.,! 2008).! The! natural! bryzoan! product!desformulflustrabromine! (Kim! et! al.,! 2007;! Liu,! 2013),! the! endogenous! estrogenic!steroid! 17XβXestradiol! (Paradiso! et! al.,! 2001),! Zn2+! (Hsiao! et! al.,! 2001,! 2006,! 2008;!Moroni! et! al.,! 2008),! and! the! synthetic! compounds! NSX9283! (Timmermann! et! al.,!2012;!Olsen!et!al.,!2013)!and!NSX206!(Olsen!et!al.,!2013)!are!examples!of!type!I!PAMs!that! show! selectivity! for! α4β2*! nAChRs.! The! endogenous! metabolite! choline,!produced! by! the! hydrolysis! of! ACh! by! AChE,! which! was! reported! to! act! as! a! full!agonist! at! α7! nAChRs! and!weak! partial! agonist! at! α3β4*! nAChRs! (Alkondon! et! al.,!1997b;!Alkondon!and!Albuquerque,!2006),!was!also!found!to!potentiate!AChXinduced!responses!at!α4β4!nAChRs!in!X.!laevis!oocytes!at!concentrations!under!10!mM!(Zwart!and!Vijverberg,!2000),!at!higher!concentrations!however,!choline!was!found!to!inhibit!ACh!responses!at!α4β2*!nAChRs,!suggesting!a!complex,!subXtype!specific!regulatory!role! for! choline! at! nAChRs! (Alkondon! and! Albuquerque,! 2006).! Members! of! the!Ly6/urokinase! receptor! like! gene! family! (Ly6/uPAR)! have! also! been! reported! to!exhibit!type!I!PAM!activity!(and!NAM!activity;!see!section!1.1.5.3)!at!nAChRs,!namely!the! secreted! Ly6/uPAR! related! proteinX1! (SLURPX1)(Chimienti! et! al.,! 2003),! and!LypdX6!(Darvas!et!al.,!2009).!The! first! compounds! to! be! observed! as! nAChR! PAMs! were! the! naturally!occurring! acetylcholinesterase! (AChE)! inhibitors! physostigmine! and! galantamine,!isolated! from! the! calabar! bean! and! the! common! snowdrop! respectively.! Both! are!currently! prescribed! as! symptomatic! therapeutics! for! patients! suffering! from!Alzheimer’s!disease,!where!it!is!now!proposed!that!in!addition!to!AChE!inhibition!and!subsequent! elevation! of! ACh! availability! at! cholinergic! synapses,! direct! interaction!with! nAChRs! also! play! a! role! (Maelicke! et! al.,! 2000).! Physostigmine!was! originally!reported! to! act! as! an! open! channel! blocker,! and! at! lower! concentrations,! a! weak!agonist! at! muscle! nAChRs! –! independent! from! AChE! inhibition.! Sensitivity! to!blockade!by!competitive!nAChR!antagonists!was!at!first!conflicting!(Shaw!et!al.,!1985;!Pereira!et!al.,!1993),!but!later!studies!provided!more!evidence!that!physostigmine,!as!well!as!galantamine!and!the!morphine!derivative!codeine,!were!acting!independently!of! the!ACh!binding!site! (Okonjo!et!al.,!1991;!Storch!et!al.,!1995;!Akk!and!Steinbach,!
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2005).!Channel! activation!by!physostigmine!and!galantamine!were! inhibited!by! the!monoclonal! antibody! FK1! and! benzoquinonium,! implying! action! at! a! binding! site!close!to!but!distinct!from!that!of!ACh!(Okonjo!et!al.,!1991;!Pereira!et!al.,!1993,!1994).!Photoaffinity! labelling! of! [3H]physostigmine! at! Torpedo! nAChR,! subsequent!proteolytic!cleavage!and!sequencing!indicated!a!binding!site!within!the!α!subunit,!in!which!the!residue!LysX125!was!strongly!labelled!and!therefore!implicated!in!binding!(Schrattenholz! et! al.,! 1993).! Although! singleXchannel! activation! events! have! been!observed! in!response! to! these!compounds!alone,! they!did!not!amount! to!wholeXcell!currents!as!observed!in!response!to!ACh.!It!was!therefore!suggested!that!they!may!act!primarily!by!sensitizing!nAChRs! to! submaximal!orthosteric!activation! (Storch!et!al.,!1995),! a! concept! that! was! later! confirmed! (Samochocki! et! al.,! 2003).! More! recent!studies! using! a! mutational! approach! and! photoaffinity! labelling! with! protein!sequencing! methods! have! provided! evidence! for! multiple! binding! sites! for!galantamine!and!physostigmine!at!the!canonical!and!nonXcanonical!subunit!interfaces,!and!an!intraluminal!site,!perhaps!with!different!consequences!for!nAChR!activity!for!each!(Hansen!and!Taylor,!2007;!Hamouda!et!al.,!2013).!! Discovery! of! a! site! that! binds! exogenous! compounds! distinct! from! the! ACh!binding! site! raised! the! possibility! of! an! endogenous! ligand! existing! for! this! site.!Indeed,! evidence! has! been! provided! for! competitive! actions! of! the! astrocytic!metabolite!kynurenic!acid!(KYNA;!see!section!1.1.5.3)!with!galantamine!at!α7!nAChRs!(Lopes!et!al.,!2007),!and!interestingly,!the!neurotransmitter!5Xhydroxytryptamine!(5XHT)!has!been!reported!act!in!a!similar!way!to!galantamine,!with!potentiating!effects!that!are!also!sensitive!to!the!FK1!antibody,!suggesting!actions!at!the!same!binding!site.!As!with!galantamine,!higher,!micromolar!concentrations! inhibited!responses! to!ACh!rather!than!potentiating!them!(Schrattenholz!et!al.,!1996).!These!findings!may!imply!crossXneurotransmitter! effects! as! a! further! modulatory! phenomenon! in! neural!networks.!! By! creating! a! range! of! α7/5HT3! receptor! chimeras,! Bertrand! et! al.! (2008)!revealed!a!novel!allosteric!site! in!the!extracellular!M2XM3!loop!of!α7!nAChRs!which!was!crucial!for!the!potentiating!actions!of!the!synthetic!type!I!PAM!NSX1738.!Using!a!similar! approach,! Grønlien! et! al.! (2010)! reported! that! the! same! M2XM3! region! is!important! for! the!actions!of! the!naturally!occurring! isoflavone!genistein,!which!also!acts! as! a! type! I! α7! nAChR! PAM.! Substitution! of! this! region!with! a! 5XHT3A! receptor!
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sequence! however! did! not! affect! potentiation! elicited! by! 5XHI,! indicating! a! distinct!binding!site!for!genistein!and!NSX1738.!! Interestingly,! the! α4(+)/(X)α4! subunit! interface! at! the! LSXα43β22! (see! 1.1.3)!nAChR!has! recently! been! characterized! as! a! third,! lowXsensitivity!ACh! binding! site,!whose! occupancy! is! required! for! full! activity,! corresponding! to! the! low! sensitivity!component!of! the!biphasic! response! to!ACh!seen!with! this! receptor! (Harpsøe!et!al.,!2011;!Mazzaferro!et!al.,!2011).!Most!α4β2!nAChR!PAMs!so!far!reported!are!selective!only!for!the!LSXα43β22,!but!Olsen!et!al.!(2013)!have!recently!reported!that!the!novel!α4β2! selective! PAM! NSX206! binds! to! a! site! distinct! to! that! of! NSX9283.! NSX206!potentiated! ACh! evoked! responses! at! both! HSX! α42β23! and! LSXα43β22! nAChRs,!whereas! NSX9283! only! potentiated! the! LSXα43β22! stoichiometry.! When! applied!together,! additive! effects! were! seen,! indicating! distinct! binding! sites.! This! was!confirmed! by! using! chimeric! nAChRs! and! site! directed! mutagenesis! approaches,!revealing!that!NSX206!bound!to!a!transmembrane!site!on!the!α4!subunit,!whereas!NSX9283!exerted!its!actions!at!the!α4(+)/(X)α4!subunit!interface.!As! expected! for! most! proteins,! ionic! content! of! the! surrounding! solution! is!important! for! function,! but! more! specific! interactions! of! certain! ions! have! been!shown!to!affect!nAChR!function!such!as!Ca2+!and!Zn2+.!Ca2+!has!been!shown!to!interact!with!GluX172!in!the!(X)!face!of!the!ACh!binding!site!producing!allosteric!potentiation!of!peak!responses!and! increased!agonist!affinity!at!α7!nAChRs! (Mulle!et!al.,!1992b;!Galzi! et! al.,! 1996).! Also,! Zn2+! ions! have! been! reported! to! confer! complementary!allosteric! actions! at! different! nAChR! subtypes.! At! concentrations! of! 1X100!μM,! Zn2+!potentiated!ACh!current! responses!at! rat!α2β2,!α2β4,!α3β4,!α4β2!and!α4β4!nAChR!heteromers! expressed! in! X.' Laevis! oocytes,! whereas! it! inhibited! ACh! responses! at!α3β2!nAChRs!(Hsiao!et!al.,!2001).!As!with!most!of!the!allosteric!modulators!discussed!so! far,! Zn2+! had! no! effect! on! the! rate! of! nAChR! desensitization,! but! in! contrast! to!modulation!by!physostigmine,!galantamine,!and!5XHI,!Zn2+!potentiation!was!seen! in!the! presence! of! saturating! concentrations! of! ACh! (Hsiao! et! al.,! 2001).! At! both! high!sensitivity!(HS)Xα42β23!and!low!sensitivity!(LS)Xα43β22!nAChRs!expressed!in!X.'laevis'oocytes,! the! two! nonXcanonical! α4(X)/(+)β2! subunit! interfaces! were! found! to!accommodate!Zn2+!ions!which!resulted!in!inhibition!of!ACh!induced!responses.!At!LSXα43β22! nAChRs! however,! Zn2+! also! resulted! in! a! potentiation! of! ACh! induced!responses! at! concentrations! of! up! to! 100! μM,! above! which! inhibition! was! caused.!
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Potentiation!in!this!case!was!found!to!require!the!α4(+)/(X)α4!interface!(Moroni!et!al.,!2008).! Zn2+! potentiation! was! blocked! by! dyethylpyrocarbonate! (DEPC),! which!carbethoxylates! imidazole! rings,! implicating! histidine! residues! in! its! coordination!with!nAChRs.!Site!directed!mutagenesis!confirmed!that!HisX195!of!the!α4(+)!face!and!GluX224! of! the! α4(X)! face!were! important! for! Zn2+! potentiation! (Hsiao! et! al.,! 2006;!Moroni!et!al.,!2008).!So! far! this!section!has! focused!on!PAMs!that! increase!peak!responses!but!do!not!affect!desensitization!rates,!widely!referred!to!as!type!I!PAMs.!A!large!proportion!of!the!compounds!discussed!so!far!have!also!been!selective!for!the!α7!nAChR!subtype,!which!is!the!most!well!studied!nAChR!subtype!with!respect!to!allosteric!modulation!(Bertrand!and!Gopalakrishnan,!2007;!Thomsen!and!Mikkelsen,!2012c).! It! is!also!the!prototypical!nAChR!subtype!for!the!study!of!type!II!PAMs;!compounds!that!affect!the!time!course!of!receptor!activation.!
1.1.5.2 Positive)allosteric)modulators)of)nAChRs)–)Type)II)Due!to! the!rapid!desensitization!of!α7!nAChRs! in! the!continued!presence!of!agonist!molecules,! measurement! of! their! responses! requires! highXresolution!electrophysiological! techniques! combined! with! rapid! solution! exchange! methods!(Papke!and!Porter!Papke,!2002;!Fedorov!et!al.,!2012).!Type! II!PAMs!have! therefore!become!extremely!useful!for!studying!α7!nAChRs,!as!they!massively!prolong!receptor!activation,!boosting!the!overall!signal.!The!urea!derivative!PNUX120596!(PNU1;!Hurst!et!al.,!2005),!used!extensively!in!this!thesis!to!reveal!α7!nAChR!responses!is!certainly!the!most! well! studied! compound! of! this! class,! others! include! TQS! (Grønlien! et! al.,!2007;!Gill!et!al.,!2011),!AX867744!(Faghih!et!al.,!2009),!AX549291!(Gopalakrishnan!et!al.,!2011),!JNJX1930942!(Dinklo!et!al.,!2011)!and!the!intriguing!allosteric!agonist!4BPXTQS!(Gill!et!al.,!2011;!Papke!et!al.,!2013).!! As! measured! by! twoXelectrode! voltageXclamp! electrophysiology! in! X.' laevis!oocytes!expressing!α7!nAChRs,!the!character!of!AChXinduced!currents!in!the!presence!of! PNU1! and! TQS! are! radically! different! from! responses! to! ACh! alone,! or! in! the!presence!of! the!peak! current! enhancing! type! I!PAMs! such!as!5XHI,! genistein!or!NSX1738! (figure! 1.1.7;! Grønlien! et! al.,! 2007).! The! typical! rapidly! decaying! currents!evoked! by! ACh! at! α7! nAChRs! are! greatly! prolonged.! Further! scrutiny! of! these!responses! indicates! a! distinct! secondary! component,! more! evident! at! lower! PAM!
Chapter!1:!Introduction!
! 19!
concentrations,!as!a!weakly!decaying,!slower!onset!and!higher!peak!current!response!(Figure! 1.1.7).! It! has! been! hypothesized! that! type! II! PAMs! destabilize! the! agonist!induced! desensitized! state! of! α7! nAChRs,! driving! the! receptor! back! to! the! open!conformation.! As! the! response! decays! however,! the! receptor! appears! to! exhibit! a!distinct! form!of!desensitization!that! is! insensitive!to!further!activation!by!agonist! in!the!presence!of!PAM,!and!also!depends!on!the!concentration!of!agonist!(Williams!et!al.,!2011b).!! A!parallel!between!the!effects!of!agonist!stimulation!observed!in!the!presence!of! type! II! PAMs! at! wild! type! α7! nAChRs! can! be! drawn! with! the! behaviour! of! the!L247T! (the! ion! channel! gate;! see! Figure! 1.1.6)! mutant! α7! in! response! to! agonist!stimulation! (Revah! et! al.,! 1991).! The!mutation! affects! the!pore! region,! and! renders!what! would! usually! be! a! desensitized! nonXconducting! state! a! conducting! one.! In!support!of!this,!compounds!that!usually!stabilize!the!desensitized!state!such!as!DHβE,!hexamethonium!and!tubocurarine!were!found!to!elicit!large!responses,!whereas!αbgt!blocked! them,! indicating! that! it! instead! stabilizes! the! resting! state! (Bertrand! et! al.,!1992).!Computer!docking!studies!conducted!by!Young!et!al.!(2008)!proposed!PNU1!to!bind!within!a!cavity!inside!the!transmembrane!domains!of!α7!nAChRs,!surrounded!by!the!residues!SerX222!and!AlaX225!from!the!M1!domain,!MetX253!from!the!M2!domain,!and!PheX455!and!CysX459!from!the!M4!domain!(Figure!1.1.8).!Interestingly,!the!same!study!also!reported!this!to!be!the!site!of!action!of!LYX2087101,!which!in!contrast!to!PNU1!does!not!affect!the!time!course!of!agonist! induced!responses,!highlighting!the!importance! of! a! reciprocal! relationship! between! ligands! and! binding! sites! for! the!overall!effect!of!receptor!function.!It!was!also!recently!published!that!potentiation!by!PNU1! is! highly! cooperative! and! requires! at! least! 4! binding! sites! to! be! occupied! to!confer! potentiation,! and! even! here,! potentiation! is! roughly! half! that! of! a! fully!saturated!pentamer!(Dacosta!and!Sine,!2013).!
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Perhaps!the!most!striking!effects!of!a!compound!acting!at!an!allosteric!site!so!far! reported! are! those! of! the! TQS!derivative! 4BPXTQS,! again! thought! to! act!within! the! TMDs.! Like! PNU1! and! TQS,!4BPXTQS! greatly! enhances! agonistXinduced! responses! and! reduces!desensitization,!but!also!has!highly!potent!and! efficacious! intrinsic! agonist! activity!and! does! not! compete! for! binding! at! the!orthosteric! site.! The! selective! α7! nAChR!competitive!antagonist!methyllycaconitine!(MLA)! blocked! 4BPXTQS! in! a! nonXcompetitive! manner,! and! the! mutation!M253L! in! the! proposed! type! II! PAM!binding! site! in! the! TMDs! (Young! et! al.,!2008)!abolished!4BPXTQS!agonist!activity,!whereas! mutating! the! orthosteric! ACh!binding!site!W148F!had!no!effect!on!4BPXTQS! activity! but! denied! ACh! activity! (Gill!et!al.,!2011).!In!a!more!recent!study,!Papke!et!al.,!(2013)!proposed!a!separate!binding!site! for! the! agonist! actions! of! 4BPXTQS!distinct!from!the!orthosteric!site!and!the!TMD!site!on!the!basis!that!its!agonist!activity!is! rapidly! reversible! upon!washout,! as! opposed! to! its! potentiating! activity,! and! the!activation!is!MLA!sensitive.!The!residue!TrpX55!was!found!to!be!essential!for!coupling!the!orthosteric!site!to!the!transmembrane!site,!as!mutating!this!residue!removed!the!necessity! for! simultaneous! orthosteric! agonist! binding! with! PAM! binding! to! elicit!maximum!responses!from!4BPXTQS,!and!conveying!intrinsic!agonist!activity!to!PNU1!and!TQS,!it!also!rendered!4BPXTQS!induced!activation!insensitive!to!blockade!by!MLA.!
!
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1.1.5.3 Negative)allosteric)modulators)of)nAChRs)A!variety!of!compounds!have!been!reported!to!negatively!affect!nAChR!function,!by!either! channel! blocking! or! stabilizing! the! nonXconducting! resting! or! desensitized!conformational!states.!Compounds!that!act!as!nonXspecific!NAMs!at!nAChRs! include!channel!blockers!like!MK801,!amantadine,!memantine!(Buisson!and!Bertrand,!1998)!and!mecamylamine! (Varanda! et! al.,! 1985);! steroid! hormones! such! as! progesterone!(Valera!et!al.,!1992);!fatty!acids!(Dalziel!et!al.,!1980;!FernándezXCarvajal!et!al.,!2006;!ColónXSáez!and!Yakel,!2011);!members!of!the!LyX6/uPAR!gene!family!lynxX1!(Miwa!et!al.,!1999;! IbañezXTallon!et!al.,!2002),! lynxX2! (Tekinay!et!al.,!2009),! and! the!prostate!stem! cell! antigen! (PSCA;!Hruska! et! al.,! 2009);! the! synthetic! compounds!UCI! 30002!(Yoshimura!et!al.,!2007)!and!COBX3!(GonzálezXCestari!et!al.,!2009);!the!west!African!psychedelic! plant! drug! ibogaine! (Arias! et! al.,! 2010);! the! dissociative! drug! of! abuse!phencyclidine!(PCP;!Arias!et!al.,!2010);!the!antidepressant!bupropion!(Alkondon!and!Albuquerque,!2005;!Radhakrishnan!et!al.,!2013);!the!flavouring!and!cigarette!additive!menthol!(Hans!et!al.,!2012;!Ashoor!et!al.,!2013;!Kabbani,!2013);!and!various!general!anaesthetics!(Bondarenko!et!al.,!2013;!Mowrey!et!al.,!2013).!Negative!regulators!of!α7!nAChRs!have!been!reported!to! include!the!endogenous!metabolite!KYNA!(Hilmas!et!al.,! 2001;! Albuquerque! and! Schwarcz,! 2013),! the! cannabinoid! receptor! agonist!anandamide! (Oz! et! al.,! 2003),! the! Alzheimer’s! Disease! associated! amyloidXβ! (Aβ)!protein!(Parri!et!al.,!2011),!and!the!synthetic!compound!HDMP!(Abdrakhmanova!et!al.,! 2010).! For! α4β2! nAChRs,! Zn2+! (Moroni! et! al.,! 2008)! and! the! synthetic! COBX3!analogue!KABX18!(Henderson!et!al.,!2010)!have!been!described!to!exhibit!NAM!effects.!! Aside! from! channel! blocking! sites,! NAMs! have! been! proposed! to! bind! to!diverse! sites! on! nAChRs.! KYNA! is! thought! to! exert! its! actions! at! the! FK1! antibody!binding! site! originally! proposed! for! physostigmine,! galantamine! and! codeine! (see!1.1.5.1)!on!the!ECD!of!αXsubunits!a!short!distance! from!the!orthosteric!binding!site.!NAMs!acting!at!subunit! interfaces! include!Zn2+!and!KABX18.!Zn2+! is!thought!to!exert!inhibitory! effects! via! a! site! at! the! nonXcanonical! α4(X)/(+)β2! subunit! interface!involving!HisX195!on! the!α4! subunit! and!AspX218!on! the!β4! subunit! (Moroni! et! al.,!2008;!see!1.1.5.4),!whilst!KABX18!was!hypothesized!to!bind!10!Å!from!the!canonical!α4(+)/(X)β2!binding!site!with!residues!PheX118,!GluX60!and!ThrX58!on!the!β2!subunit,!resulting!in!a!proposed!obstruction!of!CXloop!closure!around!the!orthosteric!agonist!binding! site! (Pavlovicz! et! al.,! 2011;! Henderson! et! al.,! 2012).! Elsewhere,! a!
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transmembrane!binding!site!was!recently!proposed!to!mediate!the!inhibitory!actions!of! menthol! at! α7! nAChRs,! involving! residues! ThrX292! and! LeuX250! based! on!computer!modelling!of!muscle!type!nAChRs!(Ashoor!et!al.,!2013).!! The! LyX6/uPAR! gene! family! products,! lynxX1! and! X2,! and! the! analogous!prostate!stem!cell!antigen!(PSCA)!are!structurally!homologous!to!αbgt!and!lynxX1!has!been!shown!to!compete!with![125I]αbgt!for!binding!at!α7!nAChRs!(Lyukmanova!et!al.,!2011).! It! is!anchored!to!the!membrane!via!a!glycophosphatidylinositol!(GPI)!anchor!(Miwa!et!al.,!1999),!and!was!found!to!enhance!α7!nAChR!mediated!responses!to!ACh!at!1!μM,!but!inhibit!α7,!α4β2*!and!α3β2*!nAChRs!at!10!μM!(Lyukmanova!et!al.,!2011).!LynxX2!was! found! to! decrease! ACh! potency! at! α4β2! nAChRs! expressed! in!X.' laevis!oocytes! (Tekinay! et! al.,! 2009),! and! PSCA! was! reported! to! antagonize! α7! nAChR!mediated! responses! (Hruska! et! al.,! 2009).! Together! the! LyX6/uPAR! gene! family!products!(also!see!1.1.5.1)!represent!a!class!of!endogenous!allosteric!modulators!that!regulate!nAChR!function.!! Perhaps! less! conventionally,! the! natural! environment! surrounding! nAChRs!can!be!described!as!having!properties!that!allosterically!affect!receptor!function,!such!as! the! composition! of! phospholipids! and! cholesterol! content! in! the! cell!membrane,!and! the! ionic! content! of! the! aqueous! phases! that! encapsulate! the! intracellular! and!extracellular! domains! (ICD;! ECD;! described! above;! 1.1.5.1).! As! well! as! providing! a!selective! barrier! to! cells,! the! phospholipid! bilayer! constituting! the! cell! membrane!provides! a! fluid! environment! that! permits! a! degree! of! motility! to! allow!conformational! changes! of! transmembrane! proteins! to! occur.! Cell! membranes! are!heterogeneous! entities! composed! of! a! range! of! different! phospholipids! whose!physical! properties! contribute! to! the! overall! fluid! character! of! the! membrane! and!affect! transmembrane! proteins! more! directly! at! the! proteinXlipid! interface.! This!occurs!via!electrostatic!interactions!or!hydrogen!bonds!between!positive!charges!on!the!protein! and!phosphate! carbonyl! of! the!hydrophilic! layer! of! the!membrane,! and!also!by!van!der!Waals!interactions!between!hydrophobic!residues!on!the!protein!and!fattyXacid!chains!of!the!membrane!(Poveda!et!al.,!2013).!Cholesterol!presents!another!important! constituent! of! cell! membranes,! and! was! found! in! early! studies! to! be!required! for!proper! functioning!of!purified!nAChRs!(Dalziel!et!al.,!1980).! It!has!also!been! demonstrated! to! contribute! to! the! speed! of! α7! nAChRs! desensitization! and!agonist! affinity! (ColónXSáez! and! Yakel,! 2011).! Here,! when! cholesterol! and!
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sphingomyelin!were!depleted!by!sequestering!agents!and!enzymatic!breakdown,!α7!nAChRs!desensitized!more!slowly,!an!effect! that!was!reversed!upon!replacement!of!cholesterol!and!sphingomylin,!implicating!these!molecules!as!α7!nAChR!NAMs.!! Together,!the!various!compounds!described!above!and!their!diverse!actions!at!nAChRs!form!fragments!of!a!bewilderingly!complex!puzzle!that!can!only!be!expected!to! deepen! as! high! throughput! drug! discovery! programs! are! utilized! and! greater!resolution!structural!details!of!receptors!are!elucidated.!Observations!of!this!wealth!of!modulatory!phenomena!have!shifted!our!understanding!of!nAChRs!from!the!simple!ligandXbinding,!open/closed!binary!view!of!LGICs!to!that!of!a!dynamic!equilibrium!of!interconvertible! conformational! states! permitted! by! the! threeXdimensional! protein!structure!and!its!surrounding!environment.!Having!focused!on!the!nAChR!structure!and!their!behaviour!and!modulation!by!endogenous!and!exogenous!factors,!it!is!now!appropriate!to!discuss!their!implications!in! a! physiological! setting.! The! scope! of! the! next! section! will! expand! beyond! the!horizon!of! the!nAChR! receptor!protein! and! into! the!processes! it! influences! in! cells,!and!how!they!are!integrated!into!biological!systems!such!as!neural!networks.!A!major!determinant! of! these! effects! is! the! high! relative! permeability! of! nAChRs! to! Ca2+! a!ubiquitous!and! fundamental!biological! actor! integral! to! a! vast! and!diverse! range!of!biochemical! processes! from! reproduction! to! programmed! cell! death,! memory!formation!to!muscle!contraction.!The!mechanisms!of!nAChR!mediated!Ca2+!signalling!are!the!focus!of!this!thesis,!and!will!be!discussed!in!the!following!section.!
1.2 Physiological)roles)of)nAChRs)nAChRs! are! expressed! throughout! the! body! and! respond! primarily! to! ACh,! this!section!will!strive!to!communicate!the!diversity!of!events!mediated!by!nAChRs,!which!project! from! their! fundamental! properties! as! LGICs.! As! much! of! this! diversity! is!shaped!by! the! surrounding!environment,! it! is!of! great! relevance! to! first! summarize!the!distribution!of!nAChRs,!with!a!focus!on!the!mammalian!CNS.!
1.2.1 nAChR)distribution)nAChRs!are!expressed!in!a!wide!range!of!neuronal!and!nonXneuronal!cells,!and!within!distinct! subXcellular! locations.! Various! techniques! have! been! used! to! ascertain! this!including! mRNA! analysis,! electron! microscopy,! radioligand! binding,!
Chapter!1:!Introduction!
! 24!
immunoprecipitation,! functional! studies,! positron! emission! tomography! (PET)! and!singleXphoton! emission! computed! tomography! (SPECT).! Although! these! methods!each!has!its!limitations,!such!as!lack!of!specificity!or!spatial!resolution,!together!they!have!contributed!towards!a!substantial!understanding!of!the!macroX!and!microscopic!distribution!of!nAChRs!in!the!body!(Gotti!and!Clementi,!2004;!Gotti!et!al.,!2006;!Hurst!et!al.,!2013).!!
! In!peripheral,!nonXneuronal!regions,!nAChRs!are!expressed!in!cells!as!diverse!as!those!of!the!immune!system,!skin,!muscle,!kidneys,!bladder,!lungs,!cardiovascular!system,! and! audiovestibular! system! (Wessler! and! Kirkpatrick,! 2008;! D’hoedt! and!Bertrand,! 2009;! Hurst! et! al.,! 2013).! nAChRs! are! also! extensively! expressed! in! the!autonomic! nervous! system!where! their!main! function! is! to!mediate! fast! excitatory!synaptic!transmission.!Here,!subunits!α3,!α5,!α7,!β2!and!β4!combine!to!form!nAChRs!subtypes!comprised!of!α3β4(α5/β2)!and!α7!pentamers!(Rust!et!al.,!1994).!The!main!focus!of!experiments!within! this! thesis!however! is!on! the!role!of!nAChRs! in!cells!of!the! CNS,! where! nAChRs! are! expressed! on! neuronal! cells! at! preX,! postX! and! periX
!
Figure'1.2.1:'Distribution'of'nAChR'subtypes'in'the'rodent'brain.'α7!and!α4β2*!nAChR!subtypes!are! the!most!widely!expressed! in! the!rodent!brain! (Gotti!et!al.,!2006;!reproduced!by!Taly!et!al.,!2009).!
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The!experimental!systems!in!this!thesis!however,!comprise!SHXSY5Y!neuroblastoma!cells! and!mouse! primary! cortical! cultures! (see! section! 3.1).! Neurons! of! the! cortex!have!been!found!to!express!α7!and!α4β2(α5)!nAChRs,!with!α7!nAChRs!also!expressed!by!astrocytes!(Gotti!et!al.,!2006;!Mao!et!al.,!2008;!Pirttimaki!et!al.,!2013). 
1.2.2 nAChR)mediated)Ca2+)signalling)The!coupling!of!ligand!binding!to!ion!channel!opening!in!nAChRs!results!in!a!selective!alteration! of! the! physiological! ionic! gradient! usually! maintained! by! the! cell!membrane.! By! virtue! of! the! nAChR! ion! channel! selectivity! filter! (see! 1.1.4.2),!intracellular! effects! of! nAChR! activation! begin!with! the! influx! of!Na+! and!Ca2+! ions.!Ca2+!is!well!suited!to!its!role!in!biological!signalling,!as!a!divalent!cation!it!forms!more!stable! complexes! than! its! monovalent! counterparts,! and! due! to! the! geometry,!flexibility!and!dimensions!of!protein!structures,!Ca2+’s!larger!radius!provides!a!better!fit! than! that! of! Mg2+! within! the! various! binding! pockets! presented! by! proteins!(Bading,! 2013).! Binding! and! coordination! reactions! also! occur! ~1000! times! faster!with! Ca2+! than!with!Mg2+! (Williams,! 2006).! The! concentration! of! intracellular! Ca2+!([Ca2+]ic)! is! strictly! controlled;! several! reasons! can! be! ascribed! to! this:! (i)! the!environment! in!which!primitive!organisms!evolved!on!Earth! is! thought!to!have!had!relatively!similar![Ca2+]!to!resting!cytoplasmic![Ca2+]!(~100!nM)!of!today’s!organisms,!which!gradually!increased!with!the!geological!evolution!of!Earth!(Kazmierczak!et!al.,!2013);!(ii)!high![Ca2+]!results!in!the!disruption!of!key!biochemicals!such!as!phosphate!groups,!proteins,!nucleic!acids!and!lipid!membranes!(Kazmierczak!et!al.,!2013);!and!(iii)!the!heterogeneity!of!Ca2+!dependent!biological!processes!and!the!ubiquity!of!Ca2+!as! a! signalling! entity.! Spatial! and! temporal! control! of! biological! Ca2+! signals! is!achieved!by!specialized!cell!morphologies!that!convey!cellular!microdomains!such!as!neuronal! dendritic! spines! or! astrocytic! processes,! membraneXbound! organelles! to!provide!a!barrier!as!in!the!case!of!the!endoplasmic!reticulum!and!mitochondria,!and!various!calcium!binding!proteins!(CaBPs)!or!active!ion!pumps!that!strongly!buffer!the!intracellular! concentration! of! Ca2+! ([Ca2+]ic)! (Grienberger! and! Konnerth,! 2012;!Bading,!2013).!The!maintenance!of!a!steep!concentration!gradient!for!Ca2+!provides!a!driving! force! for! rapid! influx,! and! several! amplification!mechanisms! exist! to! boost!Ca2+! signals! above! the! threshold! needed! to! overcome! Ca2+! buffering! or! extrusion!mechanisms!(Berridge!et!al.,!2003).!
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! LGICs! such! as! nAChRs;! purinergic! P2X! receptors;! transient! receptor! type! C!(TRPC)! channels;! and! αXaminoX3XhydroxyX5XmethylX4Xisoxazolepropionic! acid!(AMPA),! kainate,! and! NXmethylXDXaspartate! (NMDA)! type! ionotropic! glutamate!receptors! (iGluRs;! see! 1.2.2.5)! comprise! the! starting! point! for! Ca2+! entry! into! cells!either! directly! or! by! a! two! step! process! requiring! Na+! influx! which! results! in!membrane!depolarization,!and!subsequent!activation!of!voltage!gated!Ca2+!channels!(VGCCs;!see!1.2.2.4)!(Berridge,!1998;!Berridge!et!al.,!2003;!Grienberger!and!Konnerth,!2012;!Bading,!2013).!Elevated![Ca2+]ic!from!either!of!these!sources!may!then!activate!Ca2+! induced! Ca2+! release! (CICR)! from! the! endoplasmic! reticulum! (ER)! or! Golgi!apparatus! via! stimulation! of! ryanodine! receptors! (RyRs)! or! inositol! 1,4,5Xtrisphosphate! receptors! (IP3Rs)! (Berridge,! 1998;! Berridge! et! al.,! 2003;! Grienberger!and!Konnerth,! 2012;! Bading,! 2013).! GXprotein! coupled! receptor! activation! can! also!lead! to! IP3R! mediated! Ca2+! release! from! the! ER! via! GqXmediated! activation! of!phospholipase! C! (PLC),! which! hydrolyses! phosphatidylinositol! 4,5Xbisphosphate!(PIP2),!releasing!IP3!(Berridge,!1998;!Berridge!et!al.,!2003;!Grienberger!and!Konnerth,!2012;! Bading,! 2013).! Various! Ca2+Xdependent! protein! signalling! cascades! proceed!from!any!of!these!points!depending!on!location!within!the!cell.!Intracellular!free!Ca2+!is! also! rapidly! sequestered! by! (i)! CaBPs! such! calbindin! DX28,! calretinin! and!parvalbumin!in!the!cytoplasm,!and!calnexin!calreticulin!and!calsequestrin!in!the!ER;!(ii)! active! pumps! such! as! the! plasma! membrane! Ca2+! ATPases! (PMCAs),!sarco(endo)plasmic! reticulum!Ca2+!ATPases! (SERCAs)! or! secretory!pathway! (Golgi)!pumps! (SPCAs);! or! (iii)! membrane! ion! exchanger! proteins! such! as! the! Na+/Ca2+!exchangers! (NCXs)! found! on! plasma,! ER! and!mitochondrial!membranes,! as!well! as!mitochondrial! H+/Ca2+! exchangers! and! the! mitochondrial! Ca2+! uniporter! and!permeability!transition!pores!(Berridge,!1998;!Berridge!et!al.,!2003;!Bading,!2013).!The! aim! of! this! section! is! to! describe! the! details! of! nAChR!mediated! events!with!a!particular!focus!on!intracellular!Ca2+!signalling,!introducing!concepts!that!are!vital! to! the!majority!of!experiments! that! comprise! this! thesis,! and!beginning!with!a!summary!of!the!various!cellular!contributors!of!Ca2+!signals.!
1.2.2.4 Voltage)gated)Ca2+)channels)Expressed! at! the! cell! membrane,! VGCCs! are! pivotal! molecular! threshold! detectors!that!play!a!role!in!the!transduction!of!electrical!stimuli!into!the!elevation!of![Ca2+]ic!to!
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initiate!diverse!physiological!events! in!a!broad!range!of! cell! types! (Catterall,!2011).!The!presence!of!a!voltage!sensor,! thought! to!be!conferred!by!a!single,!arginineXrich!transmembrane!αXhelix!in!each!of!the!four!pore!forming!sixXtransmembrane!repeats!of! the! protein! allows! the! coupling! of! electrical! excitation! to! Ca2+! flux! (Bezanilla,!2000).!An!extracellular!pore! loop!containing!glutamate!residues!has!been!shown!to!confer!Ca2+!selectivity!(Heinemann!et!al.,!1992),!similar!to!that!seen!in!nAChRs!(see!1.2.2.6).! Subtypes! are! distinguished! according! to! their! poreXforming! subunits,!biophysical!characteristics!and!pharmacological!distinctions,!which!are!expressed!in!different!cell!types!and!subcellular!domains,!summarized!in!Table!1.2.1.!! LXtype!VGCCs!(Cav1.1X1.4)!are!characterized!by!their!longXlasting!Ca2+!currents!and!sensitivity!to!dihydropyridine!drugs!such!as!nifedipine,!they!mediate!excitationXcontraction! coupling! in! skeletal,! smooth! and! cardiac! muscle;! endocrine! secretion;!gene! transcription;! and! in! neurons! are! found! predominantly! on! cell! bodies! and!dendrites! (Catterall,! 2000).! P/QX! (Cav2.1)! and! NXtype! (Cav2.2)! channels! are! often!associated!with!the!release!of!neurotransmitters!at!nerve!terminals!and!are!sensitive!to! blockade! by! ωXconotoxin! GVIA! and! ωXagatoxin! respectively! (Catterall! and! Few,!2008).!RXtype!(Cav2.3)!channels!can!be!blocked!by!the!tarantula!toxin!SNXX492,!and!are!found!on!dendrites,!whilst!the!novel!drug!ML218!inhibits!TXtype!channels,!which!are!characterized!by!their!transient!activation!and!are!involved!in!pacemaker!activity!and!repetitive!firing!(Catterall,!2000;!Xiang!et!al.,!2011).!
Table' 1.2.1:' Distinguishing' features' of' the' voltageOgated' Ca2+' channel' subtypes.'
Adapted'from'Catterall'(2000,'2011).'Channel! Current! Pharmacology! Function!Cav1.1X1.4! L'(“LongXlasting”/”DHP!sensitive”)'
Dihydropyridine!sensitive! Muscle!contraction;!endocrine!secretion;!transcription;!neuronal!Ca2+!transients!in!cell!bodies,!dendrites;!audition;!neurotransmitter!release!from!sensory!cells!Cav2.1! P/Q'(“Purkinje”)' ωXagatoxin!sensitive! Neurotransmitter!release;!dendritic!Ca2+!transients!Cav2.2! N'(“Neuronal”)' ωXconotoxinXGVIA!sensitive! Neurotransmitter!release;!dendritic!Ca2+!transients!Cav2.3! R'(“Residual”)' SNXX482!sensitive! Neurotransmitter!release;!dendritic!Ca2+!transients!Cav3.1X3.3! T'(“Transient”)' X! Pacemaking!and!repetitive!firing!
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1.2.2.5 Ionotropic)glutamate)receptors)The! primary!mediators! of! fast! excitatory! transmission! in! the! CNS,! iGluRs! comprise!tetrameric! glutamateXgated! cation! channels! split! into! three! groups! on! the! basis! of!agonist!pharmacology!as!AMPA,!kainate,!and!NMDA!receptors!(Traynelis!et!al.,!2010).!With!respect!to!Ca2+!permeability,!NMDARs!dominate!this!class!of!receptors!and!are!crucial! initiators!of!Ca2+! signalling!events! that!underlie! longXterm!synaptic! changes.!Ca2+! permeability! of! NMDARs! is! affected! by! subunit! composition! and!phosphorylation,! and! more! importantly! their! activation! requires! coXagonism! of!glutamate! with! either! DXserine! or! glycine,! and! is! voltageXdependent! due! to! Mg2+!blockade! at! resting! membrane! potentials.! These! characteristics! add! an! important!level!of!signal!control!considering!the!gravity!of!NMDAR!effects!on!cell!behaviour,!and!qualify! NMDARs! as! coincidence! detectors.! Indeed,! overXactivation! of! NMDARs,!especially!in!nonXsynaptic!regions!is!known!to!result!in!excitotoxicity!(Hardingham!et!al.,!2002;!Lynch!and!Guttmann,!2002).!NMDARs!work! in! concert!with!AMPA! receptors,!which! primarily! flux!Na+! in!response! to! glutamateXinduced! activation,! providing! the! necessary! membrane!depolarization!to!initiate!excitatory!postsynaptic!potentials!(EPSCs)!and!remove!the!Mg2+!block!on!NMDARs!(Traynelis!et!al.,!2010).!AMPAR!tetramers!lacking!the!GluA2!subunit!have!a!higher!relative!permeability!to!Ca2+!and!can!also!initiate!cellular!Ca2+!signalling! events! independently! of! NMDARs! (Jonas! et! al.,! 1994;! Perkinton! et! al.,!1999).!
1.2.2.6 Ca2+)permeability)of)nAChRs)nAChRs! have! a! high! relative! Ca2+! permeability,! which! makes! them! important!initiators!of!cellular!Ca2+!signalling!pathways.!Determination!of!Ca2+!permeability!of!ion! channels! was! initially! ascertained! by! wholeXcell! electrophysiological!measurements! of! ion! channel! currents! at! different! holding! potentials,! allowing! the!ionic!reversal!potential!to!be!estimated!(potential!difference!at!which!current!equals!zero).!When!repeated!with!different!concentrations!of!extracellular!Ca2+!([Ca2+]ec),!a!shift! in! the!reversal!potential!occurs,!which!allows! the! theoretical!estimation!of! the!relative! permeability! of! Ca2+! to!Na+! (PCa/PNa)! by! using! the!GoldmannXHodgkinXKatz!equation! (Goldman,! 1943;! Hodgkin! and! Katz,! 1949;! Lewis,! 1979).! As! described! in!section!1.1.5!the!environment!surrounding!an!ion!channel!receptor,! including![Ca2+]!
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can!significantly!affect!its!function,!presenting!a!major!drawback!in!this!method!when!the! necessary!whole! cell! recordings! are!made! in! the! presence! of! very! high! [Ca2+]ec!(Mulle!et!al.,!1992b).!A!more!direct!method!was!pioneered!by!Neher!and!colleagues!(Schneggenburger! et! al.,! 1993),!which! allows! an! estimate! of! fractional! Ca2+! current!(Pf)! to! be! made! by! combining! fluorimetric! measurements! of! cells! loaded! with! the!ratiometric!Ca2+!indicator!furaX2!(Grynkiewicz!et!al.,!1985;!see!section!3.1.1)!with!the!recording! of! wholeXcell! currents.! Caveats! also! exist! with! this! technique,! as! the!calculation!of! [Ca2+]ic! from!ratiometric! fluorescence!values! relies!on!a! sophisticated!calibration!protocol,!and!an!assumption!that!the!sole!source!of!Ca2+!influx!is!through!the! ion! channels! in! question.! This! can! be! controlled! for! with! respect! to! VGCCs! by!maintaining!a!constant!voltage!clamp,!but!not!for!CICR!from!the!ER.!Finally,!it!must!be!assumed! that! any! Ca2+! influx!will! be! completely! bound! by! furaX2! so! that! it! can! be!measured!(Fucile,!2004;!Pankratov!and!Lalo,!2013).!Despite!these!imperfections,!the!above!techniques!have!been!used!extensively!to!provide!estimates!of!ion!channel!Ca2+!permeability,!which!are!useful!for!comparison!(Reviewed!by!Fucile,!2004;!Pankratov!and!Lalo,!2013).!! Ca2+! permeability! of! nAChRs! is! dependent! on! subunit! composition! and!stoichiometry!(see!1.1.3),!the!most!notable!being!that!of!the!homomeric!nAChRs!such!as!the!α7!subtype,!which!was!reported!to!exhibit!a!Pf!of!11.4!%!and!8.8!%!for!human!and! rat! α7! nAChRs! transiently! expressed! in! GH4C1! cells! respectively! (Fucile! et! al.,!2003).! This! rivals! that! of!NMDARs!which!was! reported! to! command!Pf! of! 8.2!%! to!14.1!%!depending!on!subunit!composition!and!expression!system!(Burnashev!et!al.,!1995;!Garaschuk!et!al.,!1996;!Egan!and!Khakh,!2004).! In!contrast,!Pf!determined!for!both! human! and! chick! α4β2! nAChRs! expressed! in! human! embryonic! kidneyX293!(HEK293)!cells!was!much!lower!at!3.1!%!(Egan!and!Khakh,!2004).!Using!the!reversal!potential! method! on! X.' laevis! oocytes! heterologously! expressing! various! nAChR!subtypes,! a! study! by! Tapia! et! al.! (2007)! reported! that! Ca2+! permeability! of!heteromeric!nAChRs!is!increased!by!the!incorporation!of!subunits!α4,!α5!and!β3!due!to! a! negatively! charged! glutamate! residue! (GluX261;! α4! numbering)! on! the!extracellular!edge!of!the!M2!domain,!which!in!α7!nAChR!pentamers!forms!a!ring!that!is! crucial! for! cationic! selectivity! (Galzi! et! al.,! 1992;! see! 1.1.4.2).! At! β2! subunits!however,! a! positively! charged! lysine! residue! in! the! same! position! restricts! Ca2+!
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permeability.! In! line!with! this,!Galzi!et!al.,! (1992)!also!reported!higher!relative!Ca2+!permeability!for!LSXα43β22!than!HSXα42β23.!
1.2.2.7 nAChR)mediated)Ca2+)signalling)pathways)In! Figure! 1.2.3,! a! simplified! diagram! of! a! cell! shows! the! basic!mechanisms! of! Ca2+!signal!amplification!following!nAChR!activation!which!can!be!summarized!as:!(i)!Ca2+!influx!through!nAChR,!(ii)!depolarization!of!the!cell!membrane!mediated!by!Na+!influx!through! nAChRs! causing! activation! of! VGCCs,! (iii)! CICR! from! ER! via! RyRs! and/or!IP3Rs,!and!(iv)!IP3!mediated!Ca2+!release!from!ER.! Interestingly,! the!first!two!routes!are!thought!to!be!mutually!exclusive!as!nAChR!mediated!Ca2+!influx!occurs!at!resting!or!hyperpolarized!membrane!potentials,!whereas!VGCCs!as!their!name!suggests!are!only!activated!under!conditions!of!depolarization,!illustrating!divergent!mechanisms!for!different!physiological! situations! (Mulle! et! al.,! 1992a).! Further! confounding! this!simplistic! categorization,! local! LGIC! or!VGCC!mediated! [Ca2+]ic! elevations! can! cause!subsequent!CICR! from!the!ER.!More!specifically,! the!ER!has!been!shown! to!act!as!a!kind!of!Ca2+!capacitor:!as!Ca2+!enters!the!cytosol!via!LGICs!or!VGCCs,!SERCAs!actively!pump! it! into! the! ER,! loading! it! with! Ca2+! (Garaschuk! et! al.,! 1997;! Berridge,! 1998).!Periods! of! more! intense! neuronal! stimulation! can! therefore! lead! to! a! cumulative!increase! in! ER! [Ca2+],! sensitizing! them! to! further! stimulation.! The! buildup! of! Ca2+!slowly!decreases!over!time!however,!as!Ca2+!leaks!back!into!the!cytoplasm!where!it!is!rapidly!buffered!by!CaBPs,!or!diffuses!within!the!ER.!This!system!provides!a!memory!of! recent! excitatory! events! in! the! same! cellular! location,! and! serves! as! a! threshold!mechanism! by! which! larger! global! Ca2+! signals! can! be! generated! that! initiate! long!term!changes!in!cell!behaviour!by!being!propagated!to!the!nucleus!(Berridge,!1998;!Bading,!2013).!! Another!synergistic!effect!exists!involving!the!IP3R,!which!can!be!activated!by!either! Ca2+! or! IP3,! but! to! a! stronger! degree! when! both! are! present,! acting! as! a!coincidence! detector! for!multiple! inputs! (Berridge,! 1993;! Simpson! et! al.,! 1995).! As!well! as! being! a! possible! preventative! measure! to! protect! against! uncontrolled!excitation,! activity! dependent! desensitization! of! nAChRs! and! other! LGICs! in! the!presence!of!continued!agonist!stimulation!presents!an!additional!memory!of!previous!events!that!at!its!most!basic!level!is!intrinsic!to!the!receptors!themselves,!but!is!also!influenced!by! intracellular!Ca2+!dependent!metabolic!processes,!specifically!the!Ca2+!
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dependent!phosphorylation!of!the!intracellular!regions!of!nAChRs!by!protein!kinase!A!(PKA)! and! protein! kinase! C! (PKC),! which! enhance! recovery! from! desensitization.!








Figure'1.2.3:'Possible'routes'of'Ca2+'entry'into''cytosol'following'nAChR'activation.'Upon!nAChR!activation,!Na+!and!Ca2+! ions!enter!the!cell!via!the!nAChR!ion!channel.!Na+!influx! results! in! depolarization! of! the! cell! membrane,! triggering! voltageXgated! Ca2+!channels! (VGCCs)! on! the! cell! membrane.! Ca2+! entering! directly! through! nAChRs! can!stimulate!Ca2+!induced!Ca2+!release!(CICR)!from!the!endoplasmic!reticulum!(ER)!via!both!ryanodine!receptors!(RyRs)!and/or!inositolX1,4,5Xtrisphosphate!receptors!(IP3Rs).!
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effects.! Examples! of! fast! cholinergic! transmission! in! the! CNS! have! however! been!reported!(Alkondon!et!al.,!1998;!Frazier!et!al.,!1998a,!1998b).!In!the!last!two!decades,!there!have!been!numerous!reports!of!different!nAChR!subtypes! coupling! to! distinct! Ca2+! signalling! pathways! in! different! cell! types,! cell!locations! and! brain! regions,! reflecting! the! segregation! of! Ca2+! signalling! to! achieve!diverse!physiological!actions!(DajasXBailador!and!Wonnacott,!2004;!Shen!and!Yakel,!2009).!nAChRs!are!capable!of!elevating![Ca2+]ic!alone!(Trouslard!et!al.,!1993),!and!it!has!been!reported!that!local!α7!nAChRXmediated![Ca2+]ic!elevations!in!filopodia!of!SHXSY5Y!human!neuroblastoma!cells!(overexpressing!α7!nAChRs)!were!not!sensitive!to!either! the! RyR! antagonist! ryanodine! (Ry)! or! hyperpolarization! using! the! K+!ionophore!valinomycin,!ruling!out!contributions!from!VGCCs!and!RyR!mediated!CICR!(Gilbert!et!al.,!2009).!Another!study!reported!that!both!α3*!and!α7!nAChR!mediated!Ca2+!transients!in!IMRX32!human!neuroblastoma!cells!were!not!coupled!to!VGCCs!or!RyR!mediated!CICR!either! (Gilbert!et!al.,!2009;!Ween!et!al.,!2010).!Fayuk!and!Yakel!(2005)! have! also! demonstrated! α7! nAChRXmediated! [Ca2+]ic! elevations! in!hippocampal! CA1! interneurons! from! rat! brain! slices! that! were! insensitive! to! the!general! VGCC! blocker! Cd2+! and! Ry.! Evidence! for! nAChR!medited! [Ca2+]ic! elevations!recruiting! secondary! Ca2+! amplification! mechanisms! involving! VGCCs! and! ER!mediated! release! is! also! well! documented! however,! highlighting! the! diversity! of!physiological!processes!influenced!by!nAChRs.!For!example,!in!chick!cilliary!ganglion!neurons,! stimulation!of!α7!nAChRs! (Vijayaraghavan!et! al.,! 1992;!Rathouz! and!Berg,!1994)! and!nonXα7!nAChRs! (Rathouz! and!Berg,! 1994)! resulted! in! [Ca2+]ic! elevations!that!were!VGCCXdependent,!as!were!nicotineXinduced![Ca2+]ic!elevations!in!rat!medial!habenula!neurons!(Mulle!et!al.,!1992b),!and!α7!nAChRXmediated![Ca2+]ic!elevations!in!rat!hippocampal!neurons! (Barrantes! et! al.,! 1995a).!Chick! sympathetic!neuronal! cell!body! [Ca2+]ic! elevations! evoked! by! the! ganglionic! nAChR! agonist!dimethylphenylpiperizinium!(DMPP)!were!reported!to!involve!LX,!and!NXtype!VGCCs!because!as!reported!of!their!inhibition!by!the!selective!VGCC!antagonists!ωXconotoxin!and!(+)Bay!k!8644!respectively!(Dolezal!et!al.,!1996).!In!other!studies,!Khiroug!et!al.,!(1997)!reported!that!nonXα7!nAChRs!coupled!to!VGCCs!in!rat!chromaffin!cells,!whilst!in!rat!intercardiac!ganglion!neurons!it!was!shown!that!muscarinic!AChRs!(mAChRs)!acted!through!IP3Rs!to!raise![Ca2+]ic!whereas!nAChRs!were!coupled!to!CICR!from!RyRs!
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(Beker!et!al.,!2003),!as!were!α9!nAChRs!in!guinea!pig!outer!cochlear!hair!cells!(Evans!et!al.,!2000).!Investigations! have! begun! to! build! an! increasingly! detailed! picture! by!providing!evidence! linking!distinct!Ca2+!amplification!pathways!to!particular!nAChR!subtypes!in!the!same!cellular!systems.!Amoung!them,!Tsuneki!et!al.!(2000)!reported!that! in! dopaminergic! neurons! of! the! substantia! nigra! pars! compacta! (SNc)! from!mouse!brain!slices,!both!α7!and!β2*!nAChRs!were!coupled!to!RyRXmediated!ER!Ca2+!release,! but! only! β2*! nAChRs! were! coupled! to! LXtype! VGCCs.! Sharma! and!Vijayaraghavan!(2001)!reported!that!in!rat!hippocampal!astrocytes,!α7!nAChR![Ca2+]ic!elevations! were! coupled! to! ERXmediated! release.! Another! study! by! Shoop! et! al.!(2001)! using! chick! ciliary! ganglion! cells! distinguished! the! local! Ca2+! transients!mediated! by! α7! nAChRs! alone! that! were! confined! to! dendritic! spines! with! α3*!nAChRXmediated!global!Ca2+!events!that!were!dependent!on!both!LXtype!VGCCs!and!RyRXmediated!ER!release.!Having!observed!α7!nAChRXmediated!Ca2+!transients!that!were!isolated!by!the!morphological!characteristic!of!dendritic!spines,!the!same!group!later!discovered! that! in!hippocampal!aspiny! interneurons,!α7!nAChRXmediated!Ca2+!transients!were!instead!constrained!by!the!close!association!and!physical!coupling!to!PMCA2! pumps! via! postsynaptic! density! protein! 95! (PSDX95)! (GomezXVarela! et! al.,!2012).!Furthermore,!two!studies!from!Wonnacott’s!group!detailed!the!segregation!of!α7! and! α3*! nAChR!mediated! [Ca2+]ic! elevations! to! ER!mediated! Ca2+! release! (both!RyRX!and!IP3RXmediated)!and!LXtype!VGCCs!respectively!in!both!SHXSY5Y!cells!(DajasXBailador! et! al.,! 2002a)! and! rat! adrenomedullary! pheochromocytoma! (PC12)! cells!(Dickinson!et!al.,!2007).!Here,!in!SHXSY5Y!cells!it!was!also!found!that!the!ERXmediated!release!could!be!divided!into!shortX!and!longXlasting!components!by!their!differential!sensitivities! to!Ry!and! the! IP3R!blocker!xestosponginXC!respectively.!Similar!studies!have! finely! dissected! the! nAChR! subtype! dependent! Ca2+! signalling! pathways! in!bovine!chromaffin!cells!revealing!that!nonXα7!nAChRs!coupled!to!LXtype!VGCCs!and!CICR! whilst! α7! nAChRs! coupled! to! nonXLXtype! VGCCs! and! CICR! (del! Barrio! et! al.,!2011).!
1.2.2.8 Ca2+)dependent)nAChR)modulation)of)neurotransmitter)release)Numerous!cases!have!also!been!described!in!which!particular!physiological!roles!for!the! distinct! Ca2+! signalling! pathways! are! initiated! by! different! nAChR! subtypes.! A!
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significant! proportion! of! nAChRs! in! the! CNS! are! proposed! to! be! located! on!presynaptic!terminals,!where!their!activation!can!stimulate!or!modulate!the!release!of!neurotransmitters! such! as! glutamate,! glycine,! dopamine,! noradrenaline,! serotonin,!and! γXaminobutyric! acid! (GABA)! (Wonnacott,! 1997;! Vizi! and! Lendvai,! 1999;!Zappettini!et!al.,!2011b;!Garduño!et!al.,!2012).!This!can!be!generalized!to!occur!in!two!main!ways:!(i)!occurring!on!a!scale!of!microseconds,!nAChR!mediated!depolarization!of!presynaptic!terminals!or!boutons,!resulting!in!the!activation!of!VGCCs!that!provide!the!Ca2+!influx!necessary!to!stimulate!the!rapid!process!of!Ca2+!dependent!exocytosis!of! neurotransmitter! containing! vesicles! by! SNARE! complexes,! and! (ii)! presynaptic!potentiation! of! neurotransmitter! release,! also! known! as! presynaptic! plasticity,! a!longer!and!more!complex!process!involving!Ca2+!dependent!metabolic!pathways!that!
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increase!the!probability!and!magnitude!of!release,!producing!effects!that!can!last!over!timescales!of!seconds!to!minutes!(Shen!and!Yakel,!2009).!! Following!on! from!Figure!1.2.3,!Figure!1.2.4!shows! the!next! level!of!possible!Ca2+! signalling! routes! that! exist! in! synaptically! connected! systems.! Here,! [Ca2+]ic!elevations!initiated!by!presynaptic!nAChRs!can!indirectly!lead!to![Ca2+]ic!elevations!in!the! postsynaptic! cells! via! the! facilitation! of! glutamate! release,! which! activates!postsynaptic! AMPA! and! NMDA! receptors,! allowing! Ca2+! influx.! Na+! influx! through!AMPA!receptors!can!also!activate!Ca2+! influx!through!postsynaptic!VGCCs,!and!as! in!the!singleXcell!model!(Figure!1.2.3),!free!Ca2+!can!stimulate!CICR!from!RyR!or!IP3Rs!on!the! ER.! Glutamate! release! can! also! activate! mGluR1,! leading! to! the! PLC! catalysed!hydrolysis!of!PIP2!to!generate!IP3,!which!acts!at!IP3Rs!to!release!Ca2+!from!the!ER!(see!
Figure' 1.2.4:' Presynaptic' nAChRs' can' influence' Ca2+' signaling' events' in' postsynaptic' cells' via'

























above).!! Earlier! studies! reported! stimulation! of! neurotransmitter! release! by!presynaptic! nAChRs! on! ganglionic! neurons,!where! it!was! found! that! DMPP! evoked![3H]Ach!release!from!neurons!of!the!guinea!pig!myenteric!plexus!were!sensitive!to!ωXconotoxin,!implicating!NXtype!VGCCs!(Takahashi!et!al.,!1992).!In!contrast!to!nicotine’s!actions!at!cell!bodies,!VGCCs!were!not!implicated!in!the!mediation!of!nicotine!evoked!noradrenaline! release! from! cultured! chick! sympathetic! neurons,! implying! that!nAChRs! could! elevate! [Ca2+]ic! sufficiently! alone! (Dolezal! et! al.,! 1996).!This!was! also!the!case! for! the! facilitation!of!GABA!release!by!β2*!nAChRs! from!slices!of! thalamus!sensory!nuclei!(Léna!and!Changeux,!1997),!and!in!anatoxinXA!evoked!glycine!release!from!rat!spinal!dorsal!horn!substantia!gelatinosa!neurons!(Kiyosawa!et!al.,!2001).!In!rat! sympathetic! axon! terminals! however,! nicotine!was! found! to! evoke! RyXsensitive!Ca2+!spikes!(Brain!et!al.,!2001).!A!report!by!Soliakov!and!Wonnacott,!(1996)!provided!evidence!for!NXtype!VGCCs!mediating!anatoxin!evoked![3H]dopamine!release!from!rat!striatal!synaptosomes,!which!was!confirmed!by!Turner!(2004),!although!here!it!was!found!that!P/QXtype!VGCCs!also!mediate!this!effect.!In!the!latter!study,!αbgt!sensitive!Ca2+! dependent! enhancement! of! [3H]dopamine! release! by! nicotine! or! choline! was!reported!to!be!independent!of!VGCCs!in!contrast!to!most!other!studies,!but!acted!via!a!calmodulin! dependent! pathway! to! increase! the! readily! releasable! pool! of!neurotransmitter! vesicles.! Indeed,! numerous! reports! have! now! presented! a!dichotomy! between! the! effects! of! presynaptic! α7! and! nonXα7! nAChRXmediated!neurotransmitter! release,! with! accompanying! differences! in! Ca2+! signalling!mechanisms.!The!more!Ca2+!permeable!α7!nAChR!is!well!established!to!play!a!role!in!the! enhancement! of! transmitter! release! rather! than! its! direct! mediation,! which! is!ascribed!to!the!less!Ca2+!permeable,!depolarizationXinducing!heteromeric!nAChRs.!! To! measure! presynaptic! potentiation! in! intact! neurons! forming! synaptic!connections,!the!frequency!of!lowXlevel,!constitutive!neurotransmitter!release!can!be!measured!from!the!postsynaptic!neuron!(miniature!EPSPs;!mEPSCs)!in!the!presence!of! tetrodotoxin! (TTX),! which! blocks! voltage! gated! Na+! channels! (VGSCs)! and!therefore! prevents! action! potential! mediated! neurotransmitter! release! on! the! preXsynaptic! neuron,! and! blocks! suprathreshold! excitatory! events! on! the! postsynaptic!neuron.! In! the! event! of! presynaptic! potentiation,! an! increase! in! the! frequency! of!mPSCs!is!expected,!as!the!probability!and!magnitude!of!release!is!enhanced.!Gray!et!al.!
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(1996)!used! this!method! to!measure!nicotineXmediated!presynaptic!potentiation!of!hippocampal! mossy! fibre! terminals! in! rat! brain! slices.! The! increased! mEPSC!frequency!was!sensitive!to!αbgt!and!MLA,!implicating!α7!nAChRs,!and!was!dependent!on! [Ca2+]ec.! FuraX2! was! then! used! to! image! nicotineXevoked! Ca2+! elevations! in! the!mossy!fibre!terminals,!which!were!unaffected!by!AMPA!and!NMDA!receptor!blockade.!Intraterminal!Ca2+!elevations!evoked!by!nicotine!were!additive!with!VGCCXdependent!Ca2+! elevations! evoked! by! electrical! stimulation,! suggesting! that! α7! nAChRs! could!elevate!Ca2+!without!the!need!for!VGCCs,!or!acted!synergistically.!Similar!studies!have!also!reported!VGCCXindependence!of!α7!nAChRXmediated!glutamatergic!potentiation!in!medial!habenula!and! interpeduncular! synapses! in! coXculture! (Girod!et!al.,!2000),!and! in! neurons! of! the! nucleus! of! the! solitary! tract! (Kalappa! et! al.,! 2011),! where!presynaptic!α7!and!nonXα7!nAChRXmediated!enhancement!of!mEPSCs!frequency!was!also! independent!of!ERXmediated!Ca2+! elevations.! Furthermore,! a! variety!of! reports!have! provided! evidence! that! links! the! potentiation! of! glutamate! release! by!presynaptic!α7!nAChRs!to!RyRXmediated!CICR!(Sharma!and!Vijayaraghavan,!2003;!Le!Magueresse!and!Cherubini,!2007;!Sharma!et!al.,!2008).!Studies!measuring!the!release!of! neurotransmitters! from! synaptosomes! found! that! whereas! α7! nAChRXmediated!neurotransmitter!release!was!dependent!on!CICR,!β2*!nAChRXmediated!release!was!VGCC! dependent.! This! was! reported! for! [3H]DXaspartate! (glutamate! surrogate)!release! from!rat!PFC!synaptosomes!(Dickinson!et!al.,!2008)!and!GABA!release! from!rat!hippocampal!synaptosomes!(Zappettini!et!al.,!2011a).!Wang!et!al.!(2006)!however!reported!that!α7!nAChRXmediated!glutamate!release!from!rat!PFC!synaptosomes!was!coupled! to! NX! and! P/QXtype! VGCCs,! and! in! a! separate! study,! nonXα7! nAChRs! on!sympathetic!terminals!of!the!mouse!vas!deferens!were!coupled!to!RyRXmediated!CICR!(Williams!et!al.,!2011a).!Lastly,!glutamatergic!terminals!synapsing!with!5XHT!neurons!in! the!dorsal! raphe!nuclei! (DRN)!were! found! to! couple!α4β2!but!not!α7!nAChRs! to!both!VGCCs!and!CICR,!as!measured!by!increased!frequency!of!mEPSCs!(Garduño!et!al.,!2012).!The! modulatory! aspect! of! Ca2+! dependent! presynaptic! nAChRXmediated!potentiation! of! neurotransmitter! release! has! been! hypothesized! to! reflect! dynamic!alterations! in! the! availability! of! readily! releasable! neurotransmitter! vesicles! that!affects! the! probability! and! magnitude! of! release.! In! support! of! this,! electron!microscopy! studies! discovered! two! distinct! pools! of! neurotransmitter! containing!
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vesicles!designated:!(i)!the!readily!releasable!pool!(RRP)!proximal!to!the!presynaptic!membrane,!and!(ii)!the!reserve!pool!(RP)!located!distal!to!the!presynaptic!membrane,!containing! vesicles!whose! association!with! the! actin! cytoskeleton! is!mediated! by! a!neuron!specific!phosphoprotein!called!synapsin! I!(Pieribone!et!al.,!1995).!Metabolic!cascades!that!result!in!the!phosphorylation!of!synapsin!I!by!CaMKII!and!extracellular!signal! regulated! kinase! (ERK)/mitogen! activated! kinase! (MAPK)! at! specific! sites!trigger!vesicle!dissociation!from!actin!whereas!Src!kinase!phosphorylation!mediates!reXaggregation!of!synaptic!vesicles! to!actin!(Kushner!et!al.,!2005;!Cesca!et!al.,!2010;!Messa! et! al.,! 2010).! Association! and! dissociation! of! vesicles! to! actin! is! thought! to!occur!in!response!to!different!modes!of!neuronal!stimulation,!where!highXfrequency!stimulation! as! opposed! to! lowXfrequency! stimulation! triggers! recruitment! of! RP!vesicles! to! the! RRP! (Pieribone! et! al.,! 1995),! and! also! in! response! to! neurotrophins!such! as! brain! derived! neurotrophic! factor! (BDNF)! (Jovanovic! et! al.,! 2000).!Interestingly,! the! CICRXdependent! facilitation! of! glutamate! release! from! PFC!synaptosomes!by!α7!but!not!β2*!nAChR!stimulation!was! found! to!be!dependent!on!ERK/MAPK! phosphorylation,! and! correlated! with! an! increase! in! synapsin! I!phosphorylation!at!ERK/MAPK!specific!sites!(Dickinson!et!al.,!2008),!whereas!a!study!probing!the!postXreceptor!effects!of!acute!nicotine!treatment!in!mice!in'vivo!reported!a! β2*! but! not! α7! nAChRXdependent! effect! of! increased! CaMKII! activity! which! was!correlated!with!an!increase!in!synapsin!I!phosphorylation!at!CaMKII!specific!sites!in!the!ventral!tegmental!area!(VTA)!and!nucleus!accumbens!(NAc)!(Jackson!et!al.,!2009).!Using! a! slightly! different! approach,! GomezXVarela! and! Berg! (2013)! supplemented!evidence! for! the! important! role! played! by! α7! nAChRs! in! modulating! presynaptic!potentiation!of!glutamate!release!by!showing! that! lateral!mobility!of!α7!nAChRs!on!glutamatergic! terminals! in! cultured! rat! hippocampal!neurons! affected! the! extent! of!the! enhancement! of! glutamate! release.! By! restricting! mobility! of! α7! nAChRs! with!crossXlinking! antibodies,! the! authors! observed! an! increase! in! the! frequency! of!mEPSCs!that!was!accompanied!by!an!enlargement!of!the!RRP!of!synaptic!vesicles.!α7!nAChRs! expressed! by! astrocytes! were! also! found! to! release! glutamate! following!elevations! of! [Ca2+]ic,! although! amplification! mechanisms! were! not! defined!(Pirttimaki!et!al.,!2013),!although!as!noted,!previous!studies!have!linked!α7!nAChRs!on!astrocytes!to!RyRXdependent!Ca2+!release!from!the!ER.!Other!studies!have!implied!the!dependence!of!α7!nAChRXmediated!presynaptic!potentiation!on!protein!kinase!A!
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(PKA)!in!hippocampal!mossy!fibre!terminals!(Cheng!and!Yakel,!2014),!and!in!mouse!ventral! hippocampal! neurons! long! lasting! (30!min)! [Ca2+]ic! elevations! in! axons! and!terminals! that!underlie!presynaptic! facilitation!of! glutamate! release!were! identified!to!arise!from!α7!nAChR!stimulation!requiring!subsequent!CICR!from!IP3Rs,!activation!of!PLC!and!CaMKII!(Zhong!et!al.,!2013).!When! taken! together! these! reports! illustrate! the! need! for! further! study! to!reconcile! some! seemingly! contradictory! results.! Indeed,! many! of! the! publications!outlined! above! have! only! concentrated! on! certain! aspects! nAChR! mediated! Ca2+!signalling,! leaving! others! open! to! speculation.! Whereas! it! may! be! that! different!methods! of! assessment! of! Ca2+! signals! can! affect! bias! towards! a! particular!mechanism,!differences!in!brain!regions!or!cell!type!probably!account!for!much!of!the!diversity.!
1.2.2.9 Long)term)Ca2+)dependent)effects)mediated)by)nAChRs)Some!targets!of!Ca2+!signalling!occur!long!distances!from!initial!Ca2+!flux,!and!require!sustained!or!global![Ca2+]ic!elevation,!such!as!those!at!the!nucleus,!where!their!effects!influence! gene! expression,! producing! longXlasting! changes! in! cell! behavior! (Bading,!2013).!In!an!environment!that!strongly!buffers![Ca2+],!this!requires!mechanisms!that!amplify!or!transduce!the!initial!signal!(see!1.2.2).!The!principle!mechanisms!by!which!these! goals! are! achieved! are:! (i)! the! activation! of! somatic! VGCCs! proximal! to! the!nucleus!occuring!after!backpropagation!of!action!potentials,!and!(ii)!via!regenerative!Ca2+! waves! propagated! along! the! ER! towards! the! nucleus,! mediated! by! successive!instances! of! IP3R!mediated! CICR.! The! ER!membrane! is! continous!with! the! nuclear!envelope,!and!Ca2+!can!diffuse!passively!through!the!nucleur!pore!complex!(Wang!et!al.,!2002).!Once!in!the!nucleus,!Ca2+!can!initiate!signalling!events!that!influence!gene!transcription,! such! as! the! activation! of! transcription! factors,! histone! modification,!DNA! methylation,! and! the! inhibition! of! cell! death! signals! (DajasXBailador! and!Wonnacott,!2004;!Shen!and!Yakel,!2009;!Bading,!2013).!As!discussed!in!section!1.2.2.8,!nAChR!mediated!Ca2+!signalling!at!presynaptic!locations! modulates! neurotransmitter! release! in! shortX! and! longXterm! processes.!With! respect! to! longXterm! signalling! that! involves! the! modulation! of! gene!transcription,! it!has!been!reported!that!nAChRXdependent!signalling!events!can!lead!to!the!upregulation!of!enzymes!required!for!the!synthesis!of!neurotransmitters!such!
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as! tyrosine! hydroxylase! (TH).! The!mechanism!was! found! to! be! dependent! on!CICR!from!the!ER,!PKA!and!the!ERK/MAPK!pathway!in!response!to!α7!nAChR!stimulation!(Gueorguiev!et!al.,!2000).!Of!course,!the!effects!of!modulated!neurotransmitter!release!and!presynaptic!potentiation!directly!affect!postsynaptic!cells!(Figure!1.2.4),!as!the!rate!and!extent!of!postsynaptic!stimulation!is! increased.!At!glutamatergic!synapses,! increased!synaptic!input! activity! underlies! the! process! of! synaptic! plasticity! known! as! long! term!potentiation! (LTP),! widely! regarded! to! underlie! learning! and! memory! (Bliss! and!Lomo,! 1973;! Lynch,! 2004).! At! its! most! basic,! LTP! involves! the! activityXdependent!potentiation!of!synaptic!efficacy! in!response!to! increased!stimulation!that!results! in!postsynaptic! [Ca2+]ic! elevations! that! trigger! signalling! pathways! leading! to,! in!chronological! order:! (i)! increased! iGluR! and! mGluR! receptor! expression! at! the!postsynaptic! density,! (ii)! transcription! of! genes! and! protein! synthesis,! and! (iii)!morphological! and! structural! changes! in! postsynaptic! regions! such! as! dendritic!spines.!Nicotinic!agents!have! long!been!known!to!have!positive!effects!on!cognition!(Levin! and! Simon,! 1998),! and! in! addition! to! their! facilitatory! effects! at! presynaptic!locations,!nAChRs!at!postsynaptic!locations!have!been!shown!to!exert!complementary!influences!on!LTP!in!the!hippocampus!which!are!crucially!dependent!on!the!timing!of!stimulation,! and! present! a! mechanism! by! which! preX! and! postsynaptic! cholinergic!stimuli!can!be!integrated!across!a!synapse!(Ji!et!al.,!2001;!Gu!et!al.,!2012).!Various! downstream! actors! involved! in! the! later! stages! of! LTP! have! been!reported! to! show! activation! following! nAChR! stimulation,! such! as! PKA,! CaMKII/IV,!ERK/MAPK!and!cyclic!AMP!(cAMP)!response!element!binding!protein!(CREB),!which!mediate!signal! transduction!pathways! that!converge!at! the!nucleus,! resulting! in! the!induction! of! immediate! early! genes! (IEGs)! such! as! cXFos! and! activity! regulated!cytoskeletal! associated! protein! (Arc)! (Sweatt,! 2001;! Bading,! 2013).! These! IEGs! are!strongly! associated! with! LTP! and! the! proXcognitive! effects! of! α7! nAChR! activation!(Thomsen! et! al.,! 2010).! cXFos! encodes! a! range! of! nuclear! transcription! factors,!responsible! for! the! induction! of! various! genes! in! response! to! neuronal! stimulation!(Curran!and!Morgan,!1995)!whilst!Arc!plays!a!more!local!synaptic!role;! its!mRNA!is!translated! at! dendrites!where! it! regulates! processes! integral! to! LTP! such! as! AMPA!receptor!trafficking!and!cytoskeletal!expansion!(Bramham!et!al.,!2008).!
Chapter!1:!Introduction!
! 42!




1.3 nAChRs)as)drug)targets)Sections!1.1!and!1.2,!have!described!nAChRs!as!dynamic!biological!signal!transducers!that!influence!a!diverse!range!of!important!cellular!events,!and!can!be!modulated!by!a!kaleidoscopic! palette! of! endogenous! and! exogenous! compounds.! This! section! will!focus!on!a!major!driving!force!behind!research!aiming!to!better!understand!nAChRs!and!their!place!within!the!labyrinth!of!physiology:!the!quest!for!drug!development!to!treat!disease.!! The!pervasive!expression!of!nAChRs!throughout!the!body,!and!their!potential!to!affect!diverse!and!important!biological!events!naturally!implicates!them!in!a!range!of!diseases,!and!their!apparent!susceptibility!to!modulation!entitles!them!as!worthy!drug! targets.! Indeed,! nAChRs! have! been! reported! to! play! a! role! in! the! pathology!and/or!potential!alleviation!of!a!variety!of!diseases!such!as!Alzheimer’s!disease!(AD),!schizophrenia,!Parkinson’s!disease!(PD),!addiction,!pain,!depression,!epilepsy,!cancer!and! immune!disorders.!This! section!will! summarize! the! links!between!nAChRs!and!disease!and!potential!treatment.!
1.3.3 Cholinergic)deficits)ACh! is! a! significant! neurotransmitter! in! the! brain,! acting! at! nAChRs! and! mAChRs,!thought! to! play! a! central! role! in! cognitive! functions! such! learning,! attention! and!working! memory! (Klinkenberg! et! al.,! 2011).! Cholinergic! influence! in! the! brain! is!particularly!widespread,!owing!to!extensive!projections!from!neurons!originating!in!the! basal! forebrain,! PPN! and! LDT! and! also! from! cholinergic! interneurons! in! the!striatum,! which! are! thought! to! act! both! locally! and! in! a! more! diffuse! manner! by!volume!transmission!(Sarter!et!al.,!2009).!Deficits! in!cholinergic! function!have!been!linked! to! diseases! that!manifest! an! impaired! cognitive! component,! prime! examples!being! AD! and! schizophrenia.! Whilst! ostensively! describing! two! very! different!illnesses,! schizophrenia!and!AD!share!an!overlapping!etiological! element!and!entail!massive! socioeconomic! burden.! Here,! the! reasons! for! nAChRs! presenting! possible!therapeutic!targets!will!be!discussed.!
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! Schizophrenia! is!an!umbrella! term!given!to!a!spectrum!of!mental! illness!that!encompasses! a! broad! aetiology! of! genetic! and! environmental! factors,! thought! to!affect! 1! %! of! the! world’s! population.! Symptoms! are! traditionally! categorized! as!positive!(gain!of!function),!which!include!hallucinations!and!delusions;!negative!(loss!of!function)!comprising!social!withdrawal,!lack!of!affect!and!anhedonia;!and!cognitive,!which!manifests! as! learning,! attentional! and! working!memory! deficits! (Young! and!Geyer,! 2013).! Patients! also! exhibit! a! high! incidence! of! comorbidity! with! other!psychiatric! illnesses! such! as! depression,! substance! misuse! and! anxietyXrelated!disorders;!symptomatic!expression! is!highly!unique!(Buckley!et!al.,!2009).!Although!many! factors!are! thought! to!be! involved!such!as!misregulation!of! the!dopaminergic!and!glutamatergic!systems,!there!are!several! lines!of!evidence!implicating!a!role!for!nAChRs!in!the!aetiology!and/or!treatment!of!schizophrenia.!Firstly,!nicotine!has!been!shown!to!exert!positive!effects!on!both!schizophrenics!and!healthy!controls!in!tests!of!attentional! performance! (Rezvani! and! Levin,! 2001).! Furthermore,! the! α7! nAChR!subtype! in! particular! has! been! implicated! in! schizophrenia,! as! it! was! found! that! a!sensory!gating!deficit!to!the!P50!evoked!potential!(Adler!et!al.,!1982),!a!characteristic!endophenotype! of! schizophrenia! was! linked! to! polymorphisms! at! chromosome!location!15q13X14,!harbouring!the!α7!nAChR!gene!(CHRNA7)!(Freedman!et!al.,!1997;!Severance!and!Yolken,!2008;!FinlayXSchultz!et!al.,!2011),!although!this!has!not!been!shown!in!all!studies!(Cabranes!et!al.,!2012).!Adding!to!this,!decreased!expression!of!α7! nAChRs! has! been! found! in! postXmortem! schizophrenic! brains! (Freedman! et! al.,!1995;!Court!et!al.,!1999;!Marutle!et!al.,!2001),!and!it!has!recently!been!suggested!that!a!partial!duplication!of! the!α7!nAChR!gene,!CHRFAM7A,! has!a!negative!effect!on!α7!nAChR!function!and!is!only!found!in!humans!(Araud!et!al.,!2011).!When!coXexpressed!in!X.'laevis'oocytes,!CHRFAM7A!inhibited!ACh!induced!α7!nAChR!currents,!and!had!no!functional! activity!when! expressed! alone,!which!was! hypothesized! to! result! from!a!truncated!protein!product! that! lacks! an!ACh!binding! site.!Another! theory!proposed!that! due! to! the! high! incidence! and! intensity! of! tobacco! smoking! (up! to! 80! %! for!schizophrenics!compared!to!25!%!in!the!general!population),!schizophrenic!patients!were! possibly! selfXmedicating! with! nicotine! in! an! attempt! to! mitigate! cognitive!symptoms,!or! antipsychotic!drug! sideXeffects! (Kumari! and!Postma,!2005).!Although!the!link!between!schizophrenia!and!smoking!is!well!reported!in!the!literature,!there!may! be! other! factors! influencing! its! prevalence,! such! as! the! need! for! a! structured!
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routine,! alleviation! of! boredom! and! pleasurable! effects! (Keltner! and! Grant,! 2006).!Importantly,!it!has!been!reported!that!the!tobacco!industry!has!played!a!major!role!in!the!funding!and!propagation!of!research!and!ideas!that!suggest!schizophrenics!need!to! smoke! and! even! that! they! are! somehow! immune! to! adverse! health! effects!associated! with! smoking! such! as! cancer,! as! well! as! suppressing! research! that!contradicted!these!claims!(Prochaska!et!al.,!2008).!!! Notwithstanding! these! debates,! there! has! been! considerable! research! into!developing! drugs! targeting! the! α7! nAChR! for! the! possible! alleviation! of! cognitive!deficits! in! schizophrenia,! with! promising! findings! in! preXclinical! studies! with! α7!nAChR!agonists!and!PAMs!(Reviewed!in!Hajós!and!Rogers,!2010;!Hurst!et!al.,!2013;!Wallace!and!Bertrand,!2013;!Young!and!Geyer,!2013).!As! schizophrenia! is!uniquely!human! disease! however,! drug! development! in! the! preXclinical! stages!must! rely! on!animal!models!of!schizophrenicXlike!phenotypes!and!often!results!in!poor!translation!to! the! clinic! (Jones! et! al.,! 2011;! Hurst! et! al.,! 2013),! and! as! mentioned! above,! the!heterogeneous!symptomatic!presentation!of!schizophrenia!poses!further!hurdles!for!rigorously!controlled!clinical!trials.!Of!note,!the!α7!nAChR!partial!agonist!GTSX21!was!found! to! improve! P50! auditory! gating! deficits! but! did! not! significantly! improve!cognitive! symptoms! in! schizophrenics,! although! some! improvement! in! negative!symptoms!was!reported!(Olincy!et!al.,!2006;!Freedman!et!al.,!2008).!The!α7!nAChR!agonist!and!5XHT3!antagonist!EVPX6124!was!recently!reported!to! improve!cognitive!symptoms!in!schizophrenics!in!a!proof!of!concept!trial!(Preskorn!et!al.,!2014),!and!the!full!α7!nAChR!agonist!TCX5619!was!found!to!have!beneficial!effects!on!cognitive!and!negative! symptoms! in! an! exploratory! trial! (Lieberman! et! al.,! 2013).! In! conclusion,!both! preXclinical! and! clinical! evidence! supports! the! further! development! of! drugs!targeting! nAChRs! for! schizophrenia,! although! numerous! factors! such! as! the! broad!aetiology! of! the! disease,! substance! abuse! (including! tobacco! smoking)! and!medical!history!of!patients!make!this!a!significantly!challenging!endeavour.!! Sharing! the! cognitive,! cholinergic! counterpart,! the! role! of! nAChRs! in! AD! is!somewhat!more!conspicuous!than!in!schizophrenia.!AD!is!the!most!prevalent!form!of!dementia;!a!devastating!disease!and!a!growing!socioeconomic!burden!exacerbated!by!an!aging!population.!The! first!and!until! recently!only!drugs! to!be!prescribed! for!AD!were!AChE!inhibitors!such!as!galantamine!(see!1.1.5.1),!rivastigmine!and!donepezil,!that!primarily!act! to! increase!the!halfXlife!of!ACh!in!the!brain!to!compensate! for!the!
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progressive! loss! of! cholinergic! neurons! characteristic! of! the! disease! (Schliebs! and!Arendt,!2011).!As!mentioned!in!section!1.1.5.1,!these!drugs!have!also!been!recognized!to!directly!modulate!nAChRs,!and!it!has!long!been!known!that!nAChR!density!in!the!brain! decreases! as! AD! progresses! (Perry! et! al.,! 1987).! βXamyloid! (Aβ)! plaques! and!neurofibrillary!tangles,!the!widely!reported!“pathological!hallmarks”!of!AD!have!also!been! observed! to! interact! with! nAChRs! (Wang! et! al.,! 2000,! 2003),! revealing! a!promising! avenue! for! potential! therapeutic! intervention!which! reiterates! a! facet! of!nAChR! mediated! signalling! alluded! to! in! section! 1.2.2.9,! nAChR! mediated!neuroprotection.!
1.3.4 Neuroprotection)nAChR!mediated!signalling!pathways!have!been!proposed!to!confer!cell!survival!and!antiXinflammatory!effects!and!are!relevant!to!other!diseases!such!as!PD,!inflammatory!diseases!and!cancer!as!well!as!AD.!A!variety!of!in'vitro!and!in'vivo!experiments!have!shown!nAChR!agonists! to!be!neuroprotective!against! toxicity! induced!by!glutamate,!kainate,!Aβ,!MPTP,!paraquat,!ethanol,!nerve!growth!factor!(NGF)!deprivation,!glucose!and!oxygen!deprivation,!oxidative!stress,!brain!injury!and!cerebral!ischemia!(Mudo!et!al.,! 2007;! Bencherif,! 2009;! Shimohama,! 2009;! Quik! et! al.,! 2012).! nAChR! mediated!neuroprotection! is! thought! to! result! from! the! overlapping! effects! of! downstream!cellular! signalling! cascades! that! result! in! the! inhibition! of! apoptosis! and!inflammation,!and!the!stimulation!of!plasticity!(see!section!1.2.2.9)!and!cell!survival,!most! of!which! but! not! all! are! Ca2+! dependent.! Among! them! are! the! PKA!mediated!ERK/MAPK! activation! of! CREB;! the! CaMK! and! phosphatidylinositol! 3Xkinase!(PI3K)/Akt!pathway;! the! Janus!kinase!2! (JAK2)/PI3K!and/or! signal! transducer! and!activator! of! transcription! 3! (STAT3)! cascades;! and! the! inhibition! of! nitric! oxide!synthase! (NOS),! which! inhibits! NO! induced! necrosis.! Together,! these! pathways!enhance! cell! survival! and!plasticity! via! increased!TH,!CREB!and!BXcell! lymphoma!2!(BclX2)!and!BclXx! activity;!whilst! reducing! caspase!3,!8! and!9!and!nuclear! factorXκB!(NFκB)!activity,! inhibiting!apoptosis!(DajasXBailador!and!Wonnacott,!2004;!Mudo!et!al.,! 2007;! Bencherif,! 2009;! Shimohama,! 2009;! Parri! and! Dineley,! 2010;! Quik! et! al.,!2012).!! In! AD,! the! prevailing! hypothesis! of! neurotoxicity! relies! on! increased!production! and! oligomerization! of! Αβ! peptides,! products! of! amyloid! precursor!
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protein!(APP)!cleavage,!which!lead!to!excitotoxic!insult!(Esposito!et!al.,!2013).!Aβ!has!been!reported!to!bind!with!high!affinity!to!α7!and!α4β2!nAChRs!in!the!low!picomolar!range!(Wang,!2000;!Wang!et!al.,!2000),!where!it!is!thought!to!play!a!role!in!synaptic!plasticity! in! a! physiological! setting! (Parri! and! Dineley,! 2010).! In! AD! however,! the!prolonged! exposure,! increased! concentration! and! oligomerization! of! Αβ! blocks! α7!nAChR! function! and! causes! internalization! of! toxic! α7XΑβ! complexes! (Nagele! et! al.,!2002).! The! interaction! of! Αβ! with! α7! nAChRs! was! also! found! to! lead! to!phosphorylation! of! the! cytoskeletal! protein! tau! via! ERK! and! JNKX1,! providing! a!possible!link!between!the!two!biochemical!markers!of!AD!(Wang!et!al.,!2003),!and!it!was!later!found!that!α7!nAChR!activation!decreased!tau!phosphorylation!via!reduced!activity! of! GSK3β! (Bitner! et! al.,! 2009).! The! reduction! of! α7! nAChRXmediated! proXsurvival! and! proXLTP! effects! are! compounded! by! the! effects! of! Αβ! on! glutamate!homeostasis!at!excitatory!synapses.!At!healthy!glutamatergic!synapses,!activation!of!postsynaptic! NR2A! containing! NMDARs! favours! the! Ca2+! dependent! activation! of!CaMKII,!ERK!and!CREB,!promoting!LTP!and!cell!survival,!whilst!inhibiting!p38XMAPK!and!GSK3β!pathways!that!lead!to!LTD!(Esposito!et!al.,!2013).!Higher!concentrations!and! oligomerization! of! Αβ! block! astrocytic! glutamate! uptake,! allowing! it! to!accumulate,! leading! to! desensitization! of! iGluRs! and! the! activation! of! nonXsynaptic,!NR2B! containing! NMDARs! via! glutamate! spill! over,! blocking! CREB! activation! and!triggering! cell! death! signals! (Hardingham! et! al.,! 2002).! Overall,! these! findings!legitimize! the! development! of! α4β2! and! α7! nAChR! selective! agonists! for! the!treatment! of! AD.! As! such,! nicotine! has! widely! been! reported! to! exert! protective!effects! in! animal! models! of! AlzheimerXlike! neurodegeneration! (Shimohama,! 2009;!Inestrosa! et! al.,! 2013),! leading! some! to! suggest! a! decreased! incidence! of! AD! in!smokers,!whilst!other!studies!have!disputed!this!claim.!A!metaXanalysis!of!43!studies!controlling!for!tobacco!industry!affiliation!however!found!that!tobacco!smoking!was!not!protective,!but!was! indeed!a!significant!risk! factor! for!AD!(Cataldo!et!al.,!2010).!Possible! reasons! for! this! include! the! difference! between! the! effects! of! tobacco!smoking,!which!entails!a!profusion!of!adverse!health!effects,!and!nicotine!alone;!not!to! mention! the! chronic! exposure! to! nicotine! in! the! smokers’! brain! compared! to!animal!and!in'vitro!studies.!! nAChR!mediated!neuroprotection! is! also! being!pursued! for! the! treatment! of!PD,! a! highly! debilitating! disease! characterized! by! the! progressive! degeneration! of!
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dopaminergic! neurons! in! the! nigroXstriatal! pathway,! leading! to! persistent! tremor,!rigidity! and! bradykinesia! (Quik! and! Wonnacott,! 2011;! Quik! et! al.,! 2012).! Current!treatments!such!as!LXdopa! increase! the!amount!of!dopamine! in! the!brain!similar! to!the! AChE! approach! used! in! AD,! providing! symptomatic! relief! but! failing! to! halt!disease!progression,!whilst!also!producing!an!array!of!side!effects!such!as!dyskinesia!and! psychiatric! symptoms! (Olanow! and! Schapira,! 2013).! The! causes! of! PD! are!uncertain,! although! various! environmental! and! genetic! risk! factors! have! been!described.!Strikingly,! it!has!been!consistently!demonstrated!that!tobacco!smoking!is!negatively! associated! with! incidence! of! PD! (Noyce! et! al.,! 2012),! which! has! driven!research! to!show!that!nicotine!protects!against!nigroXstriatal!damage!and!enhances!dopaminergic! transmission! in! animals,! most! likely! via! α4β2*! and! α6β2*! nAChRs!(Quik!et!al.,!2006a,!2006b).!Currently,!the!outcome!of!small!scale!clinical!trials!using!nicotine! to! treat! motor! symptoms! are! disappointing,! although! there! is! promising!evidence!of!nicotine!reducing!LXdopa!induced!dyskinesia!(Quik!and!Wonnacott,!2011;!Quik!et!al.,!2012;!Hurst!et!al.,!2013).!
1.3.5 Addiction)Continuing!the!theme!of!nAChR!mediated!dopaminergic!modulation,!and!recalling!the!effects!of!nicotine!on!memory!and! the! involvement!of!nAChRs! in!synaptic!plasticity!(section! 1.2.2.9),! this! final! section! will! be! concerned! with! addiction,! which! is! of!relevance! to! chapter! 5.! Addiction! arises! when! longXterm! changes! occur! in! certain!brain!regions!in!response!to!rewarding!stimuli!such!as!drug!taking,!gambling,!eating,!etc.! Clinically,! the! symptoms! of! addiction! are! defined! by! the! loss! of! control! and!compulsive!repetition!of!said!behaviours!despite!obvious!negative!consequences,!and!involve! the! building! of! tolerance,! which! precipitates! a! withdrawal! syndrome! upon!removal!of!the!rewarding!stimulus!(Nestler,!2013).!Addiction!is!a!complex!behaviour!affected! by! many! genetic! and! environmental! factors,! and! is! driven! by! cellular!mechanisms! that! underlie! memory! formation! in! various! brain! regions,! the! most!important!being! the!mesolimbic!system!dopaminergic!neurons! that!originate! in! the!VTA! and! project! to! the!NAc.! Several! other! brain! regions! such! as! the! hippocampus,!amygdala! and!PFC! are! also! integral! to! addiction,!which! are! central! to!memory! and!decision!making!behaviours!(Nestler,!2005,!2013).!This!section!will!focus!on!nicotine!addiction!and!therapeutic!strategies!targeting!nAChRs!for!possible!treatments.!
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! Tobacco! smoking! is! currently! the! leading! preventable! cause! of! death! in! the!world!and!a!major!economic!and!public!health!burden!(World!Health!Organization,!2008).!The!primary!addictive!ingredient!of!tobacco!smoke!is!thought!to!be!nicotine,!and!it!is!the!most!well!studied.!It!has!however!long!been!known!that!tobacco!smoke!contains! >4000! chemicals,!many! of!which! are! harmful! and! carcinogenic,! and! some!pharmacologically! active,! such! as! βXcarbolines! which! are! potent! inhibitors! of!monoamine! oxidase! (MAO)! enzymes,! responsible! for! the! degradation! of! dopamine,!noradrenaline!and!serotonin!(Essman,!1977;!van!Amsterdam!et!al.,!2006).!Added!to!this,!there!are!reports!of!at!least!599!additives!in!cigarettes!that!have!been!proposed!to!enhance!the!addictive!properties!of!nicotine!and!facilitate!its!delivery!(Rabinoff!et!al.,! 2007),! leading! some! to! suggest! that! the! problem! of! tobacco! addiction! involves!more! than! nicotine! alone.! Indeed,! it! has! been! demonstrated! that! nicotine! alone! is!weakly! reinforcing! compared! to! nicotine! in! combination! with! MAO! inhibitors! in!rodents!(Guillem!et!al.,!2005;!Kapelewski!et!al.,!2011),!and!this!may!present!another!potential!therapeutic!strategy.!! Nicotine! acts! on! nAChRs! in! the! brain! to! promote! the! release! of! a! range! of!neurotransmitters! (see! section! 1.2.2.8).! The! role! of! nAChRs! in! the! mesolimbic!pathway! is! thought! to! be! critical! to! the! rewarding! effects! of! nicotine,!which! result!from! increased! dopamine! release! in! the! NAc,! and! has! been! shown! to! require! β2*!nAChRs! (Picciotto! et! al.,! 1998;! Benowitz,! 2008),! and! although! not! necessary! for!developing!nicotine!addiction,! some!evidence!also!suggests!a! role! for!α7!nAChRs! in!enhancing! drugXseeking! behaviour! (Brunzell! and! McIntosh,! 2012).! Elevated!dopamine!release!in!the!NAc!occurs!directly!via!nAChRs!on!dopamine!cell!bodies! in!the!VTA! and! their! terminals,! and! also! indirectly! via! nAChR!mediated! facilitation! of!glutamate!release!and!the!inhibition!of!GABA!release!following!nAChR!desensitization!(Benowitz,!2008;!Leslie!et!al.,!2013).!Following!repeated!exposure!to!nicotine,!several!longXterm! changes! have! been! observed! in! brain! reward! circuitry,!which! contribute!towards! the! establishment! of! dependence.! This! includes! the! nicotineXmediated!desensitization,!cellXsurface!upregulation!and!subunit!substitution!of!nAChRs,!and!the!strengthening! of! neural! connections! in! brain! regions! critical! to! addiction! via! LTP!(Buisson!and!Bertrand,!2002;!Benowitz,!2008).!! Current! cessation! strategies! for! nicotine! addiction! include! nicotineXreplacement! therapy! (NRT),! in! the! form! of! chewing! gum,! transdermal! patches! and!
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vaporizers,!which! aim! to!prevent! craving! experienced!by!quitters! by!maintaining! a!level! of! nicotine! in! the! patient’s! body! to! prevent! withdrawal! symptoms,! whilst!removing! the! negative! health! risks! of! smoking! tobacco.! In! a! similar! vein,! smoking!cessation!drugs!that!have!activity!at!nAChRs!are!currently!available;!mecamylamine,!bupropion! and! varenicline! have! been! used! in! such! a!way! (Hurst! et! al.,! 2013).! The!subject! of! chapter! 5,! the! desensitizing! nAChR! agonist! sazetidineXA! has! also! shown!promising! findings! in! preXclinical! studies! for! reducing! nicotineXseeking! behaviour.!These! compounds!are! thought! to!work!by!blocking!access!of!nicotine! to!nAChRs! in!the! brain,! whilst! providing! a! nicotineXlike! effect! to! placate! withdrawal! symptoms!(Polosa!and!Benowitz,!2011).!! To! conclude,! this! section! presents! a! worthy! case! for! the! development! of!nAChR! ligands! as! therapeutics! for! a! range! of! diseases,! that! are! not! exhaustively!described! here! (for! recent! review! see! Hurst! et! al.,! 2013).! Some! drugs! that! target!nAChRs! are! already! available! and! prescribed! such! as! AChEs! and! varenicline,! with!more!currently!in!the!clinical!trial!pipeline!and!a!great!abundance!of!candidate!drugs!constituting! the! base! of! the! drug! development! pyramid,! reflecting! the! need! for!further!and!continued!research.!
1.4 Summary)This! introduction! has! described! nAChRs! as! a! group! of! allosteric! transmembrane!proteins! that! gate! Na+! and! Ca2+,! thereby! influencing! a! diverse! spectrum! of!physiological!processes!from!muscle!contraction!to!cognition.!We!have!also!outlined!an! abundance! of! ligands! that! differentially! influence! the! conformational! states! of!nAChRs,! both! endogenous! and! exogenous,! via! diverse! binding! sites! which! could!potentially!be!used!to!treat!diseases!such!as!schizophrenia,!AD,!PD!and!addiction.!
1.5 Aims)of)the)thesis)This!work! is!divided!into!three!results!chapters,!unified!by!the!underlying!theme!of!Ca2+!signalling,!which!is!used!to!measure!nAChR!function!in!each!case.!The!main!focus!of!these!studies!is!the!highly!Ca2+Xpermeable!α7!nAChR,!which!is!expressed!in!diverse!brain! regions,! and! associated!with! cognitive!processes.! Explicitly,! the! aims!of! these!chapters!are:!
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2.1.1 Compounds,NaCl,( MgCl2,( MnCl2,( Triton( X:100,( (:):nicotine( hydrogen( tartrate,( nifedipine,(mecamylamine( hydrochloride,( choline( bitartrate,( DHβE,( CdCl2,( ionomycin,( Hoechst:33342( and( NMDA( were( purchased( from( Sigma:Aldrich( (UK);( KCl,( CaCl2,( NaH2PO4,(NaHCO3,(glucose(and(HEPES(were(purchased(from(Fisher(Scientific((UK);( fluo:3(AM,(fura:2( AM,( α:bungarotoxin( and( pluronic( f:127( were( purchased( from( Life(Technologies( (UK);( sazetidine:A( dihydrochloride,( tetrodotoxin( citrate,( CGP54626(hydrochloride,( GABA,( methyllycaconitine( citrate,( (S):AMPA,( (+):MK801(maleate,( 5:iodo:A85380( dihydrochloride,( (:):bicuculline( methochloride( were( purchased( from(Tocris(Bioscience((UK);(ryanodine,(LY456236(hydrochloride,(D:AP5(were(purchased(from( Abcam( (UK);( Xestospongin:C( was( purchased( from( Calbiochem( (UK).( Novel(azetidine/pyrrolidine(containing(compounds(were(a(gift(from(Dr.(John(Fossey((School(of( Chemistry,( University( of( Birmingham).( PNU:120596( and( PNU:282987( were(provided(by(Pfizer(Inc.(
2.1.2 Antibodies,Rabbit( anti:glial( fibrillary( acidic( protein( (GFAP),( rabbit( anti:microtubule( associated(protein( type( 2( (MAP2),( rabbit( anti:neurofilament,( mouse( anti:glutamic( acid(decarboxylase((GAD)(and(mouse(anti:synaptophysin(were(purchased(from(Millipore((UK).( Anti:rabbit( Alexa( Fluor:546( and( anti:mouse( Alexa( Fluor:488( conjugated(secondary(antibodies(were(obtained(from(Life(Technologies((UK).(
2.2 Methods,




2.2.2 Primary,cell,culture,Mouse(primary(cortical(cultures(were(prepared(as(previously(described((Hoey(et(al.,(2009).(Briefly,(a(pregnant(female(CD1(mouse((University(of(Bath,(UK)(was(sacrificed(by(cervical(dislocation(and(E18(embryos(were(harvested.(Cortices(were(dissected(in(PBS(with( 30(%( glucose( (Ca2+( and(Mg2+( free)( under( a( dissection(microscope( before(being( dissociated( with( a( fire:polished( glass( Pasteur( pipette.( Tissue( was( then(centrifuged( at( 500( g( for( 5(min,( resuspended( in( neurobasal(medium( (w/out( phenol(red)( supplemented( with( B27,( 2mM( L:glutamine( and( 60μg/ml( penicillin( and( 100(μg/ml( streptomycin( (Life( Technologies,( UK).( Cortices( from( a( single( brain( were(suspended( in(12(ml(media.( For( live( imaging(experiments( (section(2.2.4),( cells(were(grown(on(25(mm(round(glass(coverslips((thickness(no.(1)(coated(with(20(μg/ml(poly:D:lysine( (Sigma:Aldrich,( UK)( and( placed( in( 6:well( tissue( culture( plates( (Corning,(USA).( For( high( content( microscopy( experiments,( cells( were( grown( in( 24:well(visiplates((Perkin:Elmer,(UK).(Cells(were(allowed(to(grow(for(10:14(d(in#vitro((DIV)(at(37(°C(in(a(humidified(atmosphere(of(95(%(air(and(5(%(CO2.(
2.2.3 969well,plate,Ca2+,fluorescence,assays,Increases( in( [Ca2+]ic( were( measured( as( described( previously( (Dajas:Bailador( et( al.,(2002a).( Briefly,( cells(were(washed( twice(with(Tyrode’s( salt( solution( (TSS:( 137(mM(NaCl,(2.7(mM(KCl,(1.0(mM(MgCl2,(1.8(mM(CaCl2,(0.2(mM(NaH2PO4,(12(mM(NaHCO3,(5.5(mM(glucose;(pH(7.4)(and(incubated(with(the(membrane:permeable,(Ca2+(sensitive(dye(fluo:3( AM( (10( μM)( and( 0.02( %( pluronic( F127( for( 1( h( at( room( temperature( in(darkness.( Cells(were( then(washed( twice(with(TSS(before(pre:incubation(with(80(μl(antagonists,(modulators( or( TSS( (20(min( for( αbgt,( 10(min( for( all( others;( 1.25( times(final(concentration).(Changes(in(fluorescence((excitation(485(nm,(emission(538(mm)(were( measured( using( a( Fluoroskan( Ascent( fluorescent( plate( reader( (Thermo(Scientific,( UK).( Basal( fluorescence( was( measured( for( 5( s( before( drugs( were(automatically( dispensed( (20( μl;( 5( times( final( concentration)( and( fluorescence( was(monitored(for(a(further(20(s.(
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Normalisation( was( achieved( by( determining( the( maximum( and( minimum(fluorescence(values(of(each(fluo:3(AM(signal(using(0.2(%(Triton(X:100((Fmax)(followed(by(40(mM(MnCl2((Fmin).(Data(were(calculated(as(a(percentage(of(Fmax:Fmin.(




where( Rmax( is( given( by( F340:F380( following( perfusion( of( cultures( with( 10( mM( Ca2+(buffer(containing(2(μM(ionomycin,(and(Rmin(is(given(by(F340:F380(following(perfusion(of(cultures( with( Ca2+:free( buffer( containing( 2( μM( ionomycin( and( 1( mM( EGTA.(Parameters( were( entered( in( the( Ultraview( software( (Perkin( Elmer,( UK)( for(calculation,(assuming(Kd(=(244(nM(of(Ca2+(for(fura:2((Grynkiewicz(et(al.,(1985).(
2.2.5 High,content,microscopy:,Ca2+,assays,with,immunofluorescence,Optimized(method,(devised( following(preliminary(experiments(described( in(chapter(4.( [Ca2+]ic( changes( and( immunofluorescence( in( large( cell( populations( were( imaged(using( high( content(microscopy( (INCell( Analyzer( 2000,( GE( healthcare,( UK).( Primary(cultures((10:14(DIV)(were(washed(twice(with(Ca2+(buffer((140(mM(NaCl,(5.0(mM(KCl,(1.0(mM(MgCl2,(1.8(mM(CaCl2,(10(mM(glucose,(5.0(mM(HEPES;(pH(7.4)(and(incubated(with( the(Ca2+( sensitive(dye( fluo:3(AM((10(μM),( the(nucleic( acid(dye(Hoechst:33342((10(μΜ)(and(0.02(%(pluronic(F127(for(1.5(h(at(room(temperature(in(darkness((200(μl(per(well).(Cells(were(then(washed(twice(with(buffer(before(pre:incubation(with(400(μl(antagonists,(modulators(or(buffer((10(min;(1.25(times(final(concentration).(Two(basal(images(were( then(acquired(at(455(and(525(nm(following(excitation(at(350(and(490(nm( 6.4( s( apart,( followed( by( automatic( dispensation( of( drugs( (100( μl;( 5( times( final(concentration).(Then(three(more(images(were(captured(at(both(wavelengths(at(10(s(intervals.(( After(completion(of(the(Ca2+(imaging(assay,(cells(were(washed(twice(with(PBS(and(fixed(in(4(%(PFA(for(20(min.(Cell(were(washed(again(three(times(with(PBS,(and(incubated( in(PBS(containing(3(%(BSA(and(0.1(%(Triton(X:100( to(block(non(specific(antibody(binding.(Primary(antibodies((1:1000)(in(PBS(were(then(added(to(cells(in(the(presence(of(1(%(BSA(and(0.1(%(Triton(X:100(and( left(overnight(at(4( °C.(Cells(were(then(washed(three(times(for(5(min(before(fluorescently(tagged(secondary(antibodies(in(PBS(with(1(%(BSA(and(0.1(%(Triton(X:100(were(added(for(1(h(at(room(temperature.(Cells( were( again( washed( three( times( with( PBS,( and( left( in( PBS( containing( 10( μM(Hoechst:33342.( Fixed( and( immunostained( cells( were( then( imaged( a( second( time(using(high(content(microscopy(at(appropriate(wavelengths.(( Image(processing(and(analysis(is(covered(extensively(in(chapter(4,(section(4.2.(HCS(Ca2+(imaging(assays(were(conducted(separately(in(triplicate(due(to(the(need(for(drug(pre:incubation(between(different(conditions.( Imaging(data(from(each(triplicate(
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was( then( saved( automatically( as( an( image( stack.( In( order( to( analyse( data( from( an(entire( 24:well( plate( simultaneously,( image( stacks( were( combined( using( INCell(Translator( software( (GE( Healthcare,( UK)( according( to( a( customized( filename(metadata( expression,( which( could( extract( parameters( such( as( date,( column,( row,(time:point(and(wavelength(from(image(filenames(and(directories.(Image(stacks(could(then( be( analysed( with( customized( algorithms( using( INCell( Developer( Toolbox(software( (GE( Healthcare,( UK),( and( visualized( using( a( file:link( to( Spotfire( (TIBCO,(Boston,(USA)(for(inspection.(( The( final( algorithm( used( to( identify,( track( and( measure( the( fluorescence(intensity(of(cell(bodies( linked( to(a(nucleus(constructed( in( INCell(Developer(Toolbox(software( is( as( follows:( Nuclear( objects( were( assigned( to( Hoescht:33342( stained(images(using(object(segmentation(with(kernel(size(5,(sensitivity(20.(A(post:processing(sieve(was(added(to(exclude(objects(smaller(than(8(μm2.(Cell(objects(were(assigned(to(the( fluo:3( stained( image( using( object( segmentation,( kernel( size( 25,( sensitivity( 30.(Post:processing(modules(were( then(added:( sieve(10(μm2,( clump(breaking( including(secondary(targets(with(radius(2,(and(border(object(removal.(To(link(cells(through(the(time( series,( track( and( block( was( defined( to( use( an( extended( blocking( method(according( to( time:point.( Target( linking(was( then( used( to( combine( cell( and( nuclear(objects( at( each( time:point.( Output( measures( were( selected( to( report( fluorescence(intensity(for(each(individual(cell(object,(which(were(then(manipulated(to(express(the(change(in(F525(between(basal(and(stimulated(time:points((ΔF525). 
2.2.6 Statistics,Statistical( tests( were( carried( out( in( Prism( 6( (GraphPad( Software,( Inc;( CA,( USA)( as(indicated( in( figure( legends.( Statistical( significance( was( defined( by( P#<( 0.05( for( all(tests;( independent( experiments( constituting( a( single( n( were( defined( by( those(conducted(on(cultures(from(separate(animals(or(separate(cell:line(passages.(( One:way(analysis(of( variance( (ANOVA)( tests( assumed(normal(distribution(of(data,(and(were(used(in(conjunction(with(post/hoc(multiple(comparisons(tests(to(detect(statistically( significant( differences( between( treatment( groups.( Comparisons( were(taken( from( pre:selected( treatment( group( pairs( (indicated( by( connecting( lines( in(figures)(and(corrected(using(Bonferroni’s(multiple(comparisons(test.((
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3.1 Introduction-As(discussed(in(section(1.2.2,(the(intrinsic(capacity(of(nAChRs(to(flux(Ca2+(places(them(in( a( pivotal( position( to( influence( an( extremely( diverse( spectrum( of( physiological(events.( Incidentally,( Ca2+( also( presents( an( effective(means( of( measuring( functional(nAChR( activity( in( an( experimental( scenario,( owing( to( its( inherent( chemical(properties.(With( the( aid( of( a(modest( pharmacological( toolkit,( the(dark( tunnels( that(comprise(the(labyrinth(of(intracellular(Ca2+(signalling(can(be(partially(illuminated(to(provide(insight(into(the(role(played(by(nAChRs(in(health(and(disease.(( This(chapter(will(detail(experiments( that(aim(to(disentangle( the(various(Ca2+(signalling(pathways(that(either(directly(or(indirectly(result(from(the(stimulation(of(α7(nAChRs( in( primary( cultured( cells( from( mouse( cerebral( cortex( with( the( aid( of(fluorescent( Ca2+( indicators( and( live( cell( imaging.( Initial( experiments( used( SH7SY5Y(cells( in( high( throughput( Ca2+( fluorescence( assays( to( evaluate( the( pharmacological(profile(of(selective(compounds(used(to(stimulate(α7(nAChRs.(As(the(majority(of(background(information(relevant(to(these(experiments(was(discussed(in(the(general(introduction((chapter(1),(this(section(will(be(concerned(with(describing(the(experimental(models(and(methods(used(to(evaluate(nAChR(mediated(Ca2+(signalling(in(neuronal(cells.(
3.1.1 Measuring-intracellular-Ca2+-signals-Intracellular( Ca2+( has( historically( been( measured( using( either( Ca2+( binding(photoproteins(or(chemical(Ca2+(indicators(as(reporter(molecules(in(combination(with(microscopy.( The( earliest( Ca2+( indicator( to( be( used(was( the( photoprotein( aequorin,(isolated(from(the(luminescent(jellyfish(Aequorea((Shimomura(et(al.,(1962),(since(then(numerous(Ca2+( chelating( fluorophores(and(genetically(encoded(Ca2+( indicators(have(been( developed,( alongside( ever( increasing( imaging( capabilities( (Grienberger( and(Konnerth,(2012).(( In( the( experiments( that( comprise( this( thesis,( extensive( use( is( made( of( the(chemical( Ca2+( indicators( fluo73( and( fura72,( which( will( be( the( focus( of( this( section((Figure(3.1.1).(These( indicators(belong( to(a( family(of(highly( selective(Ca2+( chelators(derived( from( the( EGTA( analogue( 1,27bis(o7aminophenoxy)ethane7N,N7N’,N’7tetraacetic( acid( (BAPTA),( which( binds( two( Ca2+( ions( via( its( four( carboxylic( acid(
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groups.( The( addition( of( fluorescent( chromophore( groups( makes( fluo73( and( fura72(capable(of(reporting(changes(in([Ca2+]((Tsien,(1980;(Grynkiewicz(et(al.,(1985;(Minta(et(al.,( 1989).( Important( differences( between( fluo73( and( fura72( exist( and( have(implications( for( their( use( when( measuring( [Ca2+].( When( chelating( Ca2+,( the(fluorescence(of(fluo73(is(increased(up(to(407fold,(whereas(fura72(undergoes(a(spectral-
shift.(This(feature(of(fura72(arises(from(its(dual(spectroscopic(excitation(peaks(at(340(and( 380( nm,( in( contrast( to( the( single( excitation( peak( of( fluo73( at( 488( nm.( The(excitation(of(fura72(at(either(340(or(380(nm(is(dependent(on([Ca2+],(and(therefore(the(ratio(of(fluorescence(emitted(at(510(nm(resulting(from(excitation(at(either(340(or(380(nm( is( directly( correlated( to( [Ca2+]( and( can( be( calibrated( using( minimum( and(maximum( Ca2+( buffer( solutions( to( calculate( [Ca2+]( using( the( Grynkiewicz( equation((Grynkiewicz(et(al.,(1985).(











distribution((Grynkiewicz(et(al.,(1985),(but(limits(temporal(imaging(resolution(to(the(speed(of(excitation(wavelength(switching(between(340(and(380(nm.((To( facilitate( loading,( both( fluo73( and( fura72( are(made( cell( permeable( by( the(addition(of(an(acetoxymethyl(ester(group,(which(is(cleaved(by(intracellular(esterases,(once(again(rendering(them(cell(impermeable(and(locking(them(in(the(cytosol((Tsien,(1981).( It( should( be( remembered( that( as( Ca2+( indicators( chelate( Ca2+,( they( act( as(exogenous(Ca2+(buffers,(altering(the(natural(Ca2+(buffering(capacity(of(the(cell((Neher,(1995),(slightly(distorting(the(free(cytosolic([Ca2+](dynamics(from(that(in(the(absence(of( indicator.(Using( these(compounds,(we(aim(to(measure(Ca2+(signalling( in(SH7SY5Y(cells(and(mouse(primary(cortical(cultures.(
3.1.2 SH9SY5Y-cells-The( systematic( screening( of( pharmacological( agents( to( assess( their( functional(properties(in-vitro(requires(a(relatively(uniform(biological(model,(which(is(satisfied(by(the( use( of( immortalized( cell( lines;( a( relatively( cheap,( low( maintenance( and( easily(accessible( source( of( experimental( biological( material( that( will( continue( to( divide(indefinitely.( SH7SY5Y( cells( are( a( sub7clone( from( the( SK7N7SH( cell( line,( originally(derived( from( a(metastatic( human(bone( tumour( biopsy,( first( sub7cloned( into( SH7SY,(SH7SY5( and( finally( SH7SY5Y( cells( (Biedler( et( al.,( 1978;( Kovalevich( and( Langford,(2013).( They( comprise( both( adherent( and( non7adherent( cells,( and( have( been(described( to( present( two( distinct( morphologies:( “neuroblast7like”( and( “epithelial7like”((Ross(et(al.,(1983).(( SH7SY5Y(cells(have(been(reported(to(express(α3,(α5,(β2(and(β4(nAChR(subunit(mRNA( as( evidenced( by( northern( blot( analysis( (Lukas( et( al.,( 1993).( Radioligand(binding(studies(using([125I]αbgt(also(provided(evidence(for(surface(expression(of(α7(nAChRs,(whereas(a( two( site(model( could(be( fitted( for(high(affinity( [3H]ACh(binding(experiments,( suggesting( two( distinct( non7α7( nAChR( subtypes( (Lukas( et( al.,( 1993;(Ridley( et( al.,( 2001).( Functional( 86Rb+( efflux( assays( suggested( that( the( majority( of(nAChRs(expressed(by(SH7SY5Y(cells(were(non7α7(due(to(αbgt(insensitivity((Lukas(et(al.,(1993).(Peng(et(al.((1994)(also(cloned(the(α7(nAChR(subunit(cDNA(from(SH7SY5Y(cells,( confirming( that( when( expressed( in( X.- laevis( oocytes,( the( resulting( receptors(exhibited( rapidly( desensitizing,( inwardly( rectifying( currents( that( triggered( Ca2+(sensitive( Cl7( channels,( characteristic( of( functional( α7( nAChRs( expressed( in( oocytes.(
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Furthermore,(expression(of(cloned(human(α3,(α5,(β2(and(β4(cDNA(in(X.(laevis(oocytes(suggested( assembly(of( functional( surface(α3β2,(α3β4,(α3β2α5(and(α3β4α5(nAChRs(and(it(was(also(found(that(native(SH7SY5Y(α3(subunits(were(immuno7associated(with(α5( subunits,( and( that( half( of( these(were( associated(with( β2( subunits( (Wang( et( al.,(1996;(Gerzanich(et(al.,(1998).(Surface(expression(of(α7(and(α3β2*(nAChRs(in(SH7SY5Y(cells( was( reported( to( be( upregulated( by( nicotine( as( shown( by( [125I]αbgt( and([3H]epibatidine(binding(studies((Ridley(et(al.,(2001),(and(there(have(been(reports(of(nAChR(mediated([Ca2+]ic(elevations(recruiting(VGCCs(and(CICR((Dajas7Bailador(et(al.,(2002a).( Together,( these( studies( endorse( SH7SY5Y( cells( as( an( appropriate(experimental(model(for(studying(nAChR(mediated([Ca2+](signals(in(a(high(throughput(fashion.(
3.1.3 Mouse-primary-cerebral-cortical-cultures-The( majority( of( experiments( comprising( this( thesis( were( carried( out( on( primary(cultured(cells(from(embryonic(day(18(CD1(mouse(cerebral(cortex,(which(at(this(level(of( development( has( been( reported( to( exhibit( pharmacological( properties( of( nAChR(binding( sites( similar( to( those( of( the( adult( rodent( brain( (Dávila7García( et( al.,( 1999).(Due( to( the( fact( that( neurons( are( post7mitotic( cells,( they( do( not( divide( and( cannot(therefore( be( used( continuously( like( immortalized( cell( lines( (e.g.( SH7SY5Y( cells;(above),(and(must(be(freshly(prepared.(Primary(cultures(from(rodent(brain(tissue(have(been(extensively(used(for(pharmacological,(neurochemical(and(toxicological(studies,(and( provide( a( convenient( system( to( investigate( the( properties( of( neuronal( and/or(glial(cells( from(certain(brain(regions( in( isolation((for(review,(see(Suñol(et(al.,(2008).(Following( ultrastructural( characterization,( Robert( et( al.,( (2012)( concluded( that(functional(characteristics(of(primary(cultured(rat(neurons( faithfully(represent( those(of( neurons( in( vivo,( forming( processes,( synaptic( connections( and( exhibiting(spontaneous(electrical(activity,(although(abnormally(shaped(organelles(were(found.(( Cortical(cultures(have(been(described(as(containing(mainly(glutamatergic(and(~40(%( GABAergic( neurons( (Suñol( et( al.,( 2008).( Numerous( studies( have(measured(release(of(glutamate( (Bianchi(et( al.,( 2007;(Lin(et(al.,( 2010)(and(GABA( from(primary(cortical( cultures( (Hertz( et( al.,( 1984;( Cai( and( Erdö,( 1992;( Schaffhauser( et( al.,( 1998;(Bianchi(et(al.,(2007;(García(et(al.,(2008),(and(expression(of(vesicular(neurotransmitter(transporters(is(reported(to(be(similar(to(that(in-vivo((De(Gois(et(al.,(2005;(Fattorini(et(
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al.,( 2009;( Fiederling( et( al.,( 2011).( The( expression( of( nAChRs( in( cortical( cultures( is(evidenced(to(be(the(same(as(that(in-vivo(from(numerous(pharmacological(and(ligand(binding( studies,( confined( to( α7( and( α4β2( subtypes.( Among( them,( Barrantes( et( al.((1995b)(reported(α7(nAChRs(in(rat(cortical(cultures(labelled(with([125I]αbgt(in(36(%(of(cells,(compared(to(95(%(of(cells(in(hippocampal(cultures.(Numerous(other(studies(also(provide(evidence(for(α7(expression(in(cortical(neurons((Jensen(et(al.,(1997;(Hu(et(al.,( 2009;( Lin( et( al.,( 2010;(Hammond(et( al.,( 2013),( and( also( astrocytes( (Wang( et( al.,(2013)( and( microglia( (Morioka( et( al.,( 2014).( Competition( binding( studies( using([3H]cytisine( and( [3H]epibatidine( provided( evidence( for( α4β2( nAChR( subtypes((Dávila7García( et( al.,( 1999;( Hilmas( et( al.,( 2001),( and( nicotine( mediated(neuroprotection(of(hypoxic(and(glutamatergic(insult(was(found(to(be(blocked(by(αbgt,(DHβE(and(β2(KO((Hejmadi(et(al.,(2003;(Stevens(et(al.,(2003);(whereas(57iodo7A85380((57IA)(mediated(neuroprotection(and(nicotine(mediated( increases( in(phosphor7ERK(were(blocked(by(DHβE(and(β2(KO(respectively((Steiner(et(al.,(2007;(Ueda(et(al.,(2008).(( Evidence( also( exists( for( the( expression( of(mAChRs( (Hammond( et( al.,( 2013),(group(I,(II(and(III(mGluRs((Prézeau(et(al.,(1994;(Schaffhauser(et(al.,(1998;(Koga(et(al.,(2010;(Ayala(et(al.,(2012),(GABAA((Hu(and(Ticku,(1994;(Pomés(et(al.,(1994;(García(et(al.,(2006),( GABAB( (New( et( al.,( 2006),( AMPA( (Cai( and( Erdö,( 1992;( Fischer( et( al.,( 2002;(Rainey7Smith(et(al.,(2010;(Hoey(et(al.,(2013),(NMDA((Hilmas(et(al.,(2001;(Hoey(et(al.,(2009;(Lin(et(al.,(2010),(57HT((Bianchi(et(al.,(2007),(dopamine((Kurokawa(et(al.,(2011,(2012)(and(adrenergic(receptors(in(cortical(cultures((Hansson(et(al.,(1984;(Suñol(et(al.,(2008).( Relevant( to( experiments( of( this( chapter( which( concern( intracellular( Ca2+(signalling( mechanisms,( RyR71( and( 72( have( been( reported( in( cortical( cultures((Kurokawa(et(al.,(2011,(2012),(as(have(L7type(VGCCs((Stevens(et(al.,(2003;(Hoey(et(al.,(2009).(Together,(evidence(favours(the(use(of(primary(cortical(cultures(as(a(convenient(neuronal(model,(which(can(be(easily(imaged(and(pharmacologically(manipulated,(and(contains(the(relevant(receptors(for(the(work(comprising(this(thesis.(
3.1.4 Aims-This( chapter(aims( to(evaluate( the(mechanisms(of(α7(mediated( [Ca2+]ic( elevations( in(cells( of( the( mouse( cortex( using( the( α7( selective( PAM( PNU1( and( selective( agonist(PNU2.(Numerous(possible(routes(of(Ca2+(entry(to(cells(are(possible(in(this(system((see(section(1.2.2),(which(can(be(interrogated(by(the(use(of(selective(antagonists.(
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Figure' 3.2.1:' PNU1' strongly' potentiates' αbgt' sensitive' intracellular' calcium' elevations' in' SH?SY5Y'
cells'SH7SY5Y(cells(loaded(with(fluo73(AM(were(stimulated(with(nicotine((30(μM;(red(bars),(choline((1.5(mM;(blue(bars)(and(PNU2((1(μM;(green(bars)( in( the(presence(or(absence(of(PNU1((10(μM;(dashed(bars).(Responses(observed(in(the(presence(of(PNU1(were(challenged(with(the(α7(nAChR(selective(antagonist(α7bungarotoxin((αbgt;( 100(nM;( hatched(bars).( Fluorescence( at( 538(nm(was(measured( for( 20( s( following( stimulation(with(nicotinic(agonists(or(TSS((white(bar)(alone(or(following(5(min(pre7incubation(and(co7application(of(PNU1(or(20( min( pre7incubation( of( αbgt.( Data( are( presented( as( per( cent( maximum( fluorescence( determined( by(addition(of(0.2(%(Triton(X7100(minus(minimum(fluorescence(quenched(by(350(mM(MnCl2.(Bars( represent(mean(±(SEM(of(at( least(4( independent(experiments;(*(P(<(0.05,(***(P(<(0.001,(****(P(<(0.0001,(significantly(different( from( nicotine,( choline( or( PNU2( or( in( combination( with( PNU1,( non7paired( one7way( ANOVA,(Bonferroni’s(multiple(comparisons(test.'
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18;(not( shown).( In(order( to(observe(nAChR7mediated( responses,(we(applied(30(μΜ(nicotine,( previously( reported( to( be( the( approximate( EC50( for( nicotine( in( this( assay((Ridley( et( al.,( 2002;( Dajas7Bailador( et( al.,( 2003;( Figure( 3.2.1).( This( resulted( in(fluorescence( increases(of(12.69(±(3.25(%.(Cells(were( then(exposed(to( the(α7(nAChR(selective(agonists( choline( (1.5(mM;(EC50( reported( in(electrophysiological( studies(by(Alkondon(et(al.,(1997)(and(PNU2((1(μM;(EC50(in(electrophysiological(studies(Hajós(et(al.,(2005).(Alone(these(compounds(had(very(little(effect(on(fluorescence,(comparable(to( that( of( TSS( alone.( However,( when( cells( were( pre7incubated(with( PNU1( (10( μM;(maximally(effective(concentration(for(potentiation(Hurst(et(al.,(2005;(Dickinson(et(al.,(2007)(for(5(min,(co7application(of(choline((1.5(mM)(or(PNU2((1(μM)(resulted(in(large(and( rapid( fluorescence( increases( of( 48.95( ±( 12.21( %( and( 43.81( ±( 11.04(%(respectively,(that(were(significantly(different(from(choline((1.5(mM)(and(PNU2((1(μM)(alone.( PNU1( (10( μM)( was( also( co7applied( with( nicotine( (30( μM)( for( comparison,(yielding(fluorescence(increases(of(34.57(±(7.43(%,(a(2.72(±(0.22(fold(potentiation.(( To( confirm(α7(nAChR( specificity( of( these( responses,( the(α7(nAChR( selective(antagonist(αbgt((100(nM)(was(pre7incubated(with(SH7SY5Y(cells(for(20(min(prior(to(agonist(stimulation.(Under(these(conditions,(responses(to(choline((1.5(mM)(or(PNU2((1(μM)( in( the( presence( of( PNU1( (10( μM)( were( completely( blocked( (fluorescence(changes(of(2.70(±(0.46(%(and(1.56(±(0.19(%(respectively).(( We(then(examined(the(concentration(response(profile(of(PNU1(in(combination(with( choline( (1.5( mM)( or( PNU2( (1( μM;( Figure( 3.2.2).( Following( two( reports( from(Uteshev’s(lab((Gusev(and(Uteshev,(2010;(Kalappa(et(al.,(2010),(that(showed(that(PNU1(could(enhance( “sub7threshold,(physiological( (~10(μM)”(concentrations(of( choline(at(α7(nAChRs(by(using(patch7clamp(electrophysiology(in(tuberomammillary(neurons(in(hypothalamic( slices,( and( hippocampal( CA1( pyramidal( neurons,( we( assessed( the(ability( of( PNU1( to( potentiate( the( responses( to( lower( concentrations( of( choline( and(PNU2,( as(well( as( the( concentrations( used( in( Figure( 3.2.1.( For( this(we( chose( to( use(PNU2(at(100(nM,(roughly(equivalent( to( the(difference( in(concentration(between(1.5(mM(and(10(μM(used(for(choline.(
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( SH7SY5Y( cells( loaded( with( fluo73( AM( were( pre7incubated( with( increasing(concentrations( of( PNU1( (0.3(μM(–(100(μM),( and( stimulated(with( choline( (1.5(mΜ).(Here(there(was(concentration7dependent(potentiation(by(PNU1(with(EC50(estimated(at(4.49(μΜ,(which(reached(maximal(levels(of(~50(%(at(~100(μΜ.(Upon(stimulation(of(cells(with( physiological( concentrations( of( choline( (10( μM),( PNU1( (1( μM( –( 100( μM)(concentration7dependently(potentiated( responses(with( estimated(EC50( of( 16.33(μM,(also(approaching(maximal(levels(of(~12(%(at(~100(μM.(( Cells(pre7incubated(with(varying(concentrations(of(PNU1( (0.3(μM(–(100(μM)(were(then(stimulated(with(PNU2((1(μM).(A(concentration7dependent(relationship(was(observed(for(PNU1(potentiation(with(estimated(EC50(of(6.80(μM,(tending(to(maximum(of(~64(%( at(~100( μM.( To( evaluate( the( effects( of( lower( agonist( concentrations,(we(chose(a(concentration(100(times(lower((100(nM),(as(with(choline(above.(Here,(PNU1(potentiated(responses(with(a(similar(EC50(of(13.60(μM,(approaching(maximum(of(~33(%(at(~100(μM.(Finally,(we(used(a( lower(concentration(of(PNU2((30(nM).(Here,(pre7incubation(of( PNU1( (0.3( μM(–(100(μΜ)(was( relatively( ineffective( at( boosting(PNU2(induced(responses,(with(maximum(fluorescence(increase(of(~4(%.(
(
Figure' 3.2.2:' Concentration' response' profile' of' PNU1' potentiation' of' choline' and' PNU2' evoked'
intracellular'calcium'elevations'in'SH?SY5Y'cells.'SH7SY5Y(cells(loaded(with(fluo73(AM(were(pre7incubated(with(varying(concentrations(of(PNU1((0.3(μM(–(100(μM)(for(5(min(before(stimulation(with(choline((10(μM,(1.5(mM;(a)(or(PNU2((30(nM,(100(nM,(1(μM;(b).(Fluorescence(at(538( nm( was( then( measured( for( 20( s.( Data( are( presented( as( per( cent( maximum( fluorescence( determined( by(addition(of(0.2(%(Triton(X7100(minus(minimum(fluorescence(quenched(by(350(mM(MnCl2.(Points(represent(mean(±(SEM(or(range(of(at(least(2(independent(experiments.(Data(were(fitted(to(the(Hill(equation.'
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Figure'3.2.3:'PNU1'potentiates'low'concentrations'of'choline'and'PNU2.'SH7SY5Y( cells( loaded(with( fluo73( AM(were( stimulated(with( choline( (10( μM;( blue( bars)( and( PNU2( (100(nM;(green(bars)(in(the(presence(or(absence(of(PNU1((30(μM;(dashed(bars).(Responses(observed(in(the(presence(of(PNU1(were(challenged(with(the(α7(nAChR(selective(antagonist(α7bungarotoxin((αbgt;(100(nM;(hatched(bars).(Fluorescence(at(538(nm(was(measured(for(20(s(following(stimulation(with(choline(or(PNU2(alone(or(following(5(min( pre7incubation( and( co7application( of( PNU1( or( 20(min( pre7incubation( of( αbgt.( Data( are( presented( as(percent(maximum(fluorescence(determined(by(addition(of(0.2(%(Triton(X7100(minus(minimum(fluorescence(quenched(by(350(mM(MnCl2.(Bars(represent(mean(±(SEM(of(at(least(4(independent(experiments;(*(P(<(0.05,(**(P(<(0.01(significantly(different(from(choline(or(PNU2(or(in(combination(with(PNU1,(non7paired(one7way(ANOVA,(Bonferroni’s(multiple(comparisons(test.(
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3.2.2 Preliminary* experiments* and* method* development* in* mouse* primary*



















Figure'3.2.4:'KCl'evokes'robust'F340:F380'increases'in'mouse'primary'cortical'cultures'Mouse(primary( cortical( cultures( (10714(DIV)(were( loaded(with( fura72(AM,(perfused(with(1.8(mM(calcium(buffer(at(37(°C(and(imaged(under(a(fluorescence(microscope(at(510(nm.(Basal(fluorescence((a)(was(monitored(for(60(s(before(20(s(application(of(KCl((40(mM;(b).(Still(images(show(fluorescence(in( pseudocolour,( (black/blue( =( low( F340:F380,( red/white( =( high( F340:F380)( taken( during( buffer(perfusion(and(KCl(stimulation.(Time(trace((c)(shows(coloured(lines(corresponding(to(42(regions(of(interest( selected( as( responding( cells,( circled( in( each( image.( Data( are( presented( as( a( ratio( of(fluorescence(emitted(at(510(nm( following(excitation(at(340(and(380(nm.(Data( are(presented(as( a(ratio(of(fluorescence(emitted(at(510(nm(following(excitation(at(340(and(380(nm((F340:F380).(
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typically(took(~20(s(to(reach(cells(through(perfusion(lines(and(provoke(a(response.(In(one(experiment,(KCl(evoked(responses(from(35/42(regions(of( interest((ROIs;(Figure(3.2.4b)(in(a(densely(populated(field(of(view.(The(average(peak(F340:F380(increase(was(0.87( (SD( =( 0.21),( and( was( slightly( variable( between( ROIs,( ranging( from( 1.0171.91(above(basal(levels((0.59;(SD(=(0.02).(Following(calibration,(average(basal([Ca2+]ic(was(determined(by(the(Grynkiewicz(equation((see(methods;(Grynkiewicz(et(al.,(1985)(to(be(278.91(±(86.74(nM,(which(is(higher(than(others(report((<100(nM;(Dajas7Bailador(et(al.,( 2000;(Beker( et( al.,( 2003;(Evans( and(Cousin,( 2007),( furthermore(basal( [Ca2+]ic( of(some(cells(was(calculated(to(be(“0(nM”.(Three(repeats(of(calibration(were(carried(out,(but(did(not(give(repeatable(results,(therefore(here(we(present(data(as(F340:F380.(
( Having( observed( positive( responses( to( KCl,( we( then( aimed( to( verify( the(presence(of(functional(α7(nAChRs(in(mouse(primary(cortical(cultures(by(stimulating(them(with(α7(nAChR(selective(drugs(whilst(monitoring(changes( in( the( fluorescence(ratio(F340:F380.((
(
















Alone,(20(s(perfusion(with(PNU2(did(not(elicit(a(detectable(increase(in(F340:F380((repeated(3(times;(Figure(3.2.5).(In(this(experiment,(subsequent(perfusion(of(40(mM(KCl( for( 20( s( to( the( same( cells( resulted( in( large( and( rapid( increases( in( F340:F380( of(0.33(±(0.03( (5(cells)(above(basal( levels( (0.44(±(0.17),( confirming( that( the(cells(were(responsive.( We( therefore( used( the( α7( nAChR( PAM( PNU1( to( enhance( α7( nAChR(activation( to( detectable( levels.( Pre7incubation( of( PNU1( (10( μM)( for( 3( min( had( no(measurable(effect(on(basal(F340:F380((Figure(3.2.6).(However,(co7application(of(PNU2((3(μM)(with(PNU1((10(μM)(resulted(in(large(F340:F380(increases(of(0.42(±(0.08(above(basal((0.30(±(0.03),(averaged(from(35(experiments(on(14(independent(cultures.(These(responses( occurred( in( a( subpopulation( of( cells( counted( at( 12(%( of( all( visible( cells(from( a( sample( of( 20( measurements( from( 14( independent( cultures,( a( much( lower(proportion(than(that(responding(to(KCl((40(mM;(82(%).(Individual(responses(to(PNU2((3(μM)(in(the(presence(of(PNU1((10(μM)(were(highly(variable:(peak(F340:F380(increases(measured(of(455(cells(from(14(independent(cultures(ranged(from(0.00(to(2.26(with(an(average(of(0.46(±(0.04(above(basal( levels((0.32(±(0.01)(with(a(standard(deviation(of(0.92.(For(this(reason(when(comparing(different(drug(treatments(to(control(responses,((
Figure' 3.2.6:' PNU1' alone' does' not' affect' F340:F380,' but' enhances' PNU2'

































To( confirm( the( α7( nAChR( selectivity,( responses( to( PNU2( with( PNU1( were(challenged( with( the( α7( nAChR( selective( competitive( antagonist( methyllycaconitine((MLA(100(nM;(as(opposed(to(using(αbgt,(which(requires(lengthy(pre7incubation,(~20(min).(Control(responses(to(PNU2((20(s;(3(μM)(in(the(presence(of(PNU1((10μM;(3(min)(gave(average(peak(F340:F380(increases(of(0.20(±(0.13(above(basal(levels((0.25(±(0.06).(MLA(pre7incubated(for(10(min(fully(blocked(subsequent(responses(elicited(by(PNU2((3( μM)( in( combination(with( PNU1( (10( μM;( 93.86( ±( 7.26(%;( Figure( 3.2.9a,( d)( in( all(previously( responding( cells,( (39( cells( pooled( from( 4( experiments( conducted( in( 3(independent(cultures;(SD(=(11.00(%;(Figure(3.2.21).(Following(10(min(washout,(3(min(pre7incubation(and(co7application(of(PNU1(with(PNU2(for(20(s(resulted(in(a(variable(recovery(of(the(original(response((89.68(±(22.73(%;(Figure(3.2.9c,(d).(
( In( one( experiment,( cultures(were( exposed( to( PNU1( (10( μM)( in( combination(with( PNU2( (3( μM)( multiple( times( to( evaluate( whether( responses( would( remain(consistent((Figure(3.2.10).(Initially,(cells(were(pre7incubated(with(PNU1((10(μM)(for(3(min,(and(then(exposed(to( three(consecutive(20(s(PNU2((3(μM)(co7applications,(50(s(
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Figure'3.2.9:'MLA'fully'blocks'responses'evoked'by'PNU1'in'combination'with'PNU2'in'mouse'primary'cortical'cultures.'Cultures((10714DIV)(were( loaded(with( fura72(AM,(perfused(with(1.8(mM(calcium(buffer(at(37(°C(and( imaged(under(a( fluorescence(microscope(at(510(nm.(Cells(were(pre7incubated(with(PNU1((10(μM;(3(min)(before(recording(basal(F340:F380(for(30(s,(after(which(PNU2((3(μM;(a)(was(co7applied(for(20(s.(After(3(min(wash(out,(cells(were(then(pre7incubated(for(10(min(with(MLA((100(nM)(and(PNU1((10(μM)(prior(to(recording(F340:F380(before,(during(and(after(co7stimulation(with(PNU2((3(μM;(20(s;(b).(Finally,(following(10(min(wash(out,(the(protocol(was(repeated(in(the(absence(of(MLA((c).(Still(images(show(fluorescence(in(pseudocolour,((black/blue(=( low( F340:F380,( red/white( =( high( F340:F380)( taken( during( PNU2( stimulation.( Traces( show( coloured( lines( corresponding( to( 20( regions( of( interest( selected( as(responding( cells,( circled( in( each( image.( Data( are( presented( as( a( ratio( of( fluorescence( emitted( at( 510( nm( following( excitation( at( 340( and( 380( nm( from( a(representative(experiment.(Bars((d)(represent(mean(peak(F340:F380(increase(from(basal(expressed(as(a(percentage(of(the(initial(stimulation(response(from(the(same(region(of(interest(±(SEM(from(3(independent(experiments;(**(P"<(0.01(significantly(different(from(initial(response(to(PNU2(in(combination(with(PNU1((100(%),(one(sample(t7test.(
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PNU1# PNU2# PNU1# PNU2# PNU1# PNU2#
b"i."
a"i."
PNU1# PNU2# PNU2# PNU2#
a"ii."
b"ii." Figure'3.2.10:'Repetitive'stimulation'of'mouse'primary'cortical' cultures'with'PNU2' in'combination'
with'PNU1'Cultures((10714DIV)(were(loaded(with(fura72(AM,(perfused(with(1.8(mM(calcium(buffer(at(37(°C(and(imaged(under( a( fluorescence(microscope( at( 510( nm.( Cells(were( pre7incubated(with( PNU1( (10( μM;( 3(min)( before(recording(basal(F340:F380(for(30(s,(after(which(PNU2((3(μM)(was(co7applied(for(20(s,.((a(i)(Two(further(PNU2(applications((3(μM;(20(s)(were(given(after(50(s( intervals,(perfusion(of(PNU1((10(μM)(was(left(on(the(whole(time.((a(ii)(Cells(were(exposed(to(three(more(consecutive(PNU2((3(μM;(20(s)(co7applications(in(the(presence(of(PNU1((10(μM;(30(s)(followed(by(3(min(washouts.(Traces(show(coloured(lines(corresponding(to(individual(regions(of(interest(selected(as(responding(cells.(Data(are(presented(as(a(ratio(of(fluorescence(emitted(at(510(nm( following( excitation( at( 340( and( 380( nm.( Bars( (a( ii,( b( ii)( represent(mean( peak( F340:F380( of( consecutive(responses(to(PNU2(in(the(presence(of(PNU1(from(traces(a(i(and(b(i(respectively.((
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3.2.3 α7& nAChR& mediated& Ca2+& elevations& in& mouse& cortical& cultures& are&
dependent&on&VGCC&activation.&If( α7( nAChR( mediated( [Ca2+]ic( elevations( in( mouse( primary( cortical( cultures( were(augmented(by(VGCC(activation(following(depolarization(of(the(cell(membrane(due(to(α7( nAChR( mediated( Na+( influx,( we( hypothesized( that( increases( in( F340:F380( in(response( to( PNU2( in( the( presence( of( PNU1(would( be( diminished( by( non7selective(blockade(of(VGCCs(with(Cd2+.(As(discussed(in(section(1.2.2.4,(various(VGCC(subtypes(exist( performing( specialized( roles( in( different( cells( and( tissues.( Here( we( also(attempted(to(evaluate(the(dependence(of(α7(nAChR(mediated([Ca2+]ic(on(L7type(VGCC(by(using(the(dihydropyridine(drug(nifedipine.(Initial(application(of(PNU2((3(μM)(in(combination(with(PNU1((10(μM)(yielded(average(peak(F340:F380(increases(of(0.23(±(0.10(above(basal(levels((0.29(±(0.08).(Pre7incubation(and(co7application(of(Cd2+((10(min;(50(μM;(Figure(3.2.11b,(d)(with(PNU2((3(μM)(in(combination(with(PNU1((10(μM)(resulted(in(a(70.07(±(5.07(%(inhibition(of(the(original(response(elicited(by(PNU2((3(μM;(Figure(3.2.11a,(d)(and(PNU1((10(μM)(in(all( cells( examined,( although( to( a(more( variable( degree( than( blockade( observed( for(MLA,( with( standard( deviation( of( 21.27(%( from( 34( cells( in( 3( independent( cultures((Figure( 3.2.21).( Following( 10( min( washout,( a( third( stimulation( with( PNU2( (3( μM;(Figure( 3.2.11c,( d)( in( combination(with( PNU1( (10( μM)( elicited( a( response( that( had(recovered(to(76.56(±(3.99(%.(( In( experiments( where( nifedipine( was( used,( we( observed( average( peak(F340:F380(increases(above(basal(levels((0.35(±(0.04)(of(0.70(±(0.34(in(response(to(PNU2((3(μM;(20(s;(Figure(3.2.12a,(d)(in(the(presence(of(PNU1((10(μM;(3(min)(from(23(cells(in(3( cultures.( Pre7incubation( and( co7application( of( nifedipine( (3( μM;( 10(min)( had( no(significant( effect( on( responses( elicited( by( PNU2( (3( μM;( 20( s)( in( combination( with(PNU1((10(μM;(3(min)(but(there(was(a(downward(trend(of(31.89(±(15.61(%.(This(effect(was(highly(variable,(with(standard(deviation(of(42.00(%((Figure(3.2.21).(After(10(min(washout,(responses(to(further(stimulation(with(PNU2((3(μM;(20(s)(with(PNU1((10(μM;(3(min)(did(not(recover(but(declined(further(to(48.33(±(9.99(%(of(the(original(response((Figure(3.2.12c,(d).(
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3.2.4 α7& nAChR& mediated& Ca2+& elevations& in& mouse& cortical& cultures& are&
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3.2.5 Contribution- of- glutamatergic- neurotransmission- to- α7- nAChR-mediated-
Ca2+-elevations-in-mouse-cortical-cultures-α7(nAChRs(are(well(known(to(reside(on(presynaptic(terminals(in(neurons(of(the(CNS(where( activation( enhances( the( probability( of( neurotransmitter( release,( a( Ca2+(dependent(process((Wonnacott,(1997).(We(hypothesized(that(if(α7(nAChRs(existed(on(glutamatergic( terminals( in(mouse( primary( cortical( cultures,( application( of( PNU2( in(combination(with( PNU1(would( indirectly( lead( to( [Ca2+]ic( elevations( in( postsynaptic(cells,( via( facilitation(of(glutamate( release(and(subsequent(activation(of(postsynaptic(ionotropic( and/or( metabotropic( glutamate( receptors( (iGluRs( and/or( mGluRs;( see(section( 1.2.2.5).( To( test( this,( we( used( a( range( of( antagonists( to( block( the( various(GluRs:( CNQX( for( AMPA( type( GluRs,( MK801( for( NMDA( type( GluRs,( and( LY456236((LY4)(for(group(I(mGluRs.(
3.2.5.1 Dependence-on-AMPA-receptors-Firstly,(we(assessed(the(ability(of(AMPA(to(elicit([Ca2+]ic(elevations(in(mouse(primary(cortical(neurons.(Cells(were(loaded(with(fura72(and(perfused(with(buffer(at(37(°C(as(above,(and(stimulated(with(AMPA((20(s;(10(μM)(which(resulted( in(average(F340:F380(increases( of( 1.14( ±( 0.70( (45( cells( pooled( from( 6( experiments( on( 2( independent(cultures)(above(basal(levels((0.38(±(0.02).(In(3(of(these(experiments((from(1(culture),(cells( were( also( exposed( to( PNU2( (3( μM)( in( the( presence( of( PNU1( (3(min( pre7incubation;( 10(μM)( to( compare( the( response( amplitude( and( number( of( responding(cells(to(that(induced(by(AMPA((10(μM).(We(observed(F340:F380(increases(of(0.76(±(0.07(above(basal(levels((0.37(±(0.03),(92.18(±(8.45(%(of(the(response(evoked(by(AMPA((10(μM),(but(this(occurred(in(only(5/31(cells(that(responded(to(AMPA((10(μM).(In(these(experiments,(pre7incubation(and(co7application(of(the(competitive(AMPAR(antagonist(CNQX((10(min;(10(μM;(Honoré(et(al.,(1988)(blocked(further(responses(to(AMPA((20(s;(10(μM)(by(50.31(±(1.41(%(of( the(original( response,( recovering( to(76.48(±(23.32(%(when(stimulated(with(AMPA((20(s;(10(μM)(again(after(10(min(washout.(( Having(demonstrated(robust(responses(to(AMPA(and(their(blockade(by(CNQX,(we( sought( to( evaluate( the( dependence( of( [Ca2+]ic( elevations( evoked( by( α7( nAChR(stimulation(in(primary(cortical(cultures.(Following(control(responses(to(PNU2((20(s;(3(μM)(in(the(presence(of(PNU1((3(min;(10(μM),(which(gave(F340:F380(increases(of(0.30(±(0.16( above( basal( levels( (0.28( ±( 0.65),( blockade( by( CNQX( (10(min;( 10( μM)( variably(
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3.2.5.2 Dependence+on+NMDA+receptors+In( a( single( experiment,( we( stimulated( fura72( AM( loaded( primary( mouse( cortical(cultures(with(NMDA((50(μm),(which(elicited(average(F340:F380(peak(increases(of(0.30(±(0.05( from( 9( cells.( Pre7incubation( and( co7application( of( the( non7competitive( NMDA(receptor( channel( blocker( MK801( (2.5( μM;( 10( min;( Wong( et( al.,( 1986)( completely(blocked(these(responses((98.90(±(0.42(%).(After(30(s(washout,(a( further(NMDA((50(μM)(application(for(20(s(gave(an(average(peak(F340:F380(increase(of(37.75(±(10.47(%.(
















Figure'3.2.17:'MK801'blocks'NMDA'evoked'Ca2+'elevations'in'mouse'primary'cortical'cultures'Cultures((10714DIV)(were(loaded(with(fura72(AM,(perfused(with(1.8(mM(calcium(buffer(at(37(°C(and(imaged(under(a(fluorescence(microscope(at(510(nm.(Basal(F340:F380(was(recorded(for(30(s,(after(which(NMDA((50(μM;(a)(was(applied(for(20(s.(After(3(min(wash(out,(cells(were(then(pre7incubated(for(10(min(with(MK801((2.5(μM)(prior(to(recording(F340:F380(before,(during(and(after(co7stimulation(with(NMDA((50(μM;(20(s;(b).(Cells(were(then(stimulated(again(with(NMDA((50(μM;(20(s)(after(30(s(washout((b).(Still( images( show( fluorescence( in( pseudocolour,( (black/blue( =( low( F340:F380,( red/white( =( high(F340:F380)( taken(during(PNU2(stimulation.(Traces(show(coloured( lines(corresponding(to(9(regions(of(interest(selected(as(responding(cells.(Data(are(presented(as(a(ratio(of(fluorescence(emitted(at(510(nm(following(excitation(at(340(and(380(nm.((
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Figure'3.2.19:'α7'nAChR'mediated'calcium'elevations'are'partially'blocked'by'CNQX'and'MK801'in'mouse'primary'cortical'cultures.'Cultures((10714DIV)(were( loaded(with( fura72(AM,(perfused(with(1.8(mM(calcium(buffer(at(37(°C(and( imaged(under(a( fluorescence(microscope(at(510(nm.(Cells(were(pre7incubated(with(PNU1((10(μM;(3(min)(before(recording(basal(F340:F380(for(30(s,(after(which(PNU2((3(μM;(a)(was(co7applied(for(20(s.(After(3(min(wash(out,(cells( were( then( pre7incubated( for( 10(min( with( CNQX( (10( μM),( MK801( (2.5( μM)( and( PNU1( (10( μM)( prior( to( recording( F340:F380( before,( during( and( after( co7stimulation(with(PNU2((3(μM;(20(s;(b).(Finally,(following(10(min(wash(out,(the(protocol(was(repeated(in(the(absence(of(CNQX(and(MK801((c).(Still(images(show(fluorescence(in(pseudocolour,((black/blue(=(low(F340:F380,(red/white(=(high(F340:F380)(taken(during(PNU2(stimulation.(Traces(show(coloured(lines(corresponding(to(4(regions(of(interest(selected(as(responding(cells,(indicated(with(coloured(arrow(heads(in(each(image.(Data(are(presented(as(a(ratio(of(fluorescence(emitted(at(510(nm( following( excitation( at( 340( and( 380( nm( from( a( representative( experiment.( Bars( (d)( represent( mean( peak( F340:F380( increase( from( basal( expressed( as( a(percentage(of(the(initial(stimulation(response(from(the(same(region(of(interest(±(range(from(2(independent(experiments.(
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Figure' 3.2.20:' Effects' of'mGluR1' blockade' on'
intracellular' calcium' elevation' elicited' by'





Figure'3.2.21:'Contributions'to'α7'mediated'[Ca2+]ic'elevations'in'mouse'primary'cortical'cultures.'Summary(of(experiments(presented(in(previous(figures.(Cells(were(pre7incubated(with(PNU1((10(μM;(3(min)(before(recording(basal(F340:F380(for(30(s,(after(which(PNU2((3(μM)(was(co7applied(for(20(s.(After(3(min(wash(out,( cells( were( then( pre7incubated( for( 10(min(with(MLA( (100( nM),( Cd2+( (50( μM),( nifedipine( (Nif;( 3( μM),(ryanodine((Ry;(30(μM),(xestospongin(C((XeC;(5(μM),(CNQX((10(μM),(MK801((2.5(μM),(or(LY4((10(μM)(in(the(presence(of(PNU1((10(μM)(prior(to(recording(F340:F380(before,(during(and(after(co7stimulation(with(PNU2((3(μM;( 20( s).( Data( points( represent( individual( ROIs( selected( as( responding( cells( pooled( from( repeat(experiments,( presented( as( percentage( of( initial( response( to( PNU2( in( combination(with( PNU1.( Black( lines(represent(mean(±(SD.(


























3.3 Discussion+In( this( chapter( we( have( investigated( mechanisms( of( α7( nAChR( mediated( Ca2+(elevations( in( mouse( primary( cortical( cultures( using( fura72( AM( live( cell( imaging,(following( initial( experiments( that( aimed( to( optimize( conditions( for( α7( nAChR(stimulation(with(the(selective(PAM(PNU1(and(agonist(PNU2(in(SH7SY5Y(cells.(
3.3.1 Summary+In(SH7SY5Y(cells(loaded(with(fluo73(AM(exposure(to(the(α7(nAChR(selective(agonists(choline( and( PNU2( had( no( measurable( effect( on( F538.( In( the( presence( of( PNU1(however,( large( fluorescence( increases( were( observed( that( were( dependent( on( the(concentrations( of( agonists( and( PNU1.( These( responses( were( blocked( by( αbgt,(confirming(their(α7(nAChR(selectivity.(( In( primary( cortical( cultures,( a( protocol( was( developed( to( image( changes( in([Ca2+]ic(with(the(aid(of(fura72(AM(and(live(cell(imaging.(Here,(drugs(were(applied(via(a(perfusion(system,(so(that(individual(cells(could(be(subjected(to(repeated(stimulation(in( the( presence( of( antagonists.( Initially,( cultures( were( stimulated( with( KCl,( which(elicited( large(responses(from(the(majority(of(cells( imaged.(TTX(was(used(to(prevent(spontaneous( Ca2+( oscillations,( and( recording( time( was( limited( to( prevent(photobleaching(and(focus(drift.(No(responses(were(observed(following(application(of(PNU2,(however(in(the(presence(of(PNU1,(a(sub7population(of(cells(responded(to(PNU2(with(considerably(variable(magnitude.(These(responses(were(consistently(blocked(by(MLA,(confirming(α7(selectivity.(( To(assess(the(contribution(to(these(responses(of(other(sources(of(Ca2+(we(used(selective(inhibitors.(The(general(VGCC(blocker(Cd2+,(the(RyR(blocker(Ry,(and(the(IP3R(blocker(XeC(all( significantly(attenuated( responses( induced(by(PNU2( in( combination(with( PNU1,( but( the( degree( of( inhibition( was( variable.( The( L7type( VGCC( blocker(nifedipine( also( produced( a( downward( trend( in( responses( to( PNU1( and( PNU2.(Blocking( AMPA( and( NMDA( receptors( with( CNQX( and( NMDA( was( also( shown( to(variably( inhibit( responses( to( PNU2( in( the( presence( of( PNU1,( whilst( there( was( no(significant(reduction(when(blocking(mGluR1(with(LY4.(
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3.3.2 PNU1+reveals+α7+nAChR+mediated+Ca2++elevations+in+SHFSY5Y+cells+Application( of( nicotine( (30( μM)( to( SH7SY5Y( cells( loaded( with( fluo73( AM( evoked(modest(and(sustained(increases(in(F538(indicative(of([Ca2+]ic(elevations(similar(to(that(reported(previously(in(this(assay((Dajas7Bailador(et(al.,(2002),(which(are(attributed(to(heteromeric( α3β2(α5)( and( α3β4(α5)( nAChRs( (see( section( 3.1.2).( In( contrast,(application( of( the( selective( α7( nAChR( agonists( choline( (1.5(mM)( and( PNU2( (1(μM)(failed( to( evoke( detectable( responses,( consistent( with( the( widely( reported( rapid(desensitization( kinetics( that( characterize( the( α7( nAChR( subtype( (Giniatullin( et( al.,(2005).( It( is( well( established( that( to( observe( activation( events(mediated( by( rapidly(desensitizing(receptors(such(as(α7(nAChRs(requires(fast(solution(exchange(methods(of(agonist(application,(as(the(peak(response(of(the(receptor(occurs(so(rapidly(that(by(the(time(peak(agonist(concentration(in(the(extracellular(environment(is(achieved,(the(receptor(desensitizes((Papke(and(Porter(Papke,(2002;(Fedorov(et(al.,(2012;(Pesti(et(al.,(2014).(The(kinetic(properties(of(α7(nAChRs(make(them(notoriously(difficult(to(study,(and( the( dependence( of( receptor( activation( events( on( solution( exchange( speed(confounds( pharmacological( observations( such( as( agonist( concentration( response(relationships((Pesti(et(al.,(2014).(However,(when(the(α7(nAChR(selective(type(II(PAM(PNU1( (10( μM)( was( pre7incubated( for( 5( min( prior( to( stimulation,( a( significant(potentiation(was(observed(for(nicotine,(choline(and(PNU2.(This(effect(has(been(widely(reported,( for(example( in(PC12(cells(using(the(same(assay(with(choline,(nicotine(and(the(α7(nAChR(selective(agonist(Compound(A((Dickinson(et(al.,(2007;( Innocent(et(al.,(2008);(in(α7(nAChR(expressing(SH7EP1(cells(with(Ca2+(fluorimetry(with(ACh((Hurst(et(al.,(2005);(and(in(electrophysiological(studies(in(X.#laevis(oocytes(and(rat(hippocampal(neurons(with(ACh(and(PNU2((Hurst(et(al.,(2005;(Grønlien(et(al.,(2007;(Williams(et(al.,(2011c,(2012).(Potentiation(by(PNU1(is(thought(to(occur(via(destabilization(of(the(α7(nAChR(desensitized(state(without(affecting(ion(selectivity((Hurst(et(al.,(2005;(Grønlien(et( al.,( 2007;(Williams( et( al.,( 2011b;( Szabo( et( al.,( 2014).( The( effects( of( PNU1( on( the(desensitized(state(of(α7(nAChRs(are(analogous(to(the(effects(of(the(α7(nAChR(L247T(mutant,( which( modifies( the( pore( region,( transforming( what( would( be( a( non7conducting(desensitized(state(in(a(wild7type(receptor(into(a(conducting(one((Revah(et(al.,(1991;(Bertrand(et(al.,(1992),(and(it(was(also(recently(reported(that(PNU1(binds(to(the(desensitized(state(with(1007fold(higher(affinity(than(the(resting(state((Szabo(et(al.,(2014).( Pre7incubation( with( the( α7( nAChR( antagonist( αbgt( (100( nM)( completely(
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blocked(the(effects(of(PNU1,(supporting(the(α7(nAChR(selectivity(of(this(approach(and(emphasizing(its(advantages(in(studying(α7(nAChR(responses.(( Examination(of(the(concentration(dependence(of(PNU1(potentiation(of(choline((1.5( mM)( and( PNU2( (1( μM)( yielded( EC50( estimates( of( 15.89(μΜ( and( 4.17( μM(respectively( (Figure(3.2.2),(which( are( slightly( higher( than( the(EC50( value( of( PNU1’s(potentiating( effects( reported( by( Grønlien( et( al.( (~1.5( μM;( 2007).( In(electrophysiological( studies( that( are( able( to( detect( α7( nAChR( responses( to( agonist(alone,(co7application(of(PNU1(is(consistently(reported(to(shift(the(EC50(to(the(left,(and(increase(Emax(of(agonists(such(as(ACh,(PNU2(and(GTS721((Hurst(et(al.,(2005;(Grønlien(et(al.,(2007).(Here(we(also(assessed(the(potentiating(effects(of(PNU1(when(combined(with( lower( concentrations( of( agonists,( following( reports( from(Uteshev’s( lab( (Gusev(and( Uteshev,( 2010;( Kalappa( et( al.,( 2010),( who( showed( that( physiological(concentrations( of( choline( found( in( cerebrospinal( fluid( (CSF;( ~10( μM)( were(significantly( potentiated( by( PNU1,( activating( native( α7( nAChRs( in( hypothalamic(tuberomamillary( neurons( and( hippocampal( CA1( pyramidal( neurons.( We( also(observed(significant(potentiation(of(10(μM(choline(and(a(lower(concentration(of(PNU2((100(nM)(by(PNU1((10(μM),(which(were(both(sensitive(to(αbgt((100(nM).(The(effects(of(PNU1(were(not(observed(in(the(presence(of(30(nM(PNU2,(highlighting(the(agonist(concentration(dependence(of(PNU1.(Assessment(of(the(concentration(dependence(of(PNU1( potentiation( yielded( rightward( shifted( EC50( values( and( decreased( maximum(stimulation(values.(( These( data( suggest( that( α7( PAMs( like( PNU1( could( be( used( as( therapeutics(aimed( at( enhancing( endogenous( α7( nAChR( function,( retaining( spatio7temporal(specificity( of( endogenous( stimulation,( which( could( be( a( safer( approach( than( using(nicotinic( agonists,( as(was( suggested(by(Uteshev’s( group( (Gusev( and(Uteshev,( 2010;(Kalappa(et(al.,(2010).(This(hypothesis(raises(many(concerns(however,(as(the(intended(therapeutic( use( of( any( pharmacological( agent( entails( unwanted( side( effects.( By(dramatically( reducing(desensitization( such(PAMs(greatly( increase( total( ion( flux(and(could( allow( cytotoxic( levels( of( Ca2+( to( accumulate( in( cells,( and( undermine( the(physiological( memory( of( recent( events( and( protective( mechanisms( that( receptor(desensitization( is( thought( to( provide.( Changing( the( kinetics( of( a( receptor( so(much(could( severely( disrupt( synchrony( in( neural( networks( (Reviewed( in(Williams( et( al.,(2011;(Uteshev,(2012).(
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3.3.3 Live+ imaging+ of+ α7+ nAChR+ mediated+ Ca2++ elevations+ in+ mouse+ primary+
cortical+cultures+Using( primary( cultured( mouse( cortex( allows( the( interrogation( of( Ca2+( signalling(mechanisms(in(a(more(physiological(setting,(albeit(still( far(removed(from(the(native(environment(of(the(mammalian(brain.(Here,(as(opposed(to(in(SH7SY5Y(cell(cultures,(a(diverse( population( of( brain( cells( including( neurons( and( glia( (see( chapter( 4( for(immunofluorescent( characterization( studies)( that( exhibit( network( connectivity( is(available( for(study( (see(3.1.3).(The(elevated(complexity(of( this( system(may( in(some(ways(be(considered(an(experimental(drawback,(requiring(a(greater(degree(of(control(and(certainty(of(any(conclusions.(Certainly,(the(use(of(higher(resolution(techniques(of(observation( like( live( imaging( used( here( dramatically( reduce( experimental(throughput,( which( highlights( the( importance( of( the( SH7SY5Y( cell( experiments( in(informing( more( basic( pharmacological( factors.( The( paramount( advantage( of( this(system( lies( in( the( ability( to( image( individual( cells( in( real( time( over( multiple( drug(applications,( and( evaluate( the( effects( of( α7( nAChR( mediated( Ca2+( elevations( on(synaptic(activity.(( As( above,( application( of( PNU2( alone( failed( to( elicit( detectable( responses( in(mouse( cortical( cultures.(When( PNU1(was( pre7incubated( and( co7applied(with( PNU2(however,( we( were( able( to( observe( sizable,( MLA( sensitive( increases( in( F340:F380(indicative( of( [Ca2+]ic( elevations( from( a( subpopulation( of( cells( that( numbered( fewer(than( those( responding( to( stimulation( with( KCl.( This( suggests( that( the( number( of(excitable( cells( exceeds( the( number( of( cells( responding( to( α7( nAChR( stimulation,(possibly( reflecting( a( more( sporadic( expression( of( α7( nAChRs( in( the( entire( cell(population.( This( agrees( with( earlier( studies( by( Barrantes( et( al.,( (1995b),( who(reported([125I]αbgt(binding(in(36(%(of(cortical(neurons(and(Hammond(et(al.((2013),(who( recently( reported( that( nAChR( influence( of( spontaneous( network( activity( was(limited(to(a(subset(of(circuits(in(rat(primary(cortical(neurons.(( Average( peak( F340:F380( increases( in( response( to( PNU2( in( combination( with(PNU1( were( highly( variable,( which( could( reflect( the( diversity( of( [Ca2+]ic( elevation(events( mediated( by( α7( nAChRs( in( these( cultures.( α7( nAChRs( are( known( to( be(expressed(in(different(neuronal( locations(such(as(pre7synaptic(terminals,(cell(bodies(and(dendrites((Fabian7Fine(et(al.,(2001;(Jones(and(Wonnacott,(2004;(Dickinson(et(al.,(2008;( Hammond( et( al.,( 2013),( as( well( as( on( astrocytes( (Shen( and( Yakel,( 2012;(
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Pirttimaki( et( al.,( 2013;(Talantova( et( al.,( 2013)( and(microglia( (Morioka( et( al.,( 2014),(and( are( known( to( mediate( a( range( of( Ca2+( dependent( cellular( events( including(neurotransmitter(release((reviewed(in(section(1.2.2.8).(Indeed,(the(aim(of(this(chapter(is(to(define(the(mechanisms(that(contribute(to(such(events,(which(have(not(yet(been(reported(for(mouse(primary(cortical(cultures.(
3.3.4 VGCCs+and+ER+contribute+to+α7+nAChR+mediated+Ca2++elevations+in+mouse+
primary+cortical+cultures+Responses( to( PNU2( in( combination( with( PNU1( were( sensitive( to( blockade( by( the(general(VGCC(blocker(Cd2+,( the(RyR(blocker(Ry(and(the(IP3R(blocker(XeC,( indicating(that(VGCCs(and(ER(mediated(Ca2+(release(follow(from(α7(nAChR(stimulation(in(mouse(primary(cortical(cultures.(The(L7type(VGCC(antagonist(nifedipine(affected(responses(to(a( lesser(extent,( and(was(non7significant,( further(experiments(would( therefore(be(needed( to( confirm( their( involvement,( but( this( suggests( that( non7L7type( VGCCs(possibly( play( a( more( substantial( role.( This( could( be( investigated( by( using( VGCC(selective(antagonists(such(as(ω7conotoxin(GVIA(for(N7type,(ω7agatoxin(for(P/Q7type,(and(SNX7482(for(R7type(VGCCs.(( The( greater( degree( of( variation( seen( from(blockade( of(VGCCs,(RyRs( and( IP3Rs( compared( to( blockade(of( α7(nAChRs(with(MLA((see( Figure( 3.2.21( for( summary)( suggests( significant( heterogeneity( of( nAChR7Ca2+(coupling(mechanisms.(It(is(likely(that(multiple(mechanisms(play(a(simultaneous(role(in( α7( nAChR7mediated( Ca2+( elevations.( To( determine( the( relative( influence( of( each(mechanism,( further( study( would( be( needed( in( which( blockade( is( attempted( with(various(combinations(of(the(antagonists(used(here.(( As( described( in( section( 1.2.2,( nAChR( mediated( Ca2+( elevations( have( been(reported( to( couple( to(VGCCs( and/or(ER(mediated( release,( seemingly( dependent( on(nAChR(subtypes(and(experimental(preparations.(It(is(important(to(reiterate(here(that(α7(nAChRs(are(highly(permeable(to(Ca2+((see(section(1.2.2.6),(and(it(therefore(follows(that( a( proportion( of( the( Ca2+( elevations( observed( in( these( experiments( are( due( to(direct( flux( through( α7( nAChR( channels.( Indeed,( there( are( numerous( reports( of( α7(nAChRs(mediating(Ca2+(elevations,(or(Ca2+(dependent(events(directly,(for(example(in(rat(hippocampal(mossy(fibre(terminals((Gray(et(al.,(1996),(glutamatergic(terminals(in(MHb7IPN( co7cultures( (Girod( et( al.,( 2000),( dendritic( spines( of( chick( ciliary( ganglion(neurons((Shoop(et(al.,(2001),(stratum(radiatum(interneurons(of(the(rat(hippocampus(
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(Fayuk( and( Yakel,( 2005),( filopodia( of( SH7SY5Y( cells( overexpressing( α7( nAChRs((Gilbert( et( al.,( 2009),( IMR732( neuroblastoma( cells( (Ween( et( al.,( 2010),( and(glutamatergic(terminals(of(neurons(of(the(solitary(tract(nucleus((Kalappa(et(al.,(2011).(( This( is( even(more( relevant( with( the( inclusion( of( PNU1,( which( as( described(above,( dramatically( increases( channel( open( time( by( destabilizing( the( desensitized(state,( therefore(allowing(a(greater(total(Ca2+( flux(directly(through(α7(nAChRs.(As(no(Ca2+( increases(were(detected( in( response( to( agonists( alone( (Figure(3.2.5),( it( can(be(concluded( that( Ca2+( or( Na+( flux( is( so( brief( (see( above)( that( it( also( fails( to( recruit(secondary(mechanisms(such(as(VGCCs(and(ER(mediated(Ca2+(release.(Conversely,(the(inclusion( of( PNU1( could( cause( such( a( large( ion( flux( that( cellular( mechanisms( that(usually( constrain( Ca2+( signals( would( be( overwhelmed,( leading( to( indiscriminate(activation(of(all(secondary(Ca2+(amplification(mechanisms(that(would(usually(be(more(tightly( regulated( in( a( physiological( setting.( Such( is( the( difficulty( in( studying( these(receptors;( experimental( limitations(must( be( balanced(with( decreased( physiological(relevance.( Despite( these( concerns,( there( have( been( reports( of( α7( nAChR(mediated(Ca2+( elevations( evoked( by( agonists( in( the( presence( of( PNU1( that( did( not( activate(VGCCs(or(CICR((Gilbert(et(al.,(2009;(Ween(et(al.,(2010).(To(evaluate(the(proportion(of([Ca2+]ic(elevations(in(mouse(primary(cortical(cultures(resulting(from(direct(α7(nAChR(mediated( ion( flux,( all( other( possible( routes( would( have( to( be( completely( blocked(simultaneously.(( It( is( reasonable( to(suggest( that( in(many(situations( in(mouse(primary(cortical(cultures,(α7(nAChRs(mediate(local(transient([Ca2+]ic(elevations(as(described(elsewhere((Shoop( et( al.,( 2001;( Gilbert( et( al.,( 2009)( which( are( not( resolved( by( the( imaging(equipment(used(here.(In(a(physiological(setting,(the(coincidence(of(cholinergic(inputs(may(determine(the(summation(of( local( into(global(Ca2+(signals,(and(the(proximity(of(α7(nAChRs(to(VGCCs,(RyRs(and/or(IP3Rs(would(also(influence(this.(( Also(worthy(of(note(are(the(effects(highly(augmented(levels(of([Ca2+]ic((such(as(that(made(possible(by(PNU1)(could(have(on(α7(nAChR(function(and(the(implications(for(repeated(stimulation,(as(it(has(been(reported(that(Ca2+(dependent(mechanisms(can(modulate( nAChR( desensitization( via( phosphorylation( by( PKA( and( PKC,( which(promotes( recovery(of( desensitization,( and(dephosphorylation(by( calcineurin,(which(delays(recovery((Khiroug(et(al.,(1998;(Giniatullin(et(al.,(2005).(
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( The( involvement( of( VGCCs( in( α7( nAChR( mediated( Ca2+( elevations( and( Ca2+(dependent( events(have(been(widely( reported(with( conflicting( results(depending(on(the(experimental(preparation.(Cd2+(blocked(αbgt(sensitive(Ca2+(elevations(evoked(by(nicotine( in(chick(ciliary(ganglion(neurons((Vijayaraghavan(et(al.,(1992;(Rathouz(and(Berg,(1994)(and(hippocampal(neurons((Barrantes(et(al.,(1995a),( indicating(coupling(of(α7(nAChRs(to(VGCCs.(VGCC(subtype(specific(information(was(also(revealed(by(using(the( L7type( VGCC( blocker( israpidine,( which( blocked( α7nAChR( mediated( Ca2+(elevations( in(rat(GH3(pituitary(cells((Feuerbach(et(al.,(2005),(whereas( the(use(of(ω7conotoxin( MVIIC( implied( non7L7type( VGCCs( were( involved( in( α7( nAChR( mediated(Ca2+(increases(evoked(by(PNU2(in(combination(with(PNU1(in(bovine(chromaffin(cells((del(Barrio(et(al.,(2011).(A(study(on(rat(PFC(synaptosomes(by(Wang(et(al.((2006)(also(reported( 47aminopyridine( (4AP)( evoked( glutamate( release( that( was( enhanced( by(nicotine( in( an( MLA( but( not( DHβE( sensitive( manner,( and( mimicked( by( choline,(suggesting( involvement( of( α7( but( not( β2*( nAChRs.( This( effect( was( blocked( by( ω7conotoxin(GVIA(and(ω7agatoxin( IVA,( implying( that(α7(nAChR(mediated(potentiation(of( glutamate( release( is( reliant(on(N7(and(P/Q7type(VGCCs.( Studies( conducted( in( the(Wonnacott( lab( directly( contradict( these( findings( (Dickinson( et( al.,( 2008),( here(enhanced(release(of([3H]D7aspartate((used(as(a(surrogate(for(glutamate)(mediated(by(β2*(nAChR(activation(was(coupled(to(VGCCs(whereas(α7(nAChRs(were(coupled(to(ER(release( via( RyRs( and( IP3Rs.( Several( reasons( can( be( ascribed( to( these( conflicting(results:((i)(Wang(et(al.((2006)(observed(the(effects(of(nicotinic(agents(on(4AP(evoked(release,(whereas(Dickinson(et(al.((2008)(were(studying(the(effects(of(nicotinic(agents(on(basal(release;((ii)(Wang(et(al.((2006)(were(measuring(basal(endogenous(glutamate(release( via( on7line( fluorimetry( of( NADPH( produced( by( oxidative( deamination( of(released( glutamate( by( glutamate( dehydrogenase( (GDH),( whereas( Dickinson( et( al.((2008)(were(measuring(the(release(of([3H]D7aspartate(in(place(of(glutamate;(and(most(importantly( (iii)( the(α7(nAChR(selectivity(of(nicotine’s(glutamate( release(enhancing(effects(reported(by(Wang(et(al.((2006)(are(inferred(from(blockade(by(MLA(at(10(μM,(a(concentration(that(is(high(enough(to(block(all(nAChRs,(including(α4β2*(nAChRs((IC50(of(MLA(for(α4β2*(nAChRs(=(0.2(μM;(Ward(et(al.,(1990;(Absalom(et(al.,(2013),(although(the( authors( reported( no( effect( of( the( β2*( nAChR( selective( antagonist( DHβE.( The(authors( also( reported( similar( enhancement( of( 4AP( evoked( glutamate( release( by(choline( at( 10( μM,( which( is( well( below( the( concentration( able( to( elicit( measurable(
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effects(from(α7(nAChRs((EC50(=(1.5(mM;(Alkondon(et(al.,(1997;(and(see(above(3.2.1).(In(contrast,(Dickinson(et(al.((2008)(used(the(α7(nAChR(selective(agonist(compound(A,(and( confirmed( selectivity( by( blocking( with( the( selective( antagonist( αbgt.(Furthermore,( similar( nAChR7Ca2+( coupling( mechanisms( to( those( reported( by(Dickinson(et(al.((2008)(were(reported(for(hippocampal(synaptosomes((Zappettini(et(al.,( 2010,( 2011a),( with( ER( mediated( CICR( being( mostly( responsible( for( α7( nAChR(mediated(potentiation(of(glutamate,( aspartate(and(GABA(release.( Indeed,(α7(nAChR(coupling(to(CICR(from(the(ER(has(been(extensively(described(elsewhere,(for(example(in(SNc(neurons(in(mouse(brain(slices((Tsuneki(et(al.,(2000),(hippocampal(astrocytes((Sharma( and( Vijayaraghavan,( 2001),( SH7SY5Y( cells( (Dajas7Bailador( et( al.,( 2002a),(hippocampal( mossy( fibre( terminals( from( rat( brain( slices( (Sharma( and(Vijayaraghavan,(2003;(Sharma(et(al.,(2008),( rat(dentate(gyrus( (Welsby(et(al.,(2006),(hippocampal( Schaffer( collateral( synapses( (Le( Magueresse( and( Cherubini,( 2007),(bovine( chromaffin( cells( (del( Barrio( et( al.,( 2011),( and( ventral( hippocampal( axons((Zhong(et( al.,( 2013).(Evidence( suggests( that(both(RyRs(and( IP3Rs( contribute( to( this(effect,( but( with( differing( temporal( dynamics.( Previously( in( SH7SY5Y( cells,( Dajas7Bailador( et( al.( (2002)( reported( that( long( term( (10( min),( αbgt( sensitive( [Ca2+]ic(elevations( evoked( by( nicotine(were( significantly( blocked( by( XeC,(whereas(Ry(more(significantly( blocked( the( early( stages( (20( s)( of( the( response.(More( recently,( it( was(reported( that( in( glutamatergic( axons( of( the( ventral( hippocampus,( IP3Rs( were(responsible(for(the(sustained((up(to(30(min)(increase(in([Ca2+]ic(evoked(by(nicotine(in(an(αbgt,( but(not(DhβΕ( sensitive(manner( (Zhong(et( al.,( 2013).(To( test( this( in(mouse(primary( cortical( cultures,( one( could( give( long( (20730( min)( drug( applications,( and(investigate(the(effect(of(Ry(vs.(XeC(on(sustained(Ca2+(signals.(( Another(important(factor(to(note(when(observing(CICR(is(the(tendency(of(ER(to(accumulate(Ca2+(via(active(pumps(following(periods(of(increased(activity(as(a(sort(of( “Ca2+( capacitor”( (see( section( 1.2.2).( To( investigate( this( effect,(we(would( need( to(conduct(experiments(where(sequential(α7(nAChR(stimulation(was(given,(followed(by(blockade( with( Ry( and/or( XeC( to( confirm( ER( mediated( CICR( dependence.(Alternatively,(thapsigargin(could(be(applied,(which(blocks(SERCA(pumps,(preventing(uptake(of(Ca2+(into(the(ER((Sharma(and(Vijayaraghavan,(2003).(( In(our(experiments,(VGCC(or(CICR(activation(following(α7(nAChR(stimulation(could( be( occurring( either( pre7( or( post7synaptically.( VGCC( or( CICR( could( also( be( a(
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result( of( the( widely( reported( effect( of( α7( nAChR( stimulation( promoting( glutamate(release,(discussed(in(the(following(section.(In(fact,(as(greater(direct(nAChR(mediated(Ca2+( flux(occurs(at( resting(or(hyperpolarized(potentials,(whereas(VGCCs( flux(Ca2+(at(depolarized(potentials,(this(may(be(the(case((Mulle(et(al.,(1992a).(
3.3.5 α7+ nAChRFmediated+ Ca2++ elevations+ in+ mouse+ primary+ cortical+ cultures:+
evidence+of+excitatory+transmission+The(inference(that(in(mouse(primary(cortical(cultures,(α7(nAChR(activation(results(in(glutamate( release,( causing( postsynaptic( [Ca2+]ic( elevations( via( AMPA( and( NMDA(receptors(is(evidenced(by(the(variable(blockade(of(responses(to(PNU2(in(combination(with( PNU1( by( CNQX( and/or(MK801.( A(wealth( of( studies( have( previously( reported(potentiation(of( glutamate( release(via(α7(nAChR(activation( in(different(preparations(and( brain( regions( such( as( frontal( and( pre7frontal( cortex( (Rousseau( et( al.,( 2005;(Dickinson(et(al.,(2008;(Konradsson7Geuken(et(al.,(2009,(2010;(Livingstone(et(al.,(2010;(Bortz( et( al.,( 2013),( hippocampus( (Gray( et( al.,( 1996;( Sharma( and( Vijayaraghavan,(2003;(Welsby(et(al.,(2006;(Sharma(et(al.,(2008;(Zappettini(et(al.,(2010;(Gomez7Varela(and(Berg,(2013;(Halff(et(al.,(2014),(striatum((Kaiser(and(Wonnacott,(2000;(Marchi(et(al.,( 2002;( Livingstone( et( al.,( 2009;( Northrop( et( al.,( 2010),( cerebellum( (Zwart( et( al.,(2002),( VTA( (Mao( et( al.,( 2011),( and( as( gliotransmitter( release( by( hippocampal((Pirttimaki(et(al.,(2013)(and(cortical((Talantova(et(al.,(2013)(astrocytes.(( The( variability( of( the( block( observed( here( (Figure( 3.2.21)( indicates( the(presence( of( both(pre7( and(postsynaptic( α7(nAChR.(Although,( as( CNQX(did(not( fully(block(control(responses(to(AMPA((~50(%;(Figure(3.2.15),( it(cannot(be(assumed(that(the(inhibition(of(PNU2(in(combination(with(PNU1(by(CNQX((Figure(3.2.16)(reveals(the(component(of(the(response(that(is(not(dependent(on(glutamate(release,(i.e.(responses(evoked( by( solely( by( somatodendritic( α7( nAChRs.( Furthermore,( residual( AMPAR(activation(may( still( sufficiently(depolarize(postsynaptic(neurons( to( relieve( the(Mg2+(block( on( NMDARs,( resulting( in( a(much( larger( response( than( if( AMPARs(were( fully(blocked.(Also,(NMDA(was(seen(to(elicit( large(Ca2+(responses(in(the(presence(of(Mg2+((in( buffer;( Figure( 3.2.17),( which( suggests( the( presence( of( endogenous( glutamate(release(activating(AMPARs,(relieving(the(Mg2+(block.(( As( both( CNQX( and( MK801( both( significantly( blocked( α7( nAChR( responses,(indicating(involvement(of(AMPA(and(NMDARs,(which(exist(on(the(same(postsynaptic(
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cells(and(work(in(concert((Traynelis(et(al.,(2010),(one(would(expect(their(effects(to(be(additive( when( applied( in( combination( (Figure( 3.2.19).( This( has( been( described(elsewhere,( for( example( in( rat( striatum( and( PFC( where( α7( nAChRs( activated( by(choline( in( the( presence( of( PNU1( enhanced( the( release( of( [3H]dopamine,( which( is(dependent(on(glutamate(release((Livingstone(et(al.,(2009).(Our(results(however(fail(to(show(additivity(when(CNQX(and(MK801(were(combined,(which(could(possibly(be(due(to( the( heterogeneity( of( Ca2+( signalling(mechanisms( activated( following( stimulation(with(PNU2(in(the(presence(of(PNU1(in(these(cultures(as(shown(above((Figure(3.2.21),(which( would( obscure( such( an( effect.( It( could( also( be( the( case( that( antagonist(concentrations(are(not(maximal.(Further(studies(and(a(larger(sample(size,(or(repeated(applications( of( PNU1( in( the( presence( of( PNU2( with( and( without( CNQX( or( MK801(followed(by(both(antagonists(in(combination(to(the(same(cells(may(also(give(a(better(chance(of(observing(this(effect.(Here,(responses(showing(dependence(on(iGluRs(could(be(examined(again(for(the(additive(effect.(( As(mentioned( in( the( previous( section,( post7synaptic( [Ca2+]ic( elevations( could(be( partly( due( to( the( activation( of( VGCCs( or( CICR( following( initial( Na+/Ca2+( influx(through( iGluRs,( and( it( would( be( difficult( to( ascertain( the( proportion( of( [Ca2+]ic(increase( mediated( solely( by( iGluRs,( as( these( secondary( mechanisms( exist( on( both(sides(of( the( synaptic( cleft,( and(are( reputed( to(be(necessary( for(α7(nAChR(mediated(glutamate( release( (see( above).( α7( nAChRs( are( also( thought( to( be( present( in(somatodendritic( locations( in( primary( cortical( cultures( (Hammond( et( al.,( 2013),(further(confounding(the(dissection(of(pre7(vs.(post7synaptic(Ca2+(signals.(An(attempt(to( block( VGCCs( and( CICR( on( the( postsynaptic( cell( would( therefore( also( block(glutamate( release.( However,( total( blockade( of( iGluRs( would( reveal( the( component(that( comprises( [Ca2+]ic( elevations(due( to( activation(of( postsynaptic(α7(nAChRs,( and(any(subsequent(amplification(by(VGCCs(and/or(CICR.(As(well(as(glutamate(release,(α7(nAChR(activation( is(also(known(to( facilitate(the(release(of(GABA,( for(example( in(the(hippocampus((Zappettini(et(al.,(2011a).(If(this(is(the(case(in(primary(cortical(neurons,(which( have( been( reported( to( contain( a( substantial( proportion( of( GABAergic( cells((Suñol( et( al.,( 2008),( it( would( be( expected( that( blockade( of( GABAA( and/or( GABAB(receptors(with(would( potentiate( α7( nAChR(mediated( Ca2+( signals.( This( situation( is(investigated(in(the(following(chapter.(
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( Our( experiments( did( not( yield( significant( evidence( for( the( involvement( of(mGluR1( in( α7( nAChR( mediated( [Ca2+]( elevations,( which( could( occur( via( the( Gq(mediated( generation( of( IP3( (see( section( 1.2.2.7).( This( was( investigated( following(reports( mGluR1( association( with( α7( nAChRs( in( hippocampal( LTP( (Welsby( et( al.,(2006),(but(the(lack(of(effect(may(be(due(to(low(expression(levels(reported(by(others(for( this(mGluR(subtype( in(primary(cortical( cultures( (Ayala(et( al.,( 2012).(To(confirm(the( functional( presence( of( mGluR1( and( their( ability( to( raise( [Ca2+]ic( following( α7(nAChR( activation,( experiments( would( need( to( conducted( using( selective( mGluR1(agonists,( to( which( the( inhibitory( effects( of( LY4( could( be( tested.( It( is( possible( that(other(mGluR( subtypes( play( a( role( here,( as( evidence( suggests( higher( expression( of(mGluR2/3( (Prézeau( et( al.,( 1994;( Schaffhauser( et( al.,( 1998),( which( are( coupled( to(inhibitory( Gi7proteins( and( are( mainly( expressed( presynaptically( (Niswender( and(Conn,( 2010).( As( such,( it( could( be( envisioned( that( blockade( of( these(mGluRs( could(have(a(potentiating(effect(on(α7(nAChR(mediated(Ca2+,(by(disinhibition(as(described(for(GABARs(above.(







4.1 Introduction+The( development( of( automated( analysis( capable( of( extracting( multiparametric(observations(from(biological(images(that(can(be(acquired(in(high7throughput(fashion(has(major(implications(for(experimental(output(and(discovery(in(biomedical(research.(High7content(screening((HCS)(has(enabled(the(generation(of(extremely(large(data(sets(from( large( cell( populations( in( relatively( short( periods( of( time( (~106( cells( per(experiment),( making( it( an( effective( solution( for( assay( optimization,( repetitive(investigations,(subtle(variable(changes,(and(increasing(statistical(power.(This(chapter(details( exploratory(work( aimed(at(developing( a(HCS(protocol( to( further( investigate(nAChR(mediated(Ca2+(signalling(mechanisms(described(in(chapter(3.(
4.1.1 High+content+screening+Over( the( last( decade,( large7scale( biological( microscopy( has( become( increasingly(sophisticated( owing( to( the( development( of( HCS( protocols( that( acquire,( process,(analyse( and( archive( vast( amounts( of( imaging( data( (Abraham( et( al.,( 2004).( These(methods(have(also(impacted(neuroscience(research,(and(have(been(extensively(used(in(the(field(of(drug(discovery((Dragunow,(2008).(At(a(basic(level,(HCS(can(be(used(to(greatly(increase(the(speed,(accuracy(and(objectivity(of(simple(but(laborious(tasks(such(as(cell(counting.(Due(to(the(flexibility(of(currently(available(HCS(software(however(–(and( with( the( correct( markers( –( these( simple( tasks( can( be( extended( to( include(multiparametric(observations(such(as(organelle(counting(and(morphological(analysis(that(exceed(even(the(capabilities(of(human(visual( inspection.(The( inclusion(of( liquid(handling( and( environmental( control( modules( inflates( the( possibilities( further( still,(enabling( live(cell(assays( to(be(conducted( in(an(array(of(different(conditions.( In( fact,(simultaneous( multiparametric( measurements( can( be( applied( to( cell( assays( to(improve( the( validity( of( findings,( as( has( been( described( for( cell( toxicity( assays((Abraham(et(al.,(2004;(Götte(et(al.,(2010).(( The(complexity(of(neuronal(and(glial(cell(morphology(increases(the(necessity(for(more(sophisticated(and(stringent(analysis(algorithms(to(segment(objects(based(on(bright7field( or( fluorescent( images.( This( is( a( challenging( endeavour,( but( has( been(pioneered( and( reported( in( the( literature(with( some( success( (Narayan( et( al.,( 2007).(Probably(the(best(example(is(the(automated(neurite(outgrowth(analysis((Ramm(et(al.,(
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2003;(Radio(et(al.,(2010),(which(tracks(changes(in(the(length(of(cellular(processes,(and(has(been(used(to(report(Aβ(toxicity(in(primary(cortical(and(hippocampal(cultures((Hu(et(al.,(2007;(Evans(et(al.,(2008).(Other(potential(applications(of(HCS(for(neuroscience(include( tracking( receptor( internalization,( protein( aggregation,( cell( migration( and(transcription( factor( translocation( (Dragunow,( 2008).( The( advantages( of( HCS( are(clearly(vast,(but(it(should(be(stressed(that(it(cannot(completely(surpass(some(aspects(of( smaller( scale( imaging( experiments,( such( as( real7time(manual( manipulation( that(allows( for( greater( creativity( in( exploratory( investigations,( and( greater( image(resolution.(In(conclusion,(HCS(is(an(exciting(field(that(promises(to(greatly(accelerate(biological( research( and( reduce( the( time( and( resources( spent( on( simple( laborious(procedures.(




4.2.1 Validation+of+a+highFcontent+screening+Ca2++imaging+assay+Live( imaging(experiments(described( in(chapter(3(required(primary(cortical(cultures(to(be(grown(on(glass(coverslips(and(assembled(into(a(perfusion(chamber,(which(was(a(lengthy( procedure.( To( enhance( experimental( throughput,( the( INCell( Analyzer( 2000((GE(Healthcare,(UK)(high7content(microscope(was(chosen(to(develop(an(assay(with(a(247well(plate(format(that(could(screen(multiple(conditions(in(a(shorter(time.(Imaging(large(cell(populations(was(central(to(the(aims(of(these(experiments;(as(such,(the(10X(objective(was(used,(giving(a( field(of(view(of(2048(X(2048(pixels,(corresponding(to(a(size(of(1.52(mm2.(( The(INCell(Analyzer(2000(contains(an(integrated(liquid(handling(system,( allowing( solutions( to( be( aspirated( from( a( separate( “compound”( plate,( and(dispensed( onto( cells( in( the( “sample”( plate.( As( with( SH7SY5Y( cell( experiments(described(in(chapter(3,(the(single7wavelength(indicator(fluo73(AM(was(used(to(report(changes(in([Ca2+]ic,(as(the(microscope(lacked(a(dual(excitation(filter(wheel(required(to(image( fura72( ratiometric( fluorescence.( In( contrast( to( the( fluorescent( plate( reader(assay( used( for( SH7SY5Y( cell( experiments( however,( fluo73( intensity( was( used( for(imaging,( allowing( individual( cells( to( be( examined.( Cells( were( also( stained( with(Hoechst733342((Hoechst)(to(reveal(cell(nuclei(to(aid(analysis.(Due(to(limitations(in(the(temporal(resolution(of(image(acquisition(in(this(system,(cells(could(not(be(imaged(in(real7time( as( in( live7cell( imaging( experiments.( Instead,( a( protocol( was( devised( to(measure(the(changes( in( fluo73(mediated(fluorescence(at(525(nm((F525)( in( individual(cells( following( drug( application( from(Hoechst( and( fluo73( positive( regions( from( five(time7points(allocated(t17t5.(t1((0(s)(and(t2((6.4(s)(were(acquired(in(the(absence(of(drug;(and( t3,( t4,( and( t5( acquired( in( sequential( 10( s( intervals( following( automated( drug(application.(
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( Upon( visual( inspection( of( images( acquired( at( “basal”( time7points( (t172),( low(levels( of( spontaneous( changes( in( fluorescence( measured( at( 525( nm( (F525)( were(apparent(in(a(small(proportion(of(cells((Figure(4.2.1ai,(bi).(Application(of(buffer(alone(directly(to(the(liquid(layer(resulted(in(large(F525(increases(at(“stimulation”(time7points((t375),(evident(upon(visual(inspection(of(images.(This(was(rectified(by(dispensing(drug(“off7center”(down(the(side(of(the(well,(minimizing(liquid(disturbance(that(previously(resulted( in( false( positive( responses( (Figure( 4.2.1aii).( As( in( previous( experiments((chapter(3),(KCl((40(mM)(was(applied(to(evoke(a(positive(response,(resulting(in(clear(F525(increases(seen(at(t375(in(a(large(proportion(of(cells((Figure(4.2.1bii),(indicating(the(suitability( of( this( protocol( for( detecting( drug( evoked( [Ca2+]ic( in( primary( cortical(neurons.(( As(discussed(in(section(4.1.1,(an(integral(part(of(HCS(is(the(powerful(automated(image(processing(and(data(analysis(that(can(be(developed(using(specialist(software.((
(
Figure'4.2.1:'KCl'evokes'robust'F525'increases'in'large'populations'of'mouse'primary'cortical'cultures.'Cultures((10714(DIV)(loaded(with(fluo73(AM(and(stained(with(Hoechst733342(were(stimulated(with(buffer((a)(or(KCl((40(mM;(b).(Images(show(fluorescence(at(525((fluo73;(excitation(490(nm;(green)(and(455(nm((Hoechst733342;( excitation( 350( nm;( blue)( before( (i)( and( after( (ii)( stimulation,( zoom( inset( shows( responding( cells((location(indicated(by(white(arrow).(
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Here(we( have( used( the( INCell( Developer( Toolbox( software( (GE(Healthcare),( which(allows( the( creation(of( highly( flexible( and( specific( algorithms( to( process( image(data(and(segment(fluorescent(objects.(The(complex(morphology(of(cells(in(primary(cortical(cultures(made(this(a(challenging(endeavour.(The(first(step(was(to(generate(a(nuclear(mask( from( the( Hoechst( stained( images,( from( which( would( be( defined( the( central(





Figure'4.2.2:'Segmentation'of'fluorescently'labelled'primary'cortical'cultures.'Cultures( (10714( DIV)( were( loaded( with( fluo73( AM,( stained( with( Hoechst733342,( and( imaged( at( 525( and(455(nm,( following(excitation(at(490(and(350(nm(respectively.(The( INCell(Developer(Toolbox(software( (GE(Healthcare)(was(used(to(construct(a(segmentation(algorithm(consisting(of(a(nuclear(mask(based(on(Hoescht733342(mediated(fluorescence(intensity((a),(and(a(cell(mask(based(on(fluo73(mediated(fluorescence(intensity((b).(Masks(were(then(linked(together,(allowing(the(tracking(of(cells(with(nuclei(over(a(time(series((c).(
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4.2.2 Measuring+ ionotropic+ glutamate+ receptor+ induced+ Ca2++ elevations+ using+
HCS+Having( observed( clear( responses( to( KCl,( the( assay( was( then( used( to( assess(pharmacological(stimulation(of( ionotropic(glutamate(receptors(using(AMPA((10(μM)(and( NMDA( (50( μM),( which( gave( robust( responses( in( live( imaging( experiments((chapter( 3).( Upon( exposure( to( AMPA( (10( μM),( cultures( loaded(with( fluo73(AM( and(Hoechst( showed( average( F525( increases( of( 68.32( ±( 9.78,( an( elevation( that( was(significantly( different( to( that( observed( following( application( of( buffer( alone( (see(Figure(4.2.9).(The(subpopulation(of(responding(cells((46.39(%;(Figure(4.2.10)(showed(F525(increases(of(146.78(±(8.69.(Pre7incubation(and(co7application(of(CNQX(attenuated(these( responses( by( 57.98( ±( 14.43( %( (Figure( 4.2.9),( also( reducing( the( percentage(responding(cells(to(27.73(%((Figure(4.2.10).(These(values(agree(with(live(cell(imaging(experiments( in( which( CNQX( blocked( AMPA( induced( responses( by( 50.31( ±( 1.41(%((chapter( 3;( section( 3.2.5.1).( An( example( of( responses( to( AMPA( (10( μM)( in( the(presence(or(absence(of(CNQX((10(μM)(is(shown(in(Figure(4.2.4.(Images(and(cell(data(plots(show(clear(F525(increases(following(application(of(AMPA((10(μM),(attenuated(by(CNQX((10(μM).(
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Figure'4.2.5:'NMDA'evoked'Ca2+'elevations'in'mouse'primary'cortical'cultures'are'blocked'by'DDAP5.'Cultures((10514(DIV)(loaded(with(fluo53(AM(and(stained(with(Hoechst533342(were(stimulated(with(NMDA((10(μM)(alone((a)(or(in(the(presence(of(D5AP5( (b;( 100(μM;(10(min(pre5incubation).( Images( show( fluorescence( at( 525(nm( (fluo53;( excitation(490(nm;( green)( and(455(nm( (Hoechst533342;( excitation( 350( nm;( blue)( before( (i)( and( after( (ii)( application( of( NMDA,( zoom( inset( shows( responding( cells((location(indicated(by(white(arrow).(Five(images(in(total(were(acquired(at(both(wavelengths:(two(before((t1,(t2;(6.4(s(interval),(and(three(after((t3,( t4,( t5,;(10(s( intervals)(stimulation.(Data((iii)(are(presented(as( the(difference(between(mean(F525(at( t35t5(and(t15t2((ΔF525).(Each(point( represents( a( single( cell( defined( by( co5localization( of(Hoechst533342( and( fluo53( segmentation(masks,( tracked( from( t15t5.( Dotted(black(line(shows(mean(ΔF525(with(SD((grey(shading).(
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4.2.3 α7' nAChRs' mediated' Ca2+' elevations' from' subpopulations' in' primary'










Figure'4.2.6:'Responses'to'PNU2'in' the'presence'of'PNU1'are'difficult' to'detect' in' large'populations'of'

































Figure' 4.2.9:' Stimulation' evoked' F525' increases' in' large' populations' of' mouse' primary'



























Figure'4.2.10:'Percentage'of'cells'responding'to'various'stimuli'as'measured'by'changes'in'F525.'Cultures( (10514(DIV)( loaded(with( fluo53(AM(and( stained(with(Hoechst533342(were( stimulated(with(buffer,(KCl((40(mM),(AMPA((10(μM)(in(the(presence(or(absence(of(CNQX((10(μM),(NMDA((50(μM)(in(the(presence(or(absence(of(MK801((2.5(μM),(or(PNU2((3(μM)(in(combination(with(PNU1((10(μM),(with(or(without( MLA( (100( nM).( Antagonists( were( pre5incubated( for( 10( min( prior( to( stimulation.( Data( are(presented(as(the(percentage(of(responding(cells((defined(as(ΔF525(>(15.87(following(excitation(at(490(nm),( averaged( from(259( independent( experiments(±( SEM;( *(P( <(0.05,( ***(P( <(0.001,( ****(P"<(0.0001(significantly( different( from( buffer,( non5paired( one5way( ANOVA,( Bonferroni’s( multiple( comparisons(test;(each(point(represents(the(percentage(of(responding(cells(per(triplicate(from(a(single(experiment.(
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( As(in(chapter(3,(responses(to(PNU2((3(μM)(in(combination(with(PNU1((10(μM)(were( examined( in( the( presence( of( various( antagonists( that( block( cellular( Ca2+(elevation( mechanisms.( In( contrast( to( live( cell( imaging( experiments,( no( significant(effects( could( be( resolved( here( following( pre5incubation( and( co5application( of( these(antagonists( with( PNU1( and( PNU2( (Figure( 4.2.11).( Notably,( pre5incubation( of( the(GABAA(receptor(antagonist(bicuculline((1(μM)(potentiated(the(effects(of(PNU2((3(μM)(in(combination(with(PNU1((10(μM),(elevating(F525(to(an(average(of(5.02(±(5.47.(This(effect(was( inconsistent,( but( an( example( of( a( clear( response( to( PNU2( (3( μM)( in( the(presence( of( PNU1( (10( μM)( and( bicuculline( (1( μM)( is( shown( in( Figure( 4.2.8.( In(conclusion,(these(experiments(provide(some(evidence(that(this(HCS(method(could(be(used( to( investigate(α7(nAChR(Ca2+( signalling,( although( further(optimization(may(be(necessary.(











Figure' 4.2.11:' Effects' of' various' antagonists' on' α7' mediated' F525' increases' in' large' populations' of'
mouse'primary'cortical'cultured'cells.'Cultures( (10514(DIV)( loaded(with( fluo53(AM(and( stained(with(Hoechst533342(were( stimulated(with(PNU2( (3(μM)( in( combination(with( PNU1( (10( μM)( in( the( presence( or( absence( of( either(MLA( (100( nM),( Cd2+( (50( μM),(ryanodine((Ry;(30(μM),(CNQX((10(μM),(MK801((2.5(μM)(CNQX((10(μM)(in(combination(with(MK801((2.5(μM),(bicuculline( (Bic;( 1( μM)( or( CGP55845( (CGP( 1( μM).( Antagonists( were( pre5incubated( for( 10( min( prior( to(stimulation.( Data( are( presented( as( the( difference( between(mean( F525( before( and( after( stimulation( following(excitation(at(490(nm((ΔF525),(averaged(from(259(independent(experiments(±(SEM;(***(P(<(0.001,(****(P"<(0.0001(significantly(different( from(buffer,( non5paired(one5way(ANOVA,(Bonferroni’s(multiple( comparisons( test;( each(point(represents(the(mean(ΔF525(of(a(triplicate(from(a(single(experiment.(
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4.2.4 Immunofluorescent0characterization0of0primary0cortical0cultures0Primary( cultures( prepared( from( mouse( cerebral( cortex( have( been( previously(described( as( a( heterogeneous( population( of( cell( types( (see( section( 3.1.3).( Here(we(used( immunofluorescent( labelling( to( characterize( cultures( for( different( cell( types.(Cultures( were( fixed( in( 4%( paraformaldehyde( (PFA)( and( fluorescently( tagged(secondary( antibodies( were( used( to( detect( binding( of( primary( antibodies( against(microtubule( associated( protein( type( 2( (MAP2)( revealing( extensive( dendritic(structures(characteristic(of(neuronal(cells((Figure(4.2.12).(Dendritic(processes(could((









Figure' 4.2.13:' Attempted' segmentation'
of'GFAP'positive'fluorescent'images.'Cultures( (10514( DIV)( were( fixed( and(stained( with( Hoechst533342( (blue)( and(incubated(with(primary(antibodies(specific(to( glial( fibrillary( acidic( protein( (GFAP),(followed( by( incubation( with( Alexa( Fluor5488( tagged( secondary( antibodies.( Cells(were(then(imaged(at(455((Hoechst533342)(and(525(nm((a;(Alexa(Fluor5488)(following(excitation(at(350(and(490(nm(respectively.(CellProfiler( software(was(used( to( segment(nuclei(based(on(Hoechst533342(staining((b;(green(outlines),(followed(by(the(attempted(segmentation(of(GFAP(positive( regions( (b;(pink(outlines).(Segmented(objects(based(on(GFAP( positive( regions( linked( to( a(segmented(nuclei(are(shown(in((c).((
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was(revealed((Figure(4.2.12).(By(using(primary(and(secondary(antibody(pairs,( three(colour( images( could( be( generated,( as( shown( in( (Figure( 4.2.14).( Here,( cells( were(stained(with(Hoechst(and(probed(with(anti5GAD(primary(antibodies,(were(co5labelled(with( either( anti5GFAP,( 5MAP2(or( 5neurofilament( specific( primary( antibodies( from(a(different( species( and( two( different( fluorescent( secondary( antibodies(were( used( for(visualization.( From( these( images,( neuronal( cells( appear( to( outnumber( astrocytes,(whilst(GAD(positive(cells(could(be(judged(at(around(20(%(of(total(neuronal(cells.(GAD(positive( regions( co5localized( more( with( neuronal( markers( compared( to( astrocytic(markers.(
( Together,( these( images( show( predominantly( neuronal( cultures( with( a(substantial(presence(of(astrocytes.(GABAergic(neurons(and(synapses(are(also(evident.(These(data(raised(the(possibility(of(gaining(further(information(that(could(inform(Ca2+(measurements( shown( in( sections( 4.2.153,( which( will( be( explored( in( the( following(section(
4.2.5 Combining0 the0high0 content0 Ca2+0 imaging0 assay0with0 immunofluorescent0
















immunofluorescent(labelling.(To(do(this,(cells(were(fixed(after(the(Ca2+(imaging(assay,(stained( with( fluorescent( antibodies( and( re5imaged.( Images( had( to( be( re5aligned(according( to( the( nuclear( (Hoechst)( stain( due( to(movement( of( the( cell( culture( plate(from( its( original( position( following( replacement( into( the( microscope( plate( holder.(This( is( a( common(problem( in( imaging,( and( various(methods( exist( for( correcting( it.(Here(we(have(used(the(normalized(cross(correlation(method(from(the(align(function(in( CellProfiler( image( analysis( software( (Broad( Institute;( Figure( 4.2.15).( Multiple(fluorescent( images(could(then(be(combined(to(an( image(stack(for(viewing( in(ImageJ((NIH).(In(this(section,(a(selection(of(images(compiled(in(this(manner(will(be(described.(( (
a.#
b.#
Figure'4.2.15:'ReJalignment'of'fluorescent'images'based'on'nuclear'stain.'Following(Ca2+( imaging( (see(4.2.1),(primary( cortical( cultures( (10514(DIV)(were(probed(for(various(markers(using(immunofluorescence.(Upon(returning(cell(culture(plates(to(the(microscope,(the(field(of(view(imaged(was(not(properly(aligned(with(the(original(image(as(shown( by( Hoechst( staining( (a;' red,( green;( both( represent( nuclei).( To( rectify( this,(Hoechst533342(images(from(before(and(after(immunofluorescent(labelling(were(used(to(realign(images(in(CellProfiler,(using(the(normalized(cross(correlation(method((b).(X5(and(Y5(offset(coordinates(could(then(be(applied(to(immunofluorescence(images(to(align(them(with(fluo53(positive(images(of(the(same(cells.(
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positive'cells.'Cultures( (10514( DIV)( loaded( with( fluo53( AM( (green)( and( stained( with( Hoechst533342( (blue)( were(imaged( at( 455( and( 525( nm( following( excitation( at( 350( and( 488( nm( respectively( before( and( after(stimulation( with( NMDA( (50( μM).( Cultures( were( then( fixed( in( 4( %( PFA( and( probed( with( primary(antibodies(to(GFAP((red)(and(GAD((yellow),(before(detection(with(Alexa(Fluor5488(and(5546(conjugated(secondary(antibodies,(in(combination(with(Hoechst533342.(Cultures(were(imaged(again(at(605,(525(and(455( nm( following( excitation( at( 543,( 490( and( 350( nm( respectively,( and( aligned( using( the( normalized(cross( correlation( coefficient(method( in( CellProfiler( software( according( to( the(Hoechst533342( staining(pattern(of(both(images.(
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4.3 Discussion+The(experiments(presented(in(this(chapter(aimed(to(develop(a(HCS(method(that(could(potentially( be( used( to( further( investigate( nAChR( mediated( Ca2+( signalling(mechanisms(in(primary(cortical(cultures.(
4.3.1 Summary+Using( the( INCell( Analyser( 2000( high( content(microscope( and( the( INCell( Developer(Toolbox( software( (GE( Healthcare),( an( algorithm( was( constructed( to( automatically(segment( cells( in( fluorescent( Hoechst( and( fluo53( labelled( images,( and( report(fluorescence(intensity(over(a(time(series,(which(included(automated(drug(application.(Using(this(protocol,(we(have(shown(clear(and(significant(fluo53(mediated(fluorescence(intensity( increases( to( stimulation(with( KCl,( AMPA( and(NMDA( on( an( individual( cell(basis(from(populations(of(~3000(cells.(Attenuation(of(these(responses(by(antagonists(CNQX,(MK801(and(D5APV(was(also(reported.(( Some(evidence(for(α7(nAChR(mediated([Ca2+]ic(elevations(in(response(to(PNU2(in(the(presence(of(PNU1(was(shown,(although(this(was(too(inconsistent(to(discern(any(significant( quantitative( effects( of( blocking( the( various( routes( of( Ca2+( amplification(that(were(investigated(in(chapter(3.(( The( multi5well( plate( format( used( here( also( allowed( further( analysis( to( be(conducted( by( immunofluorescent( labelling( following( the( Ca2+( imaging( assay.( We(provide(examples(of( fluorescent( images( that( show(co5localization(of(Ca2+(elevations(evoked(by(various(drugs(with(markers(for(astrocytic,(neuronal(and(GABAergic(cells.(
4.3.2 High+content+Ca2++imaging+assay+and+analysis+Investigations( utilizing( HCS( to( observe( primary( cultured( neuronal( cells( have( been(reported( in( the( literature,( mostly( for( the( purposes( of( neurotoxicity( assays( using(neurite(outgrowth(analysis(protocols((Ramm(et(al.,(2003;(Hu(et(al.,(2007;(Evans(et(al.,(2008;(Anderl(et(al.,(2009;(Götte(et(al.,(2010;(Radio(et(al.,(2010).(There(have(been(fewer(attempts( however( to(monitor( live( cells( from( primary( neuronal( cultures( using(HCS,(and( to(our(knowledge(none(so( far( that(have(combined( live(cell(Ca2+( imaging(assays(with( phenotypic( labelling.( Cornelissen( et( al.,( (2013)( recently( described( HCS5like(analysis( of( Ca2+( imaging( data( of( primary( cultured( hippocampal( neurons,( although(acquisition( was( performed( on( a( standard( confocal( microscope( rather( than( an(
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4.3.3 α7+nAChR+mediated+Ca2++elevations+The(HCS(Ca2+(imaging(assay(has(provided(some(evidence(of(α7(nAChR(mediated(Ca2+(elevations,( although( these( were( inconsistent( between( experiments.( When( these(responses(were(clearly(visible(however,( they(were(blocked(by(MLA,(adding( to( their(validity( as( α7( nAChR( mediated( responses.( The( percentage( of( supra5threshold(responses(from(the(total(population(also(support(this(conclusion.(In(some(cases,(F525(increases( from( t152( to( t355( following( application( of( PNU2( (3(μM)( in( the( presence( of(PNU1( (10( μM)(were( not( discernable( by( visual( inspection( of( images,( as( a( degree( of(constitutive( activity( was( seen( and( could( possibly( have( obscured( responses( from( a(small( subpopulation( of( cells.( This( further( justifies( the( use( of( a( difference( between(average( F525( at( stimulated( and( basal( time5points,( as( it( increases( the( chances( of( a(change( in( F525( being( the( result( of( stimulation( rather( than( spontaneous( activity.( In(some( cases(however,( there(was(very( little(difference(between(basal( and( stimulated(F525( following(stimulation(with(PNU2( in( the(presence(of(PNU1,(which( indicates( that(either( the( responses(were( too( low,( too( short( in(duration,( or(did(not( occur(possibly(due( to( a( much( lower( level( of( α7( nAChR( expression.( A( lack( of( temporal( resolution(could(also(make(responses(from(subpopulations(of(cells(harder(to(detect.(With(a(small(collection( of( time5points,( it( is(more( difficult( to( assess( the( duration( of( spontaneous(events,( which( in( live( cell( imaging( experiments( would( be( more( easily( disregarded(compared(to(longer,(stimulation5induced(events.(( Due( to( the( inconsistency( of( the( responses,( it( was( difficult( to( discern( any(significant(effects(of( the(antagonists( investigated( in(chapter(3.(Again,( it(may(be( that(trying( to( detect( a( partial( blockade( of( a( response( that( occurs( within( a( small(subpopulation( of( cells( is(more( difficult( with( lower( spatio5temporal( resolution.( The(inclusion(of(bicuculline((1(μM)(to(block(GABAA(receptors(had(a(potentiating(effect(in(some( experiments.( This( is( to( be( expected( if( α7( nAChRs( are( located( on( GABAergic(nerve( terminals,( promoting( the( release( of( GABA,( a( predominantly( inhibitory(neurotransmitter( (Obata,( 2013).( Positive( immunofluorescent( labelling( for(GAD( (see(
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sections(4.2.455)(also(supports(the(existence(of(GABAergic(cell(bodies(and(terminals(in(primary(cortical(cultures.(Blocking(postsynaptic(GABAA(receptors(would(push(the(equilibrium( of( GABA( mediated( inhibition( vs.( glutamatergic( excitation( towards( the(glutamatergic( excitatory( side,( manifesting( in( an( increased( ΔF525( and( percentage( of(responding(cells.(Further(experiments(would(be(needed(to(confirm(this(phenomenon.(In(agreement(with( this,(α7(nAChR(mediated(GABA(release(has(been(reported( in( the(rat( hippocampus( as( examined( by( electrophysiology( and( synaptosomal(neurotransmitter( release( assays( (Alkondon( et( al.,( 1997a,( 1999;( Zappettini( et( al.,(2011a).( α7( nAChRs( on( GABAergic( interneurons( have( been( found( to( modulate(inhibition(of(pyramidal(cells(in(the(pre5frontal(cortex((Couey(et(al.,(2007;(Poorthuis(et(al.,(2012).(
4.3.4 Enhancing+the+assay+with+immunofluorescent+labelling+The( results( of( immunofluorescent( labelling( experiments( indicate( the( presence( of(astrocytes( and( neurons,( a( smaller( proportion( of( which( (~( 20( %)( appear( to( be(GABAergic,(which(agree(with(reports(in(the(literature((discussed(in(3.1.3).(The(lower(density(of(punctate(fluorescent(objects(revealed(by(GAD(immunolabelling(compared(to( synaptophysin( immunolabelling( also( supports( this( (Figure( 4.2.12).( The(heterogeneity(of(cell(types(in(these(cultures(warrants(the(use(of(a(sophisticated(HCS(protocol( that( can( report( these( differences( between( cells,( and( this( would( greatly(enhance( our( knowledge( about( nAChR(mediated( Ca2+( signalling( in( primary( cortical(cultures.(We(have(shown(that(such(an(approach(is(possible(in(principle,(by(combining(Ca2+(imaging(assay(data(with(immunofluorescent(labelling.(Segmentation(of(complex(cell(morphologies(such(as(astrocytes(makes(this(a(daunting(task,(but(could(be(made(easier(by(optimizing(culture(density(for(imaging.(Optimization(of(immunofluorescent(labelling( conditions( would( also( help( to( resolve( individual( cells.( The( wealth( of(software(tools(for(image(processing(and(analysis(currently(available(makes(this(even(more(likely(to(bear(fruit(in(the(future.(( Astrocytes(were( found(to(be(present( in(primary(cortical(cultures(as(assessed(by(GFAP(labelling,(but(were(outnumbered(by(neuronal(cells(by(roughly(9:1,(although(this(was(variable((compare(Figure(4.2.12(to(Figure(4.2.16).(The(difference(may(be(due(to(the(age(of(the(cultures,(as(it(has(been(reported(that(astrocytes(continue(to(divide(in(contrast(to(neurons((Horner(and(Palmer,(2003).(The(presence(of(astrocytes(in(these(
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cultures(could(be(regarded(as(an(experimental(drawback(if(one(desires(to(examine(a(purely(neuronal(population.(It(should(be(noted(however(that(these(cultures(are(used(to(model(the(mammalian(brain,(which(albeit(orders(of(magnitude(more(complex(than(its(flat(representation(used(here,(contains(an(abundance(of(non5neuronal(cell(types.(In(fact,(the(intact(brain(glia(are(known(to(outnumber(neurons(substantially((Azevedo(et(al.,( 2009).( Glial( cells( are( well( known( to( play( a( supportive( role( to( neurons( both(physically(and(biochemically((Vernadakis,(1996),(and(omitting(them(completely(could(compromise( cell( viability( and( physiological( relevance( (Rita( et( al.,( 2012).( For( these(reasons( the( development( of( an( assay( that( can( reliably( distinguish( differences(between(cell(types(in(culture(makes(the(presence(of(these(cells(more(of(an(advantage(than(a(limitation.(( Qualitative(analysis(of(combined(images(revealed(Ca2+(elevations(in(astrocytes(and( neurons( following( α7( nAChR( stimulation( (Figure( 4.2.17).( In( line( with( these(observations,(α7(nAChR5mediated(Ca2+(elevations(in(astrocytes(have(been(reported(in(cells( of( the( rat( hippocampus( (Sharma( and( Vijayaraghavan,( 2001;( Pirttimaki( et( al.,(2013)( and( cortex( (Talantova( et( al.,( 2013).( The( images( also( showed( that( a( small(proportion( of( GAD5positive( neurons( exhibited( increased( fluorescence( following( α7(nAChR( stimulation.( Again,( evidence( for( α7( nAChR5mediated( Ca2+( elevations( in(GABAergic( neurons( has( been( reported( in( the( hippocampus( (Gomez5Varela( et( al.,(2012).(The(scarcity(of(these(responses(in(GAD5positive(cells(supports(the(notion(that(a( greater(proportion(of(α7(nAChRs(are(present(on(glutamatergic( cells( or( terminals,(which( has( been( reported( elsewhere( for( the( hippocampus( (Gray( et( al.,( 1996;(Zappettini(et(al.,(2010;(Cheng(and(Yakel,(2014),(nucleus(of(the(solitary(tract((Kalappa(et(al.,(2011)(and(PFC((Dickinson(et(al.,(2008;(Livingstone(et(al.,(2010).(






5.1 Introduction+The( plethora( of( candidate( compounds( screened( in( the( process( of( modern( drug(discovery(inevitably(yields(structures(which(convey(intriguing(properties(that(as(well(as( being( potentially( clinically( useful,( can( greatly( enhance( our( understanding( of(disease(pathology(and( receptor( function.(Prime(examples(discussed( in( section(1.1.5(and( used( extensively( in( the( experiments( that( comprise( this( thesis( are( the( positive(allosteric( modulators( (PAMs),( of( which( benzodiazepines,( which( target( GABAA(receptors,(have(a(long(history(of(use(in(medicine.(This( chapter(will( focus( on( the( characterization( of( sazetidine5A,( a( compound(that( exhibits( a( potentially( useful( behaviour( at( nAChRs,( that( of( receptor(desensitization,( a( property( proposed( to( convey( therapeutic( benefits( to( a( range( of(diseases.( The( experiments( that( are( described( in( this( chapter( are( aimed( at(characterizing( the(effects(of( sazetidine5A(at(α7(and(non5α7(nAChRs( in(SH5SY5Y(cell(populations,(and(in(mouse(primary(cortical(cultures,(both(with(the(aid(of(fluorescent(calcium( indicators( to( report( nAChR( activation.( In( this( section( I( will( describe( the(chemical,( pharmacological( and( behavioural( aspects( of( sazetidine5A( that( have( been(reported(in(the(literature.(
5.1.1 SazetidineHA:+Chemistry+&+pharmacology+Sazetidine5A((65[55[(2S)525azetidinylmethoxy]535pyridinyl]555hexyn515ol;(fig.(5.1.1)(is(a(derivative(of(A585380((35[(2S)525azetidinylmethoxy]pyridine;(fig.(5.1.1),(a(35pyridyl(ether( compound( originally( synthesized( as( a( structural( analogue( of( the( archetypal(nAChR(ligand(epibatidine((Figure(5.1.1),(exhibiting(picomolar(affinity(for(nAChRs(and(a(more( clinically( desirable( selectivity( profile( (Abreo( et( al.,( 1996).( The( drawback( of(nAChR(ligands(epibatidine(and(nicotine(for(clinical(use(lies(in(their(tendency(to(affect(both(the(ganglionic((α3β4*)(and(neuronal((α4β2*)(type(nAChRs,(the(former(thought(to(mediate(cardiovascular(and(gastrointestinal(side5effects((Cucchiaro(et(al.,(2008).(
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EC50%(nM)% 1.1%±%0.3% 1.1%±%0.3% 4500%±%2600% 6.1%±%1.2% 2.4%±%1.2%
Emax%(%%ACh)% 96%±%6% 48% 55%±%7% 98%±%9% 5.8%±%1.1%(
Kozikowski%et%al.%(2009)% h.α4β2% h.α4β4% h.α3β4% h.α1%
s.t.$SH'EP1$ SH'SY5Y$ TE671/RD$
86Rb+$efflux$
EC50%(nM)% 5.8% 25% 3408% 2200%
Emax%(%%CCh)% 55% 98% 97% 51%












EC50%(nM)% 6.9%±%0.8% 6.5%±%1.0% 8.0%±%0.4% —%








EC50%(nM)% 157%±%40% 19.9%±%4.8% 44.5%±%8.7%
Emax%(%%ACh)% 21.9%±%1.5% 86.3%±%10.5% 73.2%±%4.8%(
Zhang%et%al.%(2012)% h.(α4)2(β2)3% h.α4β2α5% h.(α4)3(β2)2% α4β2*%
Chapter$1: s.t.$HEK;$membrane$potential$assay$ Ca2+$flux$assay$
EC50%(nM)% 0.98%±%1% 0.02%±%2% 0.8%±%4% 27%±%12%
Emax%(%%ACh)% 109%±%2% 17%±%2% 21%±%5% 67%±%11%
IC50%(nM)% 0.2%±%1% 0.2%±%1% 0.5%±%1% —%

















Emax%(%%ACh)% 49% —% —%
Dmax%(%%ACh)% —% 77%±%7% 90%±%5%
DC50%(nM)% —% 0.12%±%0.05% 0.63%±%0.1%(
Eaton%et%al.%(2013)% h.α4β2% Concatameric%h.(α4)2(β2)3% Concatameric%h.(α4)3(β2)2%
% % %
EC50%(nM)% 2.0% 3.0% 4.6%
Εmax%(%)% 55%±%0.8% 99%±%2% 12%±%2%(
Campling%et%al.%(2013)% h.%α4β2% h.α3β4% h.α7%%
(+%RICK3;%+%VPA;%+PBA)%
s.t.$tsA20;$membrane$potential$assay$
EC50%(nM)% 2.3%±%0.3% 179%±%30% 1200%±%80%
Emax%(%%ACh)% 44% 100% 100%
IC50%(nM)% 0.48%±%0.02% 0.28%±%0.2% 330%±%100% 3500%±%400%
Chapter(5:(Characterization(of(Sazetidine3A(at(α7(and(non3α7(nAChRs(
( 142(
( Paradoxically,( a( subsequent( study( by( Zwart( et( al.( (2008)( reported( potent(agonist(effects(of( sazetidine3A(eliciting( [3H]dopamine(release( from(rat(striatal( slices(with(an(EC50(of(~1(nM.(Addition(of(100(nM(α3conotoxin(MII((αCtxMII)(did(not(affect(the(EC50(value(but(reduced(the(Emax(by(roughly(half,(indicating(–(as(seen(before(with(the( structural( analogue( 53iodo3A385380( –( substantial( contribution( from( α6β2*(nAChRs(which(partly(mediate(dopamine(release(in(the(striatum((Mogg(et(al.,(2004).(In(the( same( report,( electrophysiological( recordings( from( X.# laevis( oocytes( expressing(human(α4β2(nAChRs(were(made(to(establish(a(possible(reason(for(the(lack(of(agonist(activity( reported( previously( by( Xiao( et( al.( (2006).( By( varying( the( ratio( of( α4( to( β2(nAChR( subunit( cDNAs( injected( into( oocytes,( the( effect( of( sazetidine3A( on( different(α4β2(nAChR( stoichiometries( could( be( studied.( It(was( found( that(whilst( full( agonist(activity(was(observed(for(sazetidine3A(at(high(sensitivity(α42β23((HS3α42β23)(nAChRs,(only(6%(efficacy(relative(to(acetylcholine(was(found(for(the(lower(sensitivity(α43β22((LS3α43β22)(nAChRs,( implying( that( sazetidine3A( is(a( stoichiometry(selective,(as(well(as(subtype(selective(nAChR(agonist.(This(compelling( finding(was( later(confirmed(by(Carbone( et( al.( (2009),( who( also( used( concatenated( receptor( subunit( constructs( to(express( different( α4β2( nAChR( stoichiometries( separately( in( X.( laevis( oocytes.( No(difference(was(reported(for(concatameric(and(non3linked(α4β2(nAChRs.(Zhang(et(al.,((2012)( also( reported( full( efficacy( of( sazetidine3A( for( stably( transfected( human(HS3α42β23( in( HEK3293( cells,( whereas( at( LS3α43β22( and( α4β2α5( nAChRs( it( was( much(lower((98(±(1(%,(0.8(±(4(%,(0.02(±(2%(respectively,(relative(to(ACh).(This(group(also(reported(similar(potency(and(efficacy(for(desensitization(of(HS3α42β23,(LS3α43β22(and(α4β2α5(nAChR(subtypes((see(Table(5.1.2).(Sazetidine3A’s( functional(attributes(were(again(studied(using( the( 86Rb+(efflux(assay( in( SH3EP1( cells( expressing( human( nAChRs( during( an( investigation( into( the(chemistry( and( pharmacology( of( nine( of( its( structural( analogues( (Kozikowski( et( al.,(2009).(EC50(values(of(5.8,(25,(340(and(2200(nM;(and(efficacy(relative(to(nicotine(of(55,(98,(97(and(51(%(were( reported( for(α4β2,(α4β4,(α3β4(and(α1(nAChRs( respectively.(Here(sazetidine3A(acted(as(a(partial(agonist(at(α4β2(nAChRs(in(disagreement(with(the(two( previous( studies( described( above,( again( possibly( due( to( differences( in( nAChR(stoichiometry(in(the(experimental(system(used.(This(again(highlights(the(importance(of(nAChR(subunit(stoichiometry(in(determining(the(functional(effects(of(sazetidine3A.(
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Elaborating( on( the( findings( published( by( Zwart( and( collegues( (2008)( with(respect( to( sazetidine3A’s( actions( at(α6β2*(nAChRs,(Kuryatov( and(Lindstrom( (2011)(generated(and(expressed(concatameric(constructs(of((α6β2)2β3(nAChRs(and(different((α6β2)(α4β2)β3( nAChR( stoichiometries( in( X.( laevis( oocytes.( They( reported( high(potency(and(almost(full(efficacy(for(sazetidine3A(at((α6β2)(α4β2)β3((EC50(=(20,(45(nM(and( Emax( 86,( 73( %( for( β33α63β23α43β2( and( β33α43β23α63β2( concatamers(respectively).(At((α6β2)2β3(nAChRs,(sazetidine3A(was(less(potent(and(less(efficacious,(with(EC50(=(157(nM(and(Emax(=(22(%.(A(recent(study(by(Wageman(et(al.((2013)(probed(the(selectivity(of(sazetidine3A(for(α4β2*(nAChR(subtypes(even(further(by(employing(αCtxMII(or(α6(KO(mice(in(combination(with(α5(ΚΟ(mice,(and(found(that(the(presence(of(the(α5(subunit(in(α4β2*(nAChRs(decreased(the(potency(of(sazetidine3A(acting(as(a(desensitizer(against(ACh(in(mouse(striatal(synaptosomes.(Recently(it(was(reported(that(similar(to(its(preference(for(activating(HS3α42β23(over(LS3α43β22(nAChRs,(sazetidine3A(also(selectively(desensitizes(HS3α42β23(nAChRs(over( LS3α43β22( (Campling( et( al.,( 2013;( Eaton( et( al.,( 2013),( in( contrast( to( earlier(findings( (Zhang( et( al.,( 2012).(Whiteaker’s( group( resolved( this( phenomenon( further(still,(by(heeding(the(work(of(Harpsøe(et(al.,((2011)(and(Mazzaferro(et(al.,((2011)(who(demonstrated(that(LS3α43β22(nAChRs(contain(a(third,(low3sensitivity(agonist(binding(site( between( the(α4(+)/(3)α4( subunit( interface.( It(was( found( that( following(10(min(desensitization(pre3treatment(with(sazetidine3A,(concatameric(LS3α43β22(in(contrast(to(HS3α42β23(nAChRs(still(responded(to(acute(ACh(application,(which(was(attributed(to( allosteric( modulator3like( activity( at( the( unbound( α4(+)/(3)α4( binding( site,(reactivating( the( receptor.( The( authors( therefore( interpreted( sazetidine3A( to( be(selective( for( the(α4(+)/(3)β2(over( the(α4(+)/(3)α4(binding( site( (Eaton(et( al.,( 2013).(Considering( this,( it( is( very( interesting( to( note( that( Zhang( et( al.,( (2012)( found( that(sazetidine3A(showed(similarly( low(potency(and(efficacy(at(α4β2α5(compared( to(LS3α43β22( nAChRs,( suggesting( that( the( α4β2α5( subtype( also( contains( a( non3canonical(binding(site.(However,(recent(studies(employing(a(mutation(approach(similar(to(that(used( to( establish( the( α4(+)/(3)α4( binding( site( dispute( an( analogous( α5(+)/(3)α4(binding(site(in(the(α4β2α5(nAChR((Marotta(et(al.,(2013).(Nevertheless,(expression(of(these(subunits(as(linked,(concatameric(constructs(has(provided(evidence(that(as(well(as(occupying(the(5th,(accessory(position,(the(α5(subunit(can(replace(a(β2(subunit(that(forms(a(canonical(binding(site(with(α4,(with(no(apparent(functional(impact((Jin(et(al.,(
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2013).( The( reasons( for( sazetidine3A’s( low( activity( at( α4β2α5( remain( obscure( and(warrant(further(study.((Owing(to(previous(efforts,(which(used(a(combination(of(transfected(RIC33(and(the( chemical( chaperones( valproic( acid( and( 43phenylbutyric( acid( to( allow( high(expression( levels( of( functional( α7( nAChRs( in( cell( lines( (Kuryatov( et( al.,( 2013),(Lindstrom’s(group(were(also(able(to(measure(the(functional(effects(of(sazetidine3A(at(separately( expressed( α7( nAChRs( for( the( first( time,( using( a( fluorescent( membrane(potential( assay.( They( report( it( to( have( full( agonist( and( desensitizer( activity( at( α7(nAChRs(with(EC50(and( IC50(values(of(1.2(and(3.5(μM(respectively,(approximately(10(fold(less(potent(than(at(α3β4(nAChRs,(and(100(fold(less(than(at(α4β2(nAChRs,(which(Campling(et(al.,((2013)(declare(is(not(within(the(clinically(achievable(range.(Another( striking( and( potentially( clinically( useful( property( of( sazetidine3A(came(to(light(in(a(report(from(Hussmann(et(al.((2012),(who(found(that(in(contrast(to(nicotine( and( another( nAChR( ligand( varenicline,( currently( prescribed( as( a( smoking(cessation( aid,( 2( week( chronic( administration( of( sazetidine3A( did( not( upregulate(nAChRs( in( rodent( brain( in# vivo( measured( using( saturating( concentrations( of([3H]epibatidine.(This(effect(occurred(at(two(to(six(times(the(behaviorally(active(dose(of( sazetidine3A( in( a( nicotine( self3administration( test.( Also( contrary( to( nicotine( and(varenicline,( the( concentration(of( sazetidine3A(measured( in( the(brains(of( chronically(treated(animals(was(only(10(%(of( that( found( in(blood,( yet(with(a(Ki( of(0.05(nM( for(nAChRs( in( rat( cortex( (Zhang( et( al.,( 2012)( this( was( still( theoretically( sufficient( to(occupy(all(α4β2(nAChRs(in(the(brain((~30(nM).(Sazetidine3A(was(however(found(to(significantly( upregulate( nAChRs( in( rat( primary( cortical( cultures,( in( agreement(with(previous( findings( in( HEK3293( cells( (Xiao( et( al.,( 2006).( Hussmann( et( al.,( (2012)(suggested( that( the( difference( between( in# vivo( and( in# vitro( nAChR( upregulation( by(sazetidine3A( reflects( the( poorer( ability( of( sazetidine3A( relative( to( nicotine( and(varenicline(to(penetrate(the(blood(brain(barrier(and(subsequent(cell3(and(organelle3membranes( in# vivo.( It( would( therefore( be( able( to( reach( the( brain( at( sufficient(concentrations( to( occupy( cell( surface( nAChRs,( but( perhaps( fail( to( reach( the( ER( in(sufficient( concentrations( to( influence( nAChR( upregulation.( This( could( be( a( highly(valuable( attribute( for( clinical( uses( that( rely( on( occupation( of( nAChRs( but( would(otherwise(be(limited(by(nAChRs(upregulation.(
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To(summarize,( the(33pyridyl(ether(derivative(sazetidine3A(has(been( found( to(exhibit( high( selectivity( for(β2*(nAChRs(over(β4*( and(α7(nAChRs( in(binding( studies(comparable(to(its(forerunner(analogues,(whilst(displaying(three(intriguing(and(quite(possibly(valuable(attributes:(the(ability(to(desensitize(nAChRs(for(extended(periods(of(time,( differential( selectivity( for( α4β2( nAChR( stoichiometries,( and( failure( to(upregulate(nAChRs(in(the(brain(in#vivo(at(behaviourally(active(doses.(The(next(section(will( explore( the( implications( of( these( characteristics( by( evaluating( the( findings(garnered(from(pre3clinical(research(involving(sazetidine3A.(
5.1.2 Evaluation$of$sazetidine'A’s$effects$in$pre'clinical$models$A(steady(stream(of(animal(studies(has(begun(to(provide(evidence(for(the(potentially(beneficial(effects(of(sazetidine3A( in(a(range(of(clinical(disorders( including(addiction,(depression,( pain,( and( attention( deficits.( Whilst( offering( therapeutic( potential,(sazetidine3A’s(unique(pharmacological(properties(described(above(are(also(adding(to(our( understanding( of( the( underlying( pathology( and( neurobiology( of( such( clinical(conditions( in(a( reciprocal( fashion.(A( recurrent( theme( in(nAChR(related(disorders( is(the( at3first( paradoxical( notion( of( the( ability( of( both( agonists( and( antagonists( to(provide(the(same(beneficial(effects.(These(observations(are(however(reconciled(when(one( takes( into( account( the( intrinsic( propensity( of( nAChRs( to( desensitize( in( the(presence( of( continued( agonist( stimulation,( presenting( a( physiological( antagonistic(effect.(The(remainder(of(this(section(will(be(concerned(with(evidence(of(such(effects(produced(by(sazetidine3A.(Cucchiaro( and( colleagues,( (2008)( reported( significant( analgesic( effects( of(sazetidine3A( in( the( formalin( test( of( nociception( in(mice( at( doses( above( 0.5(mg/kg.(These(results(were(later(confirmed(by(Zhang(et(al.((2012)(and(Alsharari(et(al.((2012).(The( former( screened( a( variety( of( α4β2*3selective( agonists( with( varying(activation/desensitization( properties( and( reported( that( stronger( desensitizers( of(α4β2*( nAChRs( elicit( better( analgesia.( Interestingly,( this( study( also( concluded( that(desensitization( of( α4β2α5( nAChRs;( at( which( sazetidine3A’s( effects( were( similar( to(those( observed( for( LS3α4β2( nAChRs( was( more( important( in( determining(antinociceptive(effects(of(nicotinic(compounds.(Alsharari(et(al.,( (2012)(also(used(the(tail( flick( and( hot( plate( models( of( acute( nociception( in( which( sazetidine3A( and(varenicline,( another( α4β2( nAChR( partial( agonist,( failed( to( induce( significant(
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analgesia.( Together( these( studies( demonstrate( the( potential( therapeutic( benefit( of(sazetidine3A(for(chronic,(but(not(acute(pain(conditions.(Sazetidine3A,( like( other( compounds( affecting( α4β2( nAChRs( such( as(mecamylamine,( A385380( (Buckley( et( al.,( 2004),( SIB31508Y( (Ferguson( et( al.,( 2000),(varenicline((Rollema(et(al.,(2009),(cytisine((Mineur(et(al.,(2007)(and(TC31734((Gatto(et(al.,(2004),(was(found(to(increase(time(spent(swimming(in(the(mouse(forced(swim(test((Kozikowski( et( al.,( 2009;( Turner( et( al.,( 2010;( Caldarone( et( al.,( 2011),( designed( to(measure(antidepressant(drug(efficacy( in(mice.(Typical(antidepressant(drugs(such(as(sertraline( and( desipramine( reduce( time( spent( immobile( by( a( mouse( during( an(allocated(time(left(in(a(water(filled(container,(a(measure(of(behavioural(helplessness((Porsolt( et( al.,( 1977).( These( pre3clinical( findings( provide( incentive( to( further( study(the(effects(of(nAChR(agents(like(sazetidine3A(on(depressive(symptoms.(Promising( findings( in( the( field( of( addiction( have( also( been( reported( for(sazetidine3A.( It( reduced( nicotine( self3administration( in( rats( (Levin( et( al.,( 2010;(Rezvani(et(al.,(2010),(with(no(attenuation(in(effectiveness(even(after(a(43week(period(of(chronic(treatment((Johnson(et(al.,(2012).(These(effects(are(due(to(partial(agonism(of(sazetidine3A( for( nAChRs,( and( long( lasting( desensitization,( which( would( block( the(effects( of( nicotine.( Alcohol( self3administration( was( also( significantly( reduced( in(selectively( bred( alcohol( preferring( rats( by( both( chronic( and( acute( treatment( with(sazetidine3A( (Rezvani( et( al.,( 2010).( Here,( in( contrast( to( the( nicotine( self3administration(studies,(tolerance(began(to(develop(after(the(seventh(day(of(treatment.(Furthermore,( as(measured( by( the( novelty3induced( hypophagia( and(marble( burying(tests,(acute(sazetidine3A(mitigated(anxiogenic(effects(of(nicotine(withdrawal( in(mice((Turner( et( al.,( 2013).( Paterson( et( al.( (2010)( reported( that( sazetidine3A,( like(varenicline( and( nicotine( exhibited( reinforcing( effects( in( rats,( although( to( a( lesser(degree.( As( described( above( (section( 5.1.1),( another( important( aspect( to( note( with(respect( to( sazetidine3A’s( potential( use( for( addiction( therapy( is( the( lack( of( nAChR(upregulation( reported( in( the( brains( of( rodents( following( chronic( treatment( with(doses( that( reduced( nicotine( self3administration,( as( this( could( contribute( to( the(reduction( of( nicotine( withdrawal( symptoms,( by( reducing( the( number( of( available(nAChRs((Hussmann(et(al.,(2012).(Sazetidine3A,(which( is( reputedly( able( to( desensitize( α4β2( nAChRs( for( hours(after(brief(activation((Xiao(et(al.,(2006)(was(seen(to(enhance(and(restore(MK801(and(
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scopolamine( impaired( performance( in( the( visual( signal( task( (Rezvani( et( al.,( 2011,(2012a),( a( rodent( model( of( sustained( attention( (Bushnell,( 1995).( To( address( the(question( of( whether( activation( or( inactivation( via( desensitization( is( the( dominant(mechanism( of( sazetidine3A’s( attention( enhancing( effects,( Levin( et( al.( (2013a)( used(antagonists( of( α4β2( and( α7( nAChRs,( dihydro3β3erithroidine( (DHβE)( and(methyllycaconitine((MLA)(respectively( in(the(same(behavioural(paradigm,(achieving(similar( results.( This( group( also( investigated( hypothermic( responses( in( rodents,( a(well3known( effect( of( nicotinic( agonists,( caused( by( sazetidine3A.( In( two( separate(studies(it(was(found(that(DHβE(and(β2(subunit(knockout(but(not(MLA(or(α7(subunit(knockout(reduced(sazetidine3A( induced(hypothermic(responses( in(rodents( (Rezvani(et(al.,(2012b;(Levin(et(al.,(2013b).(This(suggests(that(the(beneficial(effects(of(nicotinic(agonists( are( indeed( due( to( a( physiological( antagonist( effect,(which( can( result( from(nAChR(desensitization.(This(would(also(be(expected(from(receptor(exposure(to(drug(in(vivo,(which(would(be(over(relatively(long(timescales.(
5.1.3 Summary$In( consideration( of( its( qualities( described( thus( far,( sazetidine3A( represents( a(promising( lead(compound( for( the(development(of( treatments( for(a( range(of( clinical(disorders( in( which( nAChRs( are( implicated,( specifically( pain,( depression,( addiction,(and( attention( deficits.( To( reiterate( its( pharmacological( profile,( sazetidine3A( is( a(compound(which(displays( full(agonist(activity( for(HS3α42β23,(partial(agonist(activity(for(α6β2*(and(almost(no(agonist(activity(for(LS3α43β22(nAChRs,(making(it(subtype(as(well(as(stoichiometry(selective.(It(also(potently(desensitizes(nAChRs(for(long(periods(of( time,( and( fails( to(upregulate(nAChRs( in(vivo.(Relatively( little(attention( so( far(has(been(paid(to(the(actions(of(sazetidine3A(at(α7(nAChRs,(which(have(been(reported(to(modulate(motivation( to( self3administer(nicotine( in( rodents( (Brunzell( and(McIntosh,(2012).( Widespread( α7( nAChR( expression( in( peripheral( systems( also( raises( the(possibility(of(them(mediating(of(side3effects(to(nicotinic(drugs((Filippini(et(al.,(2012).(This(receptor(subtype(therefore(deserves(further(study(with(respect(to(the(effects(of(sazetidine3A.(
5.1.4 Aims$The( aim( is( to( evaluate( the( functional( activity( of( sazetidine3A( at( α7( and( non3α7(nAChRs.(Sazetidine3A(has(been(reported(to(activate(and(strongly(desensitize(nAChRs,(
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5.2.1 PNU'120596$ potentiates$ intracellular$ calcium$ elevations$ elicited$ by$
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Figure&5.2.1:&Intracellular&calcium&elevations&evoked&by&sazetidine=A&in&SH=SY5Y&cell&populations.&SH3SY5Y( cells( loaded( with( fluo33AM( were( stimulated( with( sazetidine3A( (10( μΜ,( a,( b;( 100( μM,( c,( d)( in( the(presence((dark(blue(bars)(or(absence((light(blue(bars)(of(PNU1((10(μM).(Responses(were(challenged(with(the(general(nAChR(antagonist(mecamylamine((30(μM;(checkered(bars)(and(the(α7(nAChR(selective(antagonist(MLA((100(nM;(dashed(bars).(Fluorescence(at(538(nm(was(measured(for(20(s(following(stimulation(with(sazetidine3A((b)(and((d).(Data(are(presented(as(percent(maximum(fluorescence(determined(by(addition(of(0.2(%(Triton(X3100(minus(minimum(fluorescence(quenched(by(350(mM(MnCl2((a)(and((c).(Bars(represent(mean(±(SEM(of(at(least(4(independent(experiments;(*(P(<(0.05,(**(P(<(0.01,(***(P(<(0.001(significantly(different(from(sazetidine3A(or(in(combination(with(PNU1,(non3paired(one3way(ANOVA,(Bonferroni’s(multiple(comparisons(test.(
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Initially,( sazetidine3A( alone( was( applied( to( cells( loaded( with( fluo33AM( and(fluorescence( at( 538( nm( (F538)( was(monitored( for( 20( s( as( shown( in( representative(traces( (Figure( 5.2.1b,( d).( At( concentrations( of( 10( (Figure( 5.2.1a,( b)( and( 100( μM((Figure(5.2.1c,(d),(sazetidine3A(elicited(changes(in(F538(indicative(of([Ca2+]ic(elevations(of(27.97(±(4.35(%(and(30.3(±(4.4(%(respectively.(Responses(to(100(μM(sazetidine3A(appeared( to( reach(maximal( levels( faster( than( those( evoked( by( 10( μM( sazetidine3A((Figure(5.2.1b,(d).(These(responses(were(sensitive(to(blockade(by(the(general(nAChR(channel( blocker(mecamylamine( (30( μM),( but( unaffected( by( the(α7(nAChR( selective(antagonist(MLA((100(nM).(Significant(potentiation(of(these(responses(were(observed(following(pre3incubation(and(co3application(of(10(μM(PNU1((2.33(±(0.72(and(2.24(±(0.48(fold(respectively)(potentiation(was(abolished(in(the(presence(of(mecamylamine((30(μM)(or(MLA((100(nM;(Figure(5.2.1).(
We( then( examined( the( concentration3response(profile( of( sazetidine3A( in( SH3SY5Y(cells(with(and(without(PNU1((Figure(5.2.2).(Cells( loaded(with( fluo33(AM(were(stimulated( with( sazetidine3A( alone( at( concentrations( of( 0.13100( μM,( giving( a(sigmoidal( concentration3response( relationship( with( EC50( =( 4.17( μM( that( began( to(saturate( at( 100( μM.( In( the( presence( of( PNU1,( responses(were(much(more( variable((data(point( for( response( at(100(μΜ(sazetidine3A( in( the(presence(of(PNU1(has(been(
(
Figure& 5.2.2:& Concentration=response& profile& of& sazetidine=A,& intracellular&
calcium&elevations&in&SH=SY5Y&cell&populations.&SH3SY5Y(cells( loaded(with(fluo33AM(were(stimulated(with(sazetidine3A((0.1(–(100(μM)( in( the( presence( (grey( squares)( or( absence( (black( circles)( of( PNU1( (10( μΜ).(Fluorescence( at( 538( nm( was( measured( for( 20( s( following( stimulation( with(sazetidine3A.(Data(are(presented(as(percent(maximum(fluorescence(determined(by(addition(of(0.2(%(Triton(X3100(minus(minimum(fluorescence(quenched(by(350(mM(MnCl2.(Points( represent(mean(±(SEM(of(at( least(8( independent(experiments.(Data(were(fitted(to(the(Hill(equation(following(exclusion(of(data(point(representing(the(response(to(100(μM(sazetidine3A(in(the(presence(of(PNU1.(
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excluded(as(an(outlier( to(allow(points( to( fit(a(curve(described(by( the(Hill(equation),(with(EC50(=(0.42,(and(saturation(beginning(at(around(10(μM.((In( a( single( experiment,( the( potentiation( of( sazetidine3A( by( PNU1( was(compared( to( that( of( nicotine( and( another( highly( selective( α4β2( nAChR( agonist,( 53Iodo3A85380((53Iodo;(Figure(5.2.3).(Nicotine((30(μM)(and(53Iodo((1(μM)(evoked(F538(elevations(of(14.79(±(2.12(%(and(28.86(±(4.73(%(respectively,(which(were(potentiated(4.00(±(0.21( and(2.35(±(0.28( fold(by(pre3incubation( and( co3application(of(PNU1( (10(μM).(These(levels(of(potentiation(by(PNU1(are(in(the(same(range(as(observed(for(the(potentiation(of(10(μM(sazetidine3A((2.33(±(0.72(fold;(Figure(5.2.1).(( Having(observed( the(agonist(effects(and(concentration( response( relationship(of( sazetidine3A( in( the( presence( or( absence( of( PNU1( in( SH3SY5Y( populations,( we(
























elevations&by&PNU1&is&comparable&to&that&of&other&nAChR&agonists.&SH3SY5Y( cells( loaded(with( fluo33(AM(were( stimulated(with(nicotine( (30(μM;(red(bars)(or(53iodo((1(μM;(yellow(bars)( in( the(presence(or(absence(of(PNU1((10( μM;( dashed( bars).( Fluorescence( at( 538( nm( was( measured( for( 20( s(following( stimulation(with( nicotinic( agonists.( Data( are( presented( as( percent(maximum(fluorescence(determined(by(addition(of(0.2(%(Triton(X3100(minus(minimum( fluorescence( quenched(by(350(mM(MnCl2.( Bars( represent(mean(±(SEM(of(4(replicates(from(one(assay.(
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5.2.2 PNU'120596$ reveals$ sazetidine'A$ evoked$ calcium$ elevations$ in$ mouse$
primary$cortical$cultures$Mouse(primary(cortical(cultures(were( loaded(with( the(ratiometric(calcium(sensitive(dye( fura32( AM( and( continuously( perfused( with( buffer( at( 37( °C.( Stimulation( with(sazetidine3A(at(10(nM,(100(nM(and(1(μM(for(20(s(was(not(found(to(elicit(changes(in(fluorescence( ratio( (F340:F380)( in( any( cells( examined( (n( =( 1( culture,( 2( replicates( x( 2(measurements,(23(regions(of(interest;(Figure(5.2.4a3c).(At(10(μM(however,(sazetidine3A( inconsistently( provoked( short( bursts( of( elevated( F340:F380( indicative( of( [Ca2+]ic(changes(in(a(subpopulation(of(cells(from(4/8(measurements((mean(F340:F380(increase(
(
Figure& 5.2.4:& Live& cell& calcium& imaging& of&mouse&
primary& cortical& cultures& perfused& with&







































































=(0.22(±(0.13;(Figure(5.2.4d3e).(KCl((40(mM)(was(applied(to(non3responsive(cells(as(a(positive(control;(resulting(in(rapid(F340:F380(increases(of(0.28(±(0.01(that(returned(to(basal(levels(upon(washout((33(cells(from(two(measurements;(n(=(1;(Figure(5.2.4d).(In(one(experiment,(nine(cells(gave(short,(burst(like(elevations(in(F340:F380((0.04(±(0.01)(in(response(to(a(20(s(application(of(10(μΜ(sazetidine3A((Figure(5.2.5a).(After(3(min( washout,( mecamylamine( (30( μM)( was( applied( to( the( same( cells( for( 10( min,(before( co3applying( 10( μM( sazetidine3A( again( for( 20( s,( which( failed( to( produce( a(repeated(response(in(all(cells((Figure(5.2.5b).(Following(10(min(washout(however,(a(third( application( of( 10( μM( sazetidine3A( for( 20( s( in( the( absence( of( mecamylamine(resulted( in( a( 45.22( ±( 0.00( %( recovery( of( the( original( response( (Figure( 5.2.5c).(Spontaneous( elevations( in( basal( F340:F380( were( observed( at( the( start( of( recording((Figure(5.2.5a,c),(artifacts(similar(to(this(have(been(observed(previously(at(the(start(of(F340:F380(recordings(in(this(experimental(system((see(section(3.2.2).(To( examine( the( potential( agonist( effects( of( sazetidine3A( at( α7( nAChRs( in(mouse(primary(cortical(cultures,(we(employed(the(α7(selective(PAM(PNU1(to(amplify(any(responses(that(may(be(obscured(by(rapid(desensitization(typical(of(this(receptor.(A( representative( experiment( is( shown( in( figure( 5.2.6a3c.( Following( 3( min( pre3incubation( of( PNU1( (10( μM),( 20( s( co3application( of( sazetidine3A( (10( μM;( Figure(5.2.6a),( gave( more( consistent( and( prolonged( increases( in( F340:F380( of( 0.12( ±( 0.04(above(basal(levels((0.15(±(0.02)(from(14(%(of(visible(cells(imaged(in(six(experiments(from( three( separate( cultures,( similar( to( the( percentage( of( cells( responding( to( α7(nAChR( stimulation( with( PNU1( (10( μM)( in( combination( with( PNU2( (3( μM;( 12( %;(3.2.2).(These(responses(were(also(completely(blocked(by(10(min(pre3incubation(and(co3application( of( the( α7( selective( antagonist( MLA( (100( nM;( Figure( 5.2.6b,( d).( On(average,(responses(recovered(to(32.43(±(9.42(%(of(the(initial(stimulation(following(10(min( wash( out( (Figure( 5.2.6c,( d),( notably( lower( than( the( recovery( of( responses( to(PNU1(in(combination(with(PNU2(following(blockade(with(MLA,(where(89.68(±(22.73(%(%(recovery(was(observed((3.2.2).(So(far,(we(have(assessed(the(agonist(effects(of(sazetidine3A(in(fluo33(AM(loaded(SH3SY5Y( cells( in( a( population( based( calcium( fluorescence( assay,( and( in( fura32( AM(loaded(mouse(primary(cortical(cultures(using(live(cell(imaging.(The(next(section(will(concern( a( behavior( attributed( to( sazetidine3A( that( can( be( distinguished( from( the(effects( described( above,( namely( that( of( receptor( desensitization.( Here( we( will( use(
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Figure'5.2.6:'Sazetidine;A'elicits'intracellular'calcium'elevations'in'the'presence'of'PNU1'in'mouse'primary'cortical'cultures.'Cultures((10314DIV)(were(loaded(with(fura32(AM,(perfused(with(1.8(mM(calcium(buffer(at(37(°C(and(imaged(under(a(fluorescence(microscope(at(510(nm.(Cells(were(pre3incubated(with(PNU1((10(μM;(3(min)(before(recording(basal(F340:F380(for(30(s,(after(which(sazetidine3A((10(μM;(a)(was(co3applied(for(20(s.(After(3(min(wash(out,( cells(were( then(pre3incubated( for(10(min(with(MLA( (100(nM)(and(PNU1( (10(μM)(prior( to( recording(F340:F380(before,(during(and(after( co3stimulation(with(sazetidine3A( (10( μM;( 20( s;( b).( Finally,( following( 10( min( wash( out,( the( protocol( was( repeated( in( the( absence( of( MLA( (c).( Still( images( show( fluorescence( in(pseudocolour,((black/blue(=(low(F340:F380,(red/white(=(high(F340:F380)(taken(during(agonist(stimulation.(Traces(show(coloured(lines(corresponding(to(two(regions(of( interest( selected( as( responding( cells( indicated(with( coloured( arrowheads( in( each( image.( Data( are( presented( as( a( ratio( of( fluorescence( emitted( at( 510( nm(following(excitation(at(340(and(380(nm(from(a(representative(experiment.(Bars((d)(represent(mean(peak(F340:F380(increase(from(basal(expressed(as(a(percentage(of(the( initial( stimulation( response( from( the( same( region( of( interest( ±( SEM( from( 3( independent( experiments;( ****( P"<( 0.0001( significantly( different( from( initial(response(to(sazetidine3A(in(combination(with(PNU1((100(%),(one(sample(t3test.(
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5.2.3 Desensitization.of.nAChRs.by.sazetidine7A.in.SH7SY5Y.cells.To(assess( the(ability(of( sazetidine3A( to(desensitize(α3β4*(nAChRs,(cells( loaded(with(fluo33( AM( were( pre3incubated( with( sazetidine3A( for( 10( min( before( addition( of(nicotine((fig.(5.2.7a).(In(the(absence(of(sazetidine3A,(100(μM(nicotine(evoked(changes(in(fluorescence(of(33.89(±(7.21(%.(This(was(concentration3dependently(attenuated(by(sazetidine3A((0.01(–(100(μM)(with(ΙC50(=(0.52(μM((Figure(5.2.7a).(
( Sazetidine3A’s( ability( to( desensitize( α7( nAChRs( was( then( evaluated( by(stimulating(cells(with(PNU2((3(μM)(in(the(presence(of(PNU1((10(μM),(which(elicited(increases( in( fluorescence( of( 44.47( ±( 9.70( %.( As( above,( 10( min( pre3incubation( of(sazetidine3A( (0.01( –( 100( μM)( resulted( in( a( concentration3dependent( diminution( of(this(response(with(a(similar(IC50(=(0.48(μM((Figure(5.2.7b).(After( the( pre3incubation( phase,( in( which( sazetidine3A( was( added( in(combination(with(PNU1,( it(was(noticed(that(measurements(of(basal(F538(were(rising(with(increasing(concentrations(of(sazetidine3A((Figure(5.2.8).(After(pre3incubation(of(1(μM(sazetidine3A(and(10(μM(PNU1,(basal(F538(increased(171.51(%(from(basal(F538(in(the( absence( of( drugs.( In( the( absence( of( PNU1( however,( 1( μM( sazetidine3A( only(increased(F538(by(7.12(%.(This(raises(a(concern(that(the(ability(of(PNU1(to(overcome(
(
































Figure' 5.2.7:' Sazetidine3A' concentration3dependently' inhibits' nicotine' and' PNU1+PNU2' evoked'
intracellular'calcium'elevations'in'SH3SY5Y'cell'populations.'SH3SY5Y(cells(loaded(with(fluo33AM(were(stimulated(with(nicotine((100(μM;(a)(or(PNU2((3(μM;(b)(following(10(min( pre3incubation( of( PNU1( (10( μM)( in( the( presence( or( absence( of( sazetidine3A( (0.01( μM( –( 100( μM).(Fluorescence( at( 538( nm( was( measured( for( 20( s( following( stimulation( with( nicotinic( agonists.( Data( were(calculated(as(percent(maximum(fluorescence(determined(by(addition(of(0.2(%(Triton(X3100(minus(minimum(fluorescence(quenched(by(350(mM(MnCl2,(expressed(as(a(percentage(of(responses(measured(in(the(absence(of(sazetidine3A.( Points( are( fitted( to( the( Hill( equation( and( represent( mean( ±( SEM( of( at( least( 10( independent(experiments.(
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α7(nAChR(receptor(desensitization(could(compromise(subsequent(measurements(of(responses( to( agonist( stimulation.( However,( the( comparability( of( sazetidine3A’s(inhibition(of(nicotine(and(PNU2(in(combination(with(PNU13evoked(responses(argues(against(this.(
5.2.4 Desensitization. of. nAChRs. by. sazetidine7A. in. mouse. primary. cortical.
cultures.Mouse(primary(cortical(cultures(loaded(with(fura32(AM(were(perfused(with(buffer(at(37(°C.(After(10(min(pre3incubation(with(500(nM(sazetidine3A(in(combination(with(10(μΜ( PNU1( as( above,( stable( baseline( F340:F380(was( observed( prior( to( the( addition( of(PNU2((3(μΜ).(The(baseline(was(not(significantly(different(from(that(observed(in(the(absence( of( drugs( (mean( F340:F380( in( absence( of( drugs( =( 0.30( ±( 0.06,( mean( pre3incubation(F340:F380(=(0.26(±(0.04;(Figure(5.2.9).(
((
Figure' 5.2.8' Effect' of' sazetidine3A' pre3incubation' on' basal'
fluorescence'SH3SY5Y(cells(loaded(with(fluo33(AM(were(pre3incubated(for(10(min(with(TSS(or(sazetidine3A((0.01(–(100(μM)(in(the(presence(or(absence(of( PNU1( (10( μ).( Fluorescence( at( 538( nm(was(measured( for( 5( s.(Points( represent( mean( F538( ±( SEM( of( 4( replicates( from( a( single(experiment.(
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in'cortical'cultures'does'not'significantly'alter'pre3stimulation'F340:F380.'Mouse( primary( cortical( cultures( (10314( DIV)( were( loaded(with( fura32( AM(and( perfused( with( 1.8( mM( calcium( buffer( at( 37( °C.( Cultures( were( pre3incubated(with(buffer(or( sazetidine3A( (500(nM)( in( combination(with(PNU1((10(μΜ)(for(10(min.(Fluorescence(at(510(nm(following(excitation(at(340(and(380(nm(was(measured(for(10(s.(Data(are(presented(as(mean(F340:F380(±(SEM(from(individual(ROIs(from(3(independent(experiments.(
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and'sazetidine9A.'Cultures((10314DIV)(were(loaded(with(fura32(AM,(perfused(with(1.8(mM(calcium(buffer(at(37(°C(and(imaged(under(a(fluorescence(microscope(at(510(nm.(Cells(were(pre3incubated(with(PNU2((3(μM;(a(i)(or(sazetidine3A((10(μM;(b(i)(for( 10( min( prior( to( addition( of( PNU1( (3( μM;( 20( s;( a( ii;( b( ii).( Still( images( show( fluorescence( in( pseudocolour,((black/blue(=(low(F340:F380,(red/white(=(high(F340:F380).(Traces((a(iii;(b( iii)(show(coloured(lines(corresponding(to(individual( regions( of( interest( indicated(with( coloured( triangles( in( each( image.( Data( are( presented( as( a( ratio( of(fluorescence(emitted(at(510(nm(following(excitation(at(340(and(380(nm(from(a(representative(experiment.(Bars((c)(represent( mean( basal( or( peak( F340:F380( from( 1( (PNU2;( green( bars)( and( 2( (sazetidine3A;( blue( bars;( ±( range)(independent(experiments.(
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derivative( (Figure( 5.2.13( E)( that( were( examined( with( respect( to( their( activity( at(nAChRs((Feula(et(al.,(2010).(( Firstly,( competition3binding( assays( were( undertaken( using( 200( nM([3H]epibatidine(to(label(heteromeric(nAChRs(in(rat(brain(membranes(to(evaluate(the(affinity( of( compounds( A3E( for( the( orthosteric( ACh( binding( site( of( nAChRs( (Figure(5.2.14).(At(100(μM,(none(of(the(compounds(affected(the(binding(of([3H]epibatidine(as(measured(by(scintillation(counting.(
( Compounds( A3E( (100( μΜ)( were( then( applied( to( fluo33( AM( loaded( SH3SY5Y(cells( to( assess( their( potential( agonist( activity( at( nAChRs( (Figure( 5.2.15a).( In( stark(contrast( to( nicotine( (100( μM;( 32.82( ±( 6.00(%),( PNU2( (3( μM)( in( combination(with(PNU1((10(μM;(41.54(±(9.31(%)(and(sazetidine3A((100(μM;(17.97(±(14.02),(little(change(in( F538(was( observed( in( response( to( application( of( compounds(A3E( (2.73(±( 0.63(%,(3.26(±(0.24(%,(2.98(±(0.42(%,(4.29(±(0.40(%,(3.01(±(0.70(%).(There(was(no(significant(difference(between(F538( observed( in( response( to( compounds(A3E,(nor(did( they(give(significantly(different(responses(from(buffer((3.01(±(0.71(%).(
(
Figure' 5.2.14:' Novel' azetidine/pyrrolidine' compounds' A9E' do' not' compete' for' binding'
with'epibatidine'
nAChRs' in' rat' brain' membranes' were' labelled' with' 200' nM' [3H]epibatidine' in' the'
presence' or' absence' of' increasing' concentrations' of' nicotine' of' sazetidine9A,' or'
compounds'A9E'(100'μΜ).'These'experiments'were'conducted'by'Sarah'Foale'using' the'


























































































Figure' 5.2.15:' Effects' of' novel' azetidine/pyrrolidine' containing' compounds' A9E' on'
intracellular'calcium'elevations'in'SH9SY5Y'cells.'SH3SY5Y(cells(were( loaded(with( fluo33(AM(and(stimulated(with(nicotine((100(μΜ;(pink(bars;(a,(b),(PNU2( (3(μM;( green(bars;( a,( c)( in( the(presence(of(PNU1( (10(μM),( sazetidine3A( (100(μM;(dark(blue(bars;(a)(or(compounds(A3E((100(μM;( light(blue(bars;(a)( for(20(s(whilst(monitoring( fluorescence(at(538( nm.( Dashed( bars( (b,( c,( d)( indicate( 10( min( pre3incubation( of( compounds( A3E( (100( μM),(sazetidine3A((Saz;(100(μM)(or(mecamylamine((Mec;(100(μM)(before(stimulation.(Data(are(presented(as(percent(maximum(fluorescence(determined(by(addition(of(0.2(%(Triton(X3100(minus(minimum(fluorescence( quenched( by( 350(mM(MnCl2.( Bars( represent(mean( ±( SEM( of( at( least( 3( independent(experiments;( *( P( <( 0.05,( **( P( <( 0.01,( ***(P<( 0.001( significantly( different( from( nicotine,( PNU2( in(combination(with(PNU1(or(KCl(alone,(non3paired(one3way(ANOVA,(Dunnett’s(multiple(comparisons(test.(
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Increases( in( F538( in( response( to( application( of( PNU2( (3( μM)( in( combination(with(PNU1((10(μM;(Figure(5.2.15c)(however(were(only(significantly( inhibited(by(10(min( pre3incubation( of( compounds( C( and( D( (71.92( ±( 7.03(%( and( 83.66( ±( 0.96(%),(although(a(downward( trend(was(also(observed( for( compounds(A,(B(and(E( (22.33(±(11.10(%,(47.82(±(21.39(%,(18.54(±(5.70(%).(As( shown( by( our( lab( previously( (Dajas3Bailador( et( al.,( 2002a),( nAChR(mediated( [Ca2+]ic( elevations( in( SH3SY5Y( cells( are( dependent( on(multiple( secondary(mechanisms( such( as( the( release( of( calcium( from( intracellular( stores( and( via(depolarization( induced( opening( of( voltage( gated( calcium( channels( (VGCCs).( We(hypothesized(that(compounds(A3E(could(be(interfering(with(such(mechanisms(rather(than(directly(acting(at(nAChRs(to(inhibit([Ca2+]ic(elevations(in(SH3SY5Y(cells.(In(order(to(evaluate(the(specificity(of(these(effects(with(respect(to(nAChRs,(we(repeated(the(10(min(pre3incubation(of( compounds(A3E,(but( this( time( stimulated( cells(with(KCl( (100(mM;(Figure(5.2.15d),(which(depolarizes(cells(resulting(in(activation(of(VGCCs,(raising([Ca2+]ic.(Application(of(KCl((100(mM)(alone(to(fluo33(AM(loaded(SH3SY5Y(cells(evoked(F538( increases(of(27.32(±(5.36(%.(Following(10(min(pre3incubation,( these(responses(were(significantly(inhibited(by(compounds(D(and(E((75.10(±(3.15(%,(83.74(±(3.17(%),(and(a(downward(trend(was(observed(for(compound(C((46.33(±(26.35(%).(Compounds(A,(B(and(sazetidine3A(had(no(significant(effect(on(KCl(evoked(changes(in(F538.(In(this(section,(we(have(described(experiments(that(aimed(to(characterize(the(novel(azetidine/pyrrolidine(containing(compounds(A3E.(We(extended(these(methods(to(examine(potential(agonist(or(antagonist(effects(of(novel(compounds,(and(finally(to(assess(their(specificity(for(nAChRs.(
Chapter(5:(Characterization(of(Sazetidine3A(at(α7(and(non3α7(nAChRs(
( 169(
5.3 Discussion-In(this(chapter(we(have(investigated(the(effects(of(the(highly(selective,(stoichiometry(dependent,(nAChR(desensitizing(agonist(sazetidine3A(at(α7(and(non3α7(nAChRs(using(a( high( throughput( fluo33( AM( based( calcium( fluorimetry( assay( in( SH3SY5Y( cell(populations,( and( subsequently( in( finer( detail( with( the( aid( of( fura32( AM( live( cell(imaging(in(mouse(primary(cortical(cultures(to(observe(these(effects(in(real(time(on(an(individual(cell(basis.(
5.3.1 Summary-In(SH3SY5Y(cells,(sazetidine3A(alone(produced(concentration(dependent(increases(in(F538( indicative( of( [Ca2+]ic( elevations( that(were( sensitive( to( blockade( by( the( general(nAChR(antagonist(mecamylamine,(but(unaffected(by(the(presence(of(the(α7(selective(antagonist(MLA,(consistent(with(activation(of(heteromeric(nAChRs.(Pre3incubation(of(the( α7( selective( PAM( PNU1( was( seen( to( potentiate( these( responses( in( an( MLA(sensitive( manner.( Mouse( primary( cortical( cultures( inconsistently( responded( to(sazetidine3A(alone,( an(observation( that( contrasted(with( sazetidine3A’s(effects( in( the(presence( PNU1( where( it( elicited( consistent( MLA3dependent( responses( in( a( small(subpopulation(of(cells.(Using( a( 10( min( sazetidine3A( pre3incubation( protocol( we( observed( a(concentration(dependent(reduction( in(F538( increases(evoked(by(nicotine(or(PNU2( in(combination( with( PNU1,( consistent( with( reports( of( sazetidine3A( mediated( nAChR(desensitization( (Xiao( et( al.,( 2006).( This( effect( was( replicated( in( mouse( primary(cortical(cultures(for(responses(evoked(by(PNU2(in(the(presence(of(PNU1.(Application(of(PNU1(following(PNU2(or(sazetidine3A(pre3incubation(was(seen(to(elevate(F340:F380(in(a(manner(consistent(with(a(reversal(of(agonist(driven(α7(nAChR(desensitization.(Finally,( the(effects(of( the(azetidine(or(pyrrolidine(containing(compounds(A3E(were( evaluated( in( SH3SY5Y( cells.( Here,( no( competition( for( the( orthosteric( nAChR(binding( site( was( observed,( and( no( agonist( activity( was( observed( for( any( of( the(compounds,( but( they( were( all( seen( to( negatively( affect( nicotine3evoked( F538(elevations( following( 10( min( pre3incubation.( Compounds( C( and( D( also( seen( to(diminished( F538( increases( evoked( by( PNU2( in( the( presence( of( PNU1.( Lastly,( in( an(
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attempt( to( clarify( nAChR( specificity( of( these( effects,( we( observed( inhibition( of( KCl(evoked(F538(elevations(only(by(compounds(D(and(E.(
5.3.2 SazetidineGA-activates-nAChRs-in-SHGSY5Y-cells-Application(of( sazetidine3A(alone( to( SH3SY5Y( cells( loaded(with( fluo33(AM(provoked(rapid( and( prolonged( increases( in( F538,( indicative( of( [Ca2+]ic( elevations( that( were(sensitive(to(blockade(by(mecamylamine,(implying(activation(of(nAChRs.(Examination(of( the( concentration( dependence( of( this( effect( yielded( an( EC50( of( 4.17( μM,( which(agrees(with(the(values(reported(by(Kozikowski(et(al.((3.4(μM;(2009),(in(the(same(cell(line(using(the(86Rb+(efflux(assay,(and(by(Zwart(et(al.((4.5(μΜ;(2008)(in(rat(hippocampal(slices(measured(by( [3H]NA( release,(which( is( reputed( to( rely( on( activation(of(α3β4*(nAChRs( (Luo( et( al.,( 1998;( Azam( and( Mcintosh,( 2006;( Kennett( et( al.,( 2012).( Both(groups(ascribed(the(activating(effects(of(sazetidine3A(to(α3β4*(nAChRs,(although(SH3SY5Y( cells( also( express( α3β2*( nAChRs( which( could( well( be( contributing( to( these(responses((Wang(et(al.,(1996;(Gerzanich(et(al.,(1998;(Ridley(et(al.,(2001).(Considering(the(greater( affinity(of( sazetidine3A(at(β2*( compared( to(β4*(nAChRs( reported( in( the(literature((Xiao(et(al.,(2006;(Zwart(et(al.,(2008;(Kozikowski(et(al.,(2009;(Kuryatov(and(Lindstrom,(2011;(Zhang(et(al.,(2012;(Liu(et(al.,(2013),(this(seems(highly(probable,(and(could( be( confirmed( by( testing( the( sensitivity( of( these( responses( to( αCtxMII( or(αCtxPnIA( that( preferentially( block( α3β2( nAChRs( (Cartier( et( al.,( 1996;( Luo( et( al.,(1999).(The(presence(of(α5(nAChR(subunits(in(SH3SY5Y(cells(could(also(influence(the(results(of(experiments,(as(their(presence(as(an(accessory(subunit(in(nAChRs(has(been(shown(to(enhance(calcium(permeability(of(α3*(nAChRs(to(levels(comparable(to(that(of(α7( nAChRs,( but( also( increases( the( rate( of( their( desensitization( (Wang( et( al.,( 1996;(Gerzanich(et(al.,(1998).(( Responses( to( sazetidine3A( in(SH3SY5Y(cells(were( significantly(potentiated(by(pre3incubation(and(co3application(of(the(α73selective(PAM(PNU1((10(μM)(in(an(MLA((100(nM)(sensitive(manner,( suggesting( recruitment(of(α7(nAChRs.(Since(conducting(these( experiments,( sazetidine3A( was( reported( to( have( full( agonist( efficacy( at( α7(nAChRs( and( EC50( and( IC50( values( of( 1.2( and( 3.5(μΜ( respectively( (Campling( et( al.,(2013).( The( inclusion( of( PNU1( in( our( experiments( increased( the( potency( for(sazetidine3A( to( elicit( [Ca2+]ic( elevations( by( a( factor( of( ~10( (from( 4.17( to( 0.42( μM),(similar(to(the(level(of(potentiation(seen(with(ACh((Hurst(et(al.,(2005),(and(raised(the(
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maximum(response(by(~48(%.(It(should(be(noted(that(responses( in(the(presence(of(PNU1(were(highly(variable((Figure(5.2.2)(compared(to(sazetidine3A(alone.(There(are(reports( of( α7( nAChR( expression( in( SH3SY5Y( cells( decreasing( after( larger( passage(numbers,(which( could(be( a(possible( reason( for( this.(Nevertheless,( replicates(within(experiments(also(exhibited(a(high(degree(of(variability,(which(suggests(that(passage(number(may(not(be( the(cause,(as( these(replicates(would(be( from(the(same(passage.(We(propose(another(reason:(that(α7(nAChRs(are(expressed(by(a(subpopulation(of(SH3SY5Y( cells,( and( the( variability( is( an( effect( of( measuring( fluorescence( changes( in(populations( of( cells( in( which( α7( nAChRs( are( non3homogenously( expressed( in( the(region( of( measurement( between( replicates.( To( confirm( this,( immunofluorescence(experiments(with(fluorescently(tagged(αBgt(could(be(used(to(evaluate(the(uniformity(of( α7( nAChR( expression( in( SH3SY5Y( populations.( Indeed,( poor( expression( of( α7(nAChRs(has(limited(their(study(in(cell(lines(until(very(recently,(owing(to(the(work(of((Kuryatov(et(al.,(2013),(who(were(able(to(enhance(expression(by(the(use(of(chemical(chaperones(and(RIC33.(( Combining( PNU1( with( other( nAChR( agonists( such( as( nicotine( or( 53iodo(resulted(in(potentiation(in(the(same(range(as(that(of(sazetidine3A((4.00(±(0.21,(2.35(±(0.28(and(2.33(±(0.72( fold( respectively),(which( indicates( similar( levels(of( activity( for(these(compounds(at(α7(nAChRs,(albeit(only(in(the(presence(of(PNU1.(The(functional(activity(of(sazetidine3A(at(α7(nAChRs(without(PNU1(would(require(higher(resolution(techniques( such( as( patch3clamp( electrophysiology( or( the( fluorescent( membrane(potential(assay(employed(by(Campling(et(al.,((2013)(in(cells(in(which(α7(nAChRs(were(highly(expressed.(
5.3.3 PNUG120596- reveals- sazetidineGA- evoked- calcium- elevations- in- mouse-
primary-cortical-cultures-In( mouse( primary( cortical( cultures,( application( of( sazetidine3A( alone( at(concentrations(of(10(nM,(100(nM(and(1(μM(had(no(effect(on(F340:F380,(whereas(10(μM(inconsistently( elicited( short( bursts( of( activity( following( perfusion,( which( were(blocked( by( pre3incubation( and( co3application( of( mecamylamine( (30( μM)( in( one(experiment.( This( could( indicate( activation( of( α4β2*( nAChRs,( although( further(repeated( observations( of( this( effect(would( be( needed( to(make( a( reliable( judgment.(Neurons( of( the(mouse( cortex( are( known( to( express( α4β2(α5)( nAChRs( (Gotti( et( al.,(2006;( Mao( et( al.,( 2008),( so( given( the( reported( selectivity( of( sazetidine3A( for( α4β2(
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nAChRs((Xiao(et(al.,(2006;(Zwart(et(al.,(2008;(Kozikowski(et(al.,(2009;(Kuryatov(and(Lindstrom,(2011;(Zhang(et(al.,(2012;(Liu(et(al.,(2013),(we(would(have(expected( it( to(elicit( responses( at( much( lower( concentrations( than( were( used( in( SH3SY5Y(experiments( above.( It( is( possible( however,( that( the( LS3(α4)3(β2)2( stoichiometry(and/or(the(α4β2α5(nAChR(predominates(in(these(cultures,(at(which(sazetidine3A(was(reported(to(act(as(a(very(poor(partial(agonist((Zwart(et(al.,(2008;(Carbone(et(al.,(2009;(Zhang(et( al.,( 2012).(This(would( explain( the( lack(of( responses( to( sazetidine3A(alone,(although(as(previously(mentioned,(further(experiments(would(be(needed(to(confirm(that(this(is(a(reliable(effect.(A(way(to(examine(this(hypothesis(would(be(to(evaluate(the(effects( of( α4β2( nAChR( stoichiometry( selective( agonists( in( the( cultures.( The(compounds( TC32559( and( ABT3894( were( reported( to( be( more( efficacious( at( LS3(α4)3(β2)2( than( HS3(α4)2(β2)3( nAChRs( (HS/LS:( 357( %/28( %( ;( ( 120(%/50( %(respectively;( relative( to(ACh),(which(would(make( them( suitable( for( addressing( this(question((Zwart(et(al.,(2006;(Zhang(et(al.,(2012).(Another(possibility(for(the(difference(in(responses(to(sazetidine3A(alone(between(SH3SY5Y(cells(and(mouse(primary(cortical(cultures(is(the(fact,(mentioned(above,(that(in(contrast(to(mouse(cortex,(SH3SY5Y(cells(also(express(α3β2(α5)(nAChRs,(which(are(highly(permeable(to(calcium(and(perhaps(more(sensitive(to(activation(by(sazetidine3A(than(LS3(α4)3(β2)2(nAChRs.(Conversely,(in( the( presence( of( PNU1( (10( μM),( sazetidine3A( consistently( evoked( comparatively(robust(and(prolonged(responses(from(a(subpopulation(of(cells.(These(responses(were(completely(blocked(by(10(min(pre3incubation(and(co3application(of(MLA((100(nM).(( An(interesting(finding(here(was(that(after(being(blocked(by(MLA((100(nM),(the(individual( cell( responses( to( sazetidine3A( (10( μM;( 32.43( ±( 9.42( %( recovery)( in(combination( with( PNU1( (10( μM)( did( not( recover( as( well( as( responses( elicited( by(PNU2((3(μM;(89.68(±(22.73(%(recovery;(Figure(3.2.9)(in(combination(with(PNU1((10(μM)(This(suggests(that(after(10(min(washout,(sazetidine3A(is(still(bound(to(α7(nAChRs(leaving(them(desensitized.(This(effect(was(first(reported(in(the(initial(study(by(Xiao(et(al.( (2006)( for( α4β2( nAChRs,( which( remained( significantly( desensitized( after( 1( h(incubation( in( fresh( media.( Desensitization( of( nAChRs( by( sazetidine3A( will( be( the(subject(of(following(sections.(
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5.3.4 Desensitization-of-α7-and-nonGα7-nAChRs-by-sazetidineGA-in-SHGSY5Y-cells-Consistent(with(the(reports(of(others((Xiao(et(al.,(2006;(Kozikowski(et(al.,(2009;(Zhang(et( al.,( 2012;( Campling( et( al.,( 2013;( Eaton( et( al.,( 2013;(Wageman( et( al.,( 2013),( our(experiments(have(provided(evidence(for(the(desensitization(effects(of(sazetidine3A(at(nAChRs.( In( SH3SY5Y( cells,( pre3incubation(of( sazetidine3A( for( 10(min( concentration3dependently( inhibited( responses( to( nicotine( (100( μM)( and( PNU2( (3( μM)( in(combination(with(PNU1((10(μM),(with(IC50(values(of(0.52(and(0.48(μM(respectively.(We( attribute( this( to( desensitization( of( α3β4(α5)( and( α3β2(α5)( nAChRs,( and( α7(nAChRs(respectively.(These(IC50(values(are(approximately(10(fold(lower(than(the(EC50(values(discussed(above,(which(confirms(previous(findings(that(reported(sazetidine3A(to( be( a( more( potent( desensitizer( than( an( agonist( at( nAChRs( (Zhang( et( al.,( 2012;(Campling(et(al.,(2013;(Eaton(et(al.,(2013).(( It(was(noticed(in(these(experiments(that(during(the(pre3incubation(phase,(the(combination( of( sazetidine3A( and( PNU1( would( result( in( elevated( basal( F538( before(agonist(application(had(commenced,(compared(to(sazetidine3A(pre3incubation(in(the(absence( of( PNU1( (Figure( 5.2.8).( We( attribute( this( effect( to( the( ability( of( PNU1( to(reverse( α7( nAChR( desensitization( and( reveal( agonist( induced( channel( activation(effects,( therefore( during( the( pre3incubation( phase( these( receptors( were( being(activated( for( prolonged( periods( of( time,( raising( [Ca2+]ic( levels,( reflected( in( the(increased(basal(F538(values(measured.(This(could(have(affected(the(ability(of(cells(to(respond(again(to(subsequent(agonist(stimulation,(either(through(depletion(of(internal(Ca2+( stores( or( further( receptor( desensitization,( possibly( to( a( state( that( is( not(reversible(by(PNU1((Williams(et(al.,(2011b).(This(raises(concerns(about(the(reliability(of(measuring( sazetidine3A’s( desensitization( effects( at( α7( nAChRs.( Since( α7( nAChRs(desensitize(so(readily(upon(agonist(stimulation,(it(is(not(possible(to(test(its(true(effect(without( the(use(of(higher(resolution( techniques(such(as(electrophysiology.(Here(we(use(PNU1(to(overcome(this(desensitization(in(order(to(amplify(the(effects(of(α7(nAChR(stimulation( to( detectable( levels( in( our( assay.( Thus,( in( reality( the( effect( being(examined(here(is(more(appropriately(described(as(the(propensity(for(sazetidine3A(to(desensitize(α7(nAChRs(in(the(presence(of(PNU1.(Williams(et(al.,((2011)(described(two(differing( states( of( α7( nAChR( desensitization,( which( are( distinguished( by( their(reversibility( by( type( II( PAMs( such( as( PNU1.( The( difficulty( here( is( that( sazetidine3A(also(appears(to(activate(α7(nAChRs(in(the(presence(of(PNU1,(but(perhaps(with(much(
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longer(pre3incubation(times(α7(nAChRs(would(inactivate(to(the(PAM3resistant(state,(which( would( then( allow( subsequent( measurement( of( desensitization( to( further(agonist(stimulation.(Such(an(effect(is(interesting(and(deserves(further(study.(The(next(section(will(discuss(our(attempts(to(measure(this(effect(in(individual(cells(in(primary(cortical(neurons.(
5.3.5 Desensitization-of-α7-nAChRs-in-primary-cortical-cultures-by-sazetidineGA-It( is( interesting( that( the( effects( described( in( section( 5.2.3( (Figure( 5.2.8)( for( the(elevated( basal( fluorescence( in( SH3SY5Y( cells( following( 10( min( pre3incubation( of(sazetidine3A( in( combination( with( PNU1( were( not( observed( in( primary( cortical(cultures.(This(could(be(due(to(differences(in(the(model(system(being(used.(Here,(pre3incubation( of( 500( nM( sazetidine3A( in( the( presence( of( 10( µM( PNU1( for( 10( min(inhibited(responses(to(subsequent(perfusion(of(3(µM(PNU2(by(59.22(±(12.40(%,(which(validates(the(IC50(value(found(for(sazetidine3A(as(a(desensitizer(for(α7(nAChRs(in(SH3SY5Y(cells(above((0.48(μM),(and(reassures(us(that(our(observations(of(rising(basal(F538(in(these(experiments(did(not(hugely(affect(the(examination(of(sazetidine3A’s(potency(as(a(desensitizer.(As(described(above( for(responses(to(sazetidine3A( in(the(presence(of(PNU1(in(cortical( cultures( (Figure( 5.2.6),( the( recovery( of( the( response( to( PNU2( (3( µM)( in(combination(with(PNU1((10(µM),(after(blockade(by(sazetidine3A(and(following(10(min(washout( (57.38( ±( 17.83( %( recovery;( Figure( 5.2.11)( was( lower( than( that( seen( for(antagonism(by(MLA( (100(nM;(89.68(±(22.73(%;(Figure(3.2.9),( again( supporting( the(notion(that(sazetidine3A(desensitizes(α7(nAChRs(for(long(periods(of(time.(It(would(be(interesting(to(test(this(effect(for(longer(washout(periods(to(ascertain(a(measure(of(its(ultimate(duration.(This( finding( agrees(with( the( study(by(of( Xiao( et( al.,( (2006),(who(reported( long( lasting( desensitization( of( α4β2( nAChRs( by( sazetidine3A( hours( after(washout(in(HEK3293(cells.(The(long(lasting(effects(of(sazetidine3A(are(highly(relevant(to(pre3clinical( research,( as( it(would( imply( that( sazetidine3A’s( effects( could( continue(long(after(the(drug(had(been(cleared(from(the(system(in(vivo,(due(to(it(being(bound(to(and(desensitizing(nAChRs(for(long(periods(of(time.(Hussmann(et(al.,((2012)(reported(that( low(micromolar( concentrations( of( sazetidine3A( are( achievable( in( the( rat( brain(following(subcutaneous(injection(of(2.3(mg/kg.(It(has(also(been(noted(that(α7(nAChR(receptor( populations( exhibit( a( balance( of( desensitization( and( low3level( activation(
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dubbed( “smoldering( activation”( in( the( presence( of( sazetidine3A( (Campling( et( al.,(2013),( which( could( be( achieved( by( low(micromolar( concentrations( reported( to( be(effective(in(our(experiments.(There(is(also(a(great(deal(of(evidence(for(α7(nAChRs(in(the( periphery,( especially( in( cells( of( the( immune( system( (Razani3Boroujerdi( et( al.,(2007;(Skok,(2009;(Filippini(et(al.,(2012).(It(could(be(envisaged(that(a(compound(like(sazetidine3A,(which(remains(bound(to(receptors(for(long(periods(of(time,(could(affect(their(signaling.(




5.3.7 Characterization-of-novel-azetidine/pyrrolidine-containing-compounds-We(evaluated(the(potential(activities(of(several(novel(compounds((Figure(5.2.13;(A3E)(containing( structurally( similar( motifs( to( sazetidine3A.( None( of( the( compounds(affected(the(binding(of([3H]epibatidine(to(rat(brain(membranes,(suggesting(that(they(do(not(bind(to(the(orthosteric(ACh(binding(site(of(nAChRs,(whereas(sazetidine3A(dose(dependently( competed( for( binding.( At( first( glance( the( chemical( structures( of( these(compounds(possess(two(essential(components(of(the(nAChR(pharmacophore(that(are(shared(by(compounds(like(nicotine,(epibatidine(and(sazetidine3A(–(a(charged(group,(i.e.(a(protonatable(nitrogen(atom(that(forms(a(π3cation(interaction(with(a(tryptophan(residue( on( the( nAChR;( and( a( hydrogen( bond( acceptor,( i.e.( the( lone( electron( pair(present( on( the( pyridine( nitrogen( atom( which( is( reputed( to( co3ordinate( a( water(molecule,(forming(a(bridge(to(the(complimentary(nAChR(subunit((Abreo(et(al.,(1996;(Celie( et( al.,( 2004;( Dallanoce( et( al.,( 2013).( Closer( scrutiny( of( the( geometric(arrangement(of(these(ingredients(in(compounds(A3E(however,(allows(further(insights(to( emerge( that(may( help( to( explain( their( very( low( affinity( observed( for( the( nAChR(binding( site.( The( distance( between( the( two( nitrogen( atoms,( or( internitrogen( (N3N)(distance(for(optimum(affinity(is(espoused(to(be(4.6(Å((Abreo(et(al.,(1996).(Compared(to( sazetidine3A,( nicotine( or( epibatidine,( the( protonatable( azetidine( nitrogen( is( two(chemical(bonds(closer(to(the(pyridine(nitrogen(on(compounds(A3E,(which(could(put(it(out(of(the(optimum(N3N(distance,(and(also(restrict(bond(rotation.(Another(factor(that(could( further(obstruct(binding( for(compounds(A3E( is( the(benzene(ring(bound(to(the(protonatable(nitrogen(atom,(which(adds(considerable(steric(hindrance(effects,(further(constraining(positioning(of(the(pharmacophore.(Interaction(with(α7(binding(sites(was(not(carried(out(due(to(lack(of(availability(of( radioligand,( moreover,( it( could( be( possible( that( compounds( A3E( affect( different(sites( on( nAChRs,( or( somehow( interfere( with( nAChR( function.( We( therefore( used(functional(Ca2+(assays(as(above(to(evaluate(the(potential(activities(of(compounds(A3E(in( SH3SY5Y( cells.( The( failure( of( compounds(A3E( is( consistent(with( their( inability( to(compete( for( binding( to( heteromeric( nAChRs( and( indicate( no( activity( from( other(mediators(of(Ca2+(elevations(such(as(GPCRs.(
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Following(pre3incubation(as(for(sazetidine3A(above,(compounds(A3E((100(μM)(significantly(inhibited(subsequent(responses(to(nicotine,(whereas(only(compounds(D(and(E( significantly(blocked( responses( to(PNU2( in( the(presence(of(PNU1.(This( could(suggest(that(compounds(A3E(non3competitively(block(α3β2(α5)(or(α3β4(α5)(nAChRs,(and( compounds(D(and(E(also(block(α7(nAChRs.(There( is(however(a(possibility( that(these(effects(are(not(due(to(specific(interactions(with(nAChRs,(but(are(achieved(by(a(non3specific(mechanism( that( inhibits( [Ca2+]ic( elevations.( At( the( high( concentrations(tested((100(μM),(this(could(be(due(to(open(channel(block(of(nAChRs,(or(VGCCs(which(have( been( shown( to( mediate( nAChR( induced( [Ca2+]ic( elevations( in( SH3SY5Y( cells((Dajas3Bailador( et( al.,( 2002a).(We( evaluated( the( latter( by( challenging( responses( to(acutely(applied(KCl((100(mM),(which(elevates([Ca2+]ic(via(recruitment(of(VGCCs,(and(found( evidence( that( the( actions( observed( for( compounds( D( and( E( were( indeed(dependent( on( this( mechanism,( whereas( compounds( A3C( had( no( significant( effect.(Further( studies( using( lower( concentrations( of( compounds( A3C( were( not( deemed(useful.( Taken( together,( these( results( do( not( suggest( any( obvious( potential( for(compounds(A3E(with(respect(to(nAChRs.(
5.3.8 Conclusions-The( experiments( described( in( this( chapter( aimed( to( characterize( the( activity( of(sazetidine3A(at(α7(and(non3α7(nAChRs.(We(assessed(functional(activation(of(nAChRs(by(the(use(of( fluorescent(calcium(binding(dyes,(and(conclude(that(sazetidine3A(both(activates( and( desensitizes( nAChRs( in( SH3SY5Y( cells( and( mouse( primary( cortical(cultures.(We(attribute(these(effects(to(α3β2(α5)(and(α3β4(α5)(nAChRs(in(the(former.(In( both( preparations,( PNU1( either( potentiated( or( revealed( agonist( effects( of(sazetidine3A,(indicating(activity(at(α7(nAChRs.(Desensitization(of(α7(nAChR(mediated(responses(was( also( seen,( and( appeared( to(be( long( lasting.(This(desensitization(was(analogous(to(that(produced(by(the(α7(agonist(PNU2,(as(it(was(reversed(by(subsequent(application(of(PNU1.(( The(clinical(implications(of(these(findings(may(be(minor,(but(it(is(possible(that(sazetidine3A( could( enter( the( brain( at( low(micromolar( concentrations( and( therefore(affect( central( α7( nAChRs( (Hussmann( et( al.,( 2012).( There( is( also( the( possibility( of(affecting(peripheral(α7(nAChRs,(such(as(those(present(on(immune(cells(that(mediate(signal3transduction(pathways(involved(in(the(anti3inflammatory(or(oncogenic(effects(
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6.1 Conclusions-This(thesis(presents(investigations(that(aimed(to(define(the(mechanisms(of(α7(nAChR3mediated( Ca2+( elevations( in( primary( cultured( cells( from( the(mouse( cerebral( cortex(using( selective( pharmacological( agents.( α7( nAChRs( are( characterized( by( their( high(relative(Ca2+(permeability((Fucile(et(al.,(2003),(sensitivity(to(blockade(by(αbgt((Zhang(et(al.,(1994),(and(rapid(activation3desensitization(kinetics((Fenster(et(al.,(1997).(They(are(widely( expressed( in( the(mammalian(brain,(where( they(mediate(Ca2+(dependent(signalling(pathways(that(modulate(neurotransmitter(release,(synaptic(plasticity,(gene(transcription,( and( neuroprotection( (Dajas3Bailador( and(Wonnacott,( 2004).( As( such,(they(are(thought(to(play(a(role( in(cognitive(processes(such(as(working(memory(and(attention,( and( are( implicated( in( diseases( that( manifest( cognitive( deficits( such( as(schizophrenia( and( Alzheimer’s( disease( (Bencherif( and( Lippiello,( 2010;( Hurst( et( al.,(2013;(Wallace(and(Bertrand,(2013b).(( Fluorimetric(Ca2+(assays(and(live(imaging(were(employed(to(study(α7(nAChR3mediated( Ca2+( signalling( processes,( and( also( to( characterize( the( actions( of( the(desensitizing(agonist(and(prototypical(smoking3cessation(drug,(sazetidine3A(at(native(α7( nAChRs,( showing( that( the( sensitivity( of( this( subtype( to( sazetidine3A( could(contribute( to( its( behavioural( effects( or( possibly(mediate( side3effects.( In( addition,( a(novel( HCS( Ca2+( imaging( and( analysis( assay( that( can( be( combined( with(immunofluorescent( labelling(to(add(further( insight(to(Ca2+(signalling(mechanisms(in(different(cell(types(from(large(populations(was(optimized.(
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Figure' 6.1.1' Summary' of' 'α7' nAChR9mediated' Ca2+' elevation' mechanisms' in' mouse' primary' cortical'












































6.1.2 Comparison- of- methods- used- to- measure- α7- nAChR- mediated- Ca2+-
signalling-in-this-thesis-Three( different( methods( were( used( to( measure( [Ca2+]ic( elevations:( (i)( fluorescent(plate(reader(based(Ca2+(assays,((ii)( live(cell(Ca2+( imaging,(and((iii)(HCS(Ca2+( imaging(assays.( Table( 6.1.1( summarizes( and( compares( the( different( attributes( of( these(methods.(
Table'6.1.1:'Comparison'of'methods'used'to'measure'intracellular'Ca2+'elevations'in'this'thesis.'( Fluorescent(plate3reader( Live(imaging( High(content(screening(Fluorophore( Fluo33:(only(single(excitation(recording(available.(
Fura32;(dual(excitation(recording(available.( Fluo33;(only(single(excitation(recording(available.(Cells( Cells(must(be(confluent(for(reliable(readings;(limited(to(cell(lines.(
Can(image(primary(cultures(or(cell(lines.( Can(image(primary(cultures(or(cell(lines.(





Environmental(control( Temperature(control(available,(not(used(in( Temperature(control(integrated(into(perfusion( Environmental(control(possible(but(reduces(image(
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( It( is( important( to( note( the( difference( between( fluorophores( used( to( report(changes( in( [Ca2+]ic( in( these( experiments,( and( to( highlight( their( strengths( and(weaknesses(that(make(them(appropriate(for(certain(applications.(Fura32(is(well(suited(to(measuring(kinetic(properties(of(Ca2+(waves(as(in(live(imaging(experiments(due(to(its(relatively(fast(Koff(for(Ca2+((Dissociation(rate;(23(s31;(Paredes(et(al.,(2008)(compared(to(single3wavelength(indicators( like(fluo33((Koff(=(90(s31;(Zou(et(al.,(2004)).(Fura32( is(also(more(well3suited( for(measuring( small( changes( in( resting( [Ca2+]ic( because(of( its(relatively(low(Kd(for(Ca2+((140(nM;(Grynkiewicz(et(al.,(1985)(compared(to(fluo33((Kd(=(400(nM;(Minta(et(al.,(1989).(For(our(experiments,(it(was(more(important(to(measure(
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[Ca2+]ic(changes(to(sequential(drug(applications(in(individual(cells,(and(analysis(of(the(kinetic(properties(of(these([Ca2+]ic(elevations(was(not(an(important(experimental(aim(per(se.(We(could(therefore(have(used(single3wavelength(indicators(in(place(of(fura32(in( these(experiments(without( changing( the(experimental(design( significantly.(There(are(other(advantages(of(using(ratiometric(Ca2+(indicators(like(fura32(however,(such(as(the( minimization( of( technical( issues( including( uneven( loading( or( leakage( of( the(indicator(and(photobleaching( (Paredes(et(al.,(2008).(The(main( reasons( for( choosing(these( different( fluorophores( here(were( based( on( the( imaging( equipment( available.(Improved( single3wavelength( indicators( are( available( such( as( fluo34,( which( has(increased(brightness(and(faster(loading(compared(to(fluo33((Paredes(et(al.,(2008),(and(could(have(been(used(in(the(plate(reader(or(HCS(experiments.(( In(conclusion,( the(complimentary(attributes(of( these(methods(allow(different(scientific( questions( to( be( investigated,( and( together( they( can( each( provide( an(interlocking(piece(of(the(larger(puzzle.(By(considering(the(advantages(and(limitations(of( these( methods( when( formulating( experimental( aims,( they( can( be( used( to( their(potential( whilst( minimizing( their( hindrances.( Higher3throughput( techniques( are(advantageous( when( screening( multiple( conditions( in( a( short( time,( but( lack( the(flexibility( of( more( labour3intensive( techniques( that( permit( higher3resolution.( By(combining( the( two( approaches,( a( complementarity( can( be( achieved,( like( using( a(course3(and(fine3toothed(comb.(Certain(aspects(of(more(advanced(HCS(technology(are(an(exception(to(the(compromise(between(resolution(and(throughput,(as(illustrated(by(the( combination( of( Ca2+( imaging( with( immunofluorescent( labelling( explored( in(chapter(4,(which(gives(more(detail(to(each(experiment.(As(HCS(technology(advances,(it(can(be(envisaged(that(this(dichotomy(is(blurred(even(further.(
6.2 Future-Perspectives-This( section(will( describe( further( studies( and( alternative( approaches( that( could( be(used( to( investigate( α7( nAChR3mediated( Ca2+( signalling( mechanisms.( A( long( list( of(potential( experiments( to( follow( nature( down( the( rabbit3hole( can( be( imagined;( in(practice(however,(these(ideas(are(limited(by(the(experimental(techniques(available.(
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6.2.1 Further- investigations- of- α7- nAChRGmediated- Ca2+- signalling- in- cortical-
cultures-The(results(of(experiments(described(in(chapter(3(support(the(premise(that(multiple(mechanisms( play( a( role( in( α7( nAChR3mediated( Ca2+( elevations.( However,( in( a(complex(physiological(system(such(as(primary(cortical(cultures(it(may(not(be(the(case(that( all( of( these(mechanisms( occur( simultaneously( in( the( same( location( or( for( the(same( function.( This( is( reflected( by( our( results,( in( which( a( variable( degree( of(antagonism( of( α7( nAChR3mediated( Ca2+( elevations( is( seen( after( blocking( these(mechanisms( with( selective( inhibitors( (Figure( 6.1.1).( By( combining( antagonists( for(each( of( the( possible( Ca2+( amplification( mechanisms,( the( contribution( of( individual(mechanisms(could(be(evaluated(alone.(( Contribution( of( different( VGCC3subtypes( merits( further( investigation,( as(although( Cd2+( significantly( blocked( α7( nAChR3mediated( Ca2+( elevations,( using(nifedipine( to( block( L3type( VGCCs( did( not( achieve( a( clear( effect.( This( suggests(involvement(of(other(subtypes(such(as(N3,(P/Q3,(R3,(and(T3(type(VGCCs,(which(could(be(investigated( by( using( selective( toxins( (see( section( 1.2.2.4).( The( large( drug( volumes(required(in(live3imaging(experiments(precluded(this(possibility(due(to(the(expense(of(these( toxins,( but( by( using( the( HCS( Ca2+( imaging( assay( described( in( chapter( 4( this(would(be(much(more(feasible.(An(alternative(to(the(pharmacological(approach(used(in(this( thesis( to( investigate( the( involvement( of( various( cellular( actors( in( α7( nAChR3mediated( Ca2+( elevations( would( be( to( use( RNA( interference( (RNAi)( to( inhibit(transcription( of( candidate( genes( or( “gene( knockdown”( in( primary( cortical( cultures((Davidson( et( al.,( 2004).( It( should( be( noted( however,( that( this( approach( does( not(remove( candidate(proteins(100(%,(but( could( serve( as( a(useful( –( and( in( some( cases(more(specific(–(comparison.(( To( expand( the( findings( of( experiments( that( provided( evidence( for( the(involvement( of( glutamatergic( neurotransmission( in( α7( nAChR3mediated( Ca2+(elevations( (Figure( 6.1.1b),( the( postsynaptic( excitatory( effects( of( glutamate( release(could( be( evaluated( by( the( use( of( 43aminopyridine( to( stimulate( synaptic( vesicle(exocytosis( in( the( presence( of( bicuculline( to( block( postsynaptic( inhibitory( effects( of(GABA.(This(would(allow(quantification(of(excitatory(synaptic(effects( in( the(cultures,(and(also(allow(the(comparison(of(secondary(Ca2+(amplification(mechanisms(recruited(by( iGluRs( to( those( recruited( by( α7( nAChRs.( Conversely,( neurons( could( be( injected(
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with( tetanus( toxin( to( block( glutamate( release( (Gomez3Varela( and( Berg,( 2013),(allowing( postsynaptic( α7( nAChR3mediated( Ca2+( signalling( mechanisms( to( be(observed(without(the(interference(from(iGluR3(mediated(mechanisms.(This(approach(is(technically(challenging,( labour(intensive(and(low3throughput(to(the(point(of(a(few(cells(per(experiment.(Following(on(with(glutamatergic(mechanisms,(our(experiments(did( not( provide( significant( evidence( for( the( involvement( of( mGluR1( in( α7( nAChR3mediated(Ca2+(elevations(in(primary(cortical(cultures.(It(would(be(helpful(to(ascertain(whether(activation(of(these(receptors(by(selective(agonists(results(in(any(measurable(Ca2+( responses,( as( it( may( be( that( these( receptors( are( expressed( at( a( low( level,( as(reported(by(Ayala(et(al.((2012).(( The( influence( of( GABARs( on( α7( nAChR3mediated( Ca2+( elevations( deserves(more(attention,(as(α7(nAChRs(are(known(to(reside(on(GABAergic(terminals,(acting(to(facilitate(the(release(of(GABA((Alkondon(et(al.,(1997a,(1999;(Zappettini(et(al.,(2011a;(Poorthuis(and(Mansvelder,(2013).(The(majority(of(research(in(this(area(is(focused(on(the(hippocampus,(probably(due(to(the(higher(expression(of(α7(nAChRs(in(this(brain(region( (Barrantes( et( al.,( 1995b),( and( therefore( the( greater( likelihood( of( achieving(robust(and(reliable(observations.(In(our(experiments,(immunofluorescent(staining(for(GAD(revealed(the(presence(of(GABAergic(cell(bodies(and(punctate(objects(suggestive(of(pre3synaptic(terminals(in(primary(cortical(cultures.(Co3labelling(of(GAD(with(Alexa(Fluor3conjugated( αbgt( could( strengthen( evidence( for( α7( nAChRs( existing( at(GABAergic(nerve(terminals.(Our(experiments(provided(some(evidence(for(this,(as(the(pre3incubation(and(co3application(of(bicuculline(potentiated(α7(nAChR(responses( in(some(HCS(experiments.(( Looking(slightly(more(broadly(at(the(possibilities(for(future(work(in(this(area,(different( methodological( approaches( should( be( considered( to( measure( [Ca2+]ic.( As(HCS( experiments( indicate( the( presence( of( different( cell( types,( another( approach( to(measuring(cellular(Ca2+(more(specifically(in(certain(cell(types(could(be(appropriate.(A(way(of(doing(this(would(be(use(genetically(encoded(Ca2+(indicators((GECIs)(to(target(particular( cell( types.( This( has( been( achieved( using( a( specific( promoter( to( amplify(expression( of( the( GECI( G3CaMP2( in( interneurons,( but( not( Purkinje( cells( in( mouse(cerebellum((Kuhn(et(al.,(2012).(This(alternative(may(reduce(the(ambiguities(present(in(fluorescent(co3localization(methods(used(in(chapter(4,(as(the(Ca2+(signal(would(only(be( coming( from( cells( expressing( the( GECI,( and( therefore( more( specific.( These(
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indicators( do( however( have( inherent( difficulties,( such( as( the( need( for( viral(transfection(of( cells,( compared( to( the(straightforward(passive( loading(of(AM(tagged(chemical(Ca2+(indicators.(
6.2.2 Higher-content-HCS( analysis( raises( the( possibilities( of( data( extraction( astronomically,( and(experiments( described( in( chapter( 4( have( only( scratched( the( surface.( As( well( as(automating( the( analysis( of( cytosolic( Ca2+( imaging( assays( as( described( in( chapter( 4,(this( technology( enables( many( other( avenues( to( be( explored.( Higher( magnification(microscopy( could( enable( imaging( and( automated( segmentation( of( more( local( Ca2+(events( such( as( those(occurring( in(neurites( and( subcellular( compartments,( aided(by(the( ability( to( combine( immunofluorescently( labelled( images.( Distinguishing( the(effects( of( pre3( and(post3synaptic(α7(nAChRs( is( a(difficult( obstacle( to( overcome,( but(with( the(HCS(Ca2+( imaging( assay( this( could(be( achieved(using(higher(magnification(imaging(in(combination(with(post3assay(immunfluorescent(labelling(for(pre3synaptic(markers(such(as(synaptophysin,(or(post3synaptic(markers(such(as(PSD395.(( Further( analysis( of( the( glial( composition( of( these( cultures( also( warrants(investigation,(as(does(their(effect(on(α7(nAChR3mediated(signalling.(The(presence(of(other(glial(cells(such(as(microglia(was(not(evaluated(here,(but(could(be(observed(by(immunofluorescent( labelling(with( antibodies( for( cluster( of( differentiation(molecule(11b( (CD11b;( Perego( et( al.,( 2013).( Another( interesting( approach(would( be( to( grow(pure(astrocyte(or(microglial(cultures(to(examine(α7(nAChR3mediated(Ca2+(signalling(mechanisms(in(these(cell(types.(( Other(variables(to(be(considered(in(these(cultures(include(the(developmental(state(of(cells(in(culture,(and(their(plating(density.(A(method(for(culturing(hippocampal(neurons(at(low(density(was(described(by(Kaech(and(Banker,((2006),(which(relies(on(the(use(of(coverslips(to(sandwich(low(density(neurons(on(to(an(astrocyte(feeder(layer,(which(is(more(appropriate(for(live(cell(imaging(experiments(which(utilizes(a(coverslip(chamber.( This( approach( would( allow( more( reliable( quantitation( of( single( cell(observations,(although(it(should(be(noted(the(level(of(cell(density(in(a(fundamentally(interconnected(physiological(system(could(change(its(behaviour.(( An(obvious(partner(to(the(experiments(covered(in(this(thesis(would(be(to(also(assess(the(mechanisms(by(which(other(nAChRs(such(as(α4β2*(subtypes(raise(Ca2+(in(
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primary(cortical(cultures(as(a(comparison.(Previous(studies(in(this(lab(suggest(distinct(Ca2+(coupling(mechanisms(for(α7(and(β2*(nAChRs(in(PFC(synaptosomes(in(the(context(of( facilitated( [3H]D3aspartate( release( (Dickinson(et( al.,( 2008).(Within( the( timeframe(here( it( was( only( possible( to( concentrate( on( α7( nAChRs,( but( given( the( progression(seen( in( HCS( Ca2+( assay( development( this( could( be( assessed( in( parallel( in( future(studies.(( Despite( intense( research( for( the( past( half3century,( very( few( drugs( targeting(nAChRs( are( currently( marketed,( the( exception( being( the( smoking( cessation( agent(varenicline.( Although( recent( years( have( seen( an( ever3growing( portfolio( of( nAChR(ligands( with( diverse( effects( on( receptor( function( and( more( desirable( selectivity(profiles,( the(tight(therapeutic(window(required(for(these( ligands(to(exert(significant(effects( in( the( CNS( without( causing( unacceptable( side( effects( remains( the( main(difficulty.(Other( limiting( factors( such(as( the( complexity(and(contradictory(nature(of(ligand3receptor(interactions((i.e.(desensitisation),(diverse(subunit(composition(giving(possible(undefined(targets,(and(spatio3temporal(considerations(are(often(the(reasons(for(poor(performance(in(the(clinic((Hurst(et(al.,(2013).(As(this(thesis(shows(however,(ligands(that(fail(in(the(clinic(can(often(provide(useful(research(tools(such(as(PNU1(and(sazetidine3A,(whose(insights(may(at(some(point(aid(future(drug(discovery(efforts.(The(obstacles( to( developing( nAChR( drugs( may( be( daunting( in( their( numbers,( but( an(optimistic(perspective(would(allow(that( further(research(might(eventually(grant(the(necessary(foundations(for(effective(therapeutics.(( In(the(quest(to(treat(some(of(the(most(peculiar(and(debilitating(illnesses(that(warp( and(destroy( the( very( essence( of(what( it( is( to( be(human,( any( advances( in( our(understanding( of( the( enigmatic( workings( of( the( brain( are( welcome.( The( findings(presented(here(are(relevant(to(understanding(the(pathology(and(potential(treatment(of( Alzheimer’s( disease( (Bencherif( and( Lippiello,( 2010),( schizophrenia( (Young( and(Geyer,( 2013)( and( addiction( (Levin( et( al.,( 2010)( to( name( a( few.( In( addition,( the(analytical( power( of( the( HCS( assay( developed( here( may( well( contribute( to( these(endeavours.((Drawing( to( a( close,( the( almost( fractal( expansion( of( concentric( levels( of( interaction(emanating( from( the( activation( of( a( relatively( scarce( and( extraordinary( receptor(leaves(one(awestruck(by(the(complexity(and(convoluted(structure(of(nature.(The(α7(
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Abstract The aim of this study was to investigate the
ability of sazetidine-A, a novel partial agonist at a4b2
nicotinic acetylcholine receptors (nAChRs), to affect the
function of native a7 nAChRs in SH-SY5Y cells and pri-
mary cortical cultures. The a7-selective positive allosteric
modulator PNU-120596 was used to reveal receptor acti-
vation, measured as an increase in intracellular calcium
using fluorescent indicators. In the absence of PNU-
120596, sazetidine-A elicited mecamylamine-sensitive
increases in fluorescence in SH-SY5Y cells (EC50 4.2 lM)
but no responses from primary cortical neurons. In the
presence on PNU-120596, an additional response to saz-
etidine-A was observed in SH-SY5Y cells (EC50 0.4 lM)
and robust responses were recorded in 14 % of cortical
neurons. These PNU-120596-dependent responses were
blocked by methyllycaconitine, consistent with the acti-
vation of a7 nAChRs. Preincubtion with sazetidine-A
concentration-dependently attenuated subsequent respon-
ses to the a7-selective agonist PNU-282987 in SH-SY5Y
cells (IC50 476 nM) and cortical cultures. These findings
support the ability of sazetidine-A to interact with a7
nAChRs, which may contribute to sazetidine-A’s actions in
complex physiological systems.
Keywords Live cell calcium imaging ! SH-SY5Y cells !
Primary cortical neurons ! PNU-120596
Sazetidine-A (6-[5-[(2S)-2-azetidinylmethoxy]-3-pyridi-
nyl]-5-hexyn-1-ol) has the profile of a potent partial agonist
at a4b2 nicotinic acetylcholine receptors (nAChRs) and
has attracted interest as a lead compound for several ther-
apeutic targets, making detailed knowledge of its wider
activity an important consideration. Sazetidine-A is a
derivative of the nicotinic agonist A-85380, developed to
bear a long side chain for potential attachment of fluores-
cent or photoaffinity probes [1]. In binding assays it
showed improved selectivity for a4b2 nAChRs, compared
with A-85380, with Ki values of 0.4 and 0.6 nM for rat and
human a4b2 nAChRs respectively.
In contrast to the parent molecule, sazetidine-A
appeared to be devoid of agonist activity at recombinant
human a4b2 nAChRs and was described as a ‘silent
desensitizer’ [1]. Subsequent studies revealed sazetidine-A
to be a stoichiometry-dependent agonist capable of fully
activating high sensitivity human a42b23 (HS-a42b23)
nAChRs, whereas it had negligible efficacy, relative to
acetylcholine, at lower sensitivity a43b22 (LS-a43b22)
nAChRs [2, 3]. Presumably the stable cell lines employed
in the original study predominantly expressed the low
sensitivity form. The ‘accessory’ subunit occupying the
fifth position in the pentameric nAChR, a position that does
not directly contribute to either of the two high affinity,
orthosteric agonist binding sites, nevertheless can influence
receptor properties [4]. In this case the subunit occupying
this position appears to determine the ability of sazetidine-
A to affect the opening of the a4b2 nAChR channel. This
notion is reinforced by the opposing effects of a5 and b3
subunits in the fifth position: inclusion of an a5 subunit to
form a42b22a5 nAChRs abolished agonist efficacy [5],
whereas sazetidine-A is a potent and efficacious agonist at
a4a6b22b3 nAChRs (EC50 19 nM) [6].
The sobriquet ‘silent desensitizer’ reflected the obser-
vation that a brief preincubation with 1 lM sazetidine-A
induced a long lasting inhibition of recombinant human
a4b2 nAChRs expressed in SH-EP1 cells (IC50
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value * 30 nM), compared with the rapid recovery fol-
lowing preincubation with nicotine [1]. More recent studies
that have taken into account its differential interaction with
the two stoichiometries of a4b2 nAChRs have shown that
sazetidine-A selectively desensitizes HS-a42b23 nAChRs
over LS-a43b22 [7, 8].
Its partial agonist profile has raised interest in sazeti-
dine-A as a therapeutic lead for numerous indications,
including drug dependence [9, 10], cognitive and atten-
tional deficits [11], pain [12] and depression [13]. Given
the complex contributions of multiple nAChRs in the CNS
to brain function and behaviours, it is important to
understand the specificty of agents such as sazetidine-A. It
binds with much lower affinity but acts as a full or sub-
stantial agonist at recombinant a4b4, a3b4, and
a6b2*nAChRs [1, 6, 7]. Sazetidine-A’s activation of a7
nAChRs has only recently been documented, with very
different EC50 values and efficacies at human (1.2 lM;
100 %) and rat (60 lM; 6 %) a7 nAChRs [7, 14]. The
contribution of a7 nAChRs to the clinical targets men-
tioned above [15, 16], as well as a7 nAChRs credited with
functions in peripheral systems that could mediate side-
efffects [17] suggest that this nAChR subtype, in partic-
ular, merits further attention. Hitherto, sazetidine-A’s
activation of native a7 nAChRs has not been reported. In
this study we examined the ability of sazetidine-A to




Triton X-100, (-)-nicotine hydrogen tartrate and meca-
mylamine hydrochloride, were purchased from Sigma-
Aldrich (Poole, Dorset, UK); B27, L-glutamine, antibiotics,
fluo-3 AM, fura-2 AM, and pluronic f127 were obtained
from Life Technologies (Paisley, UK); sazetidine-A dihy-
drochloride, tetrodotoxin citrate, methyllycaconitine citrate
and 5-iodo-A85380 dihydrochloride were purchased from
Tocris Bioscience (Avonmouth, UK); PNU-120596 and
PNU-282987 were provided by Pfizer Inc. USA; general




Human neuroblastoma SH-SY5Y cells (ECACC, Salis-
bury, UK; passages 16–27) were cultured as previously
described [18]. In brief, cultures were maintained in
Advanced Dulbecco’s modified Eagle’s media (DMEM/
F12), supplemented with 2 % fetal bovine serum (FBS),
2 mM L-glutamine, 190 U/ml penicillin and 0.2 mg/ml of
streptomycin in 94 9 16 mm tissue culture dishes in a
humidified chamber at 37 !C with 5 % CO2. Cells were
seeded 1:2 into 96-well plates, experiments were per-
formed 72 h later with confluent cultures.
Mouse Primary Cortical Cultures
Primary cultures were prepared from embryonic mouse
cortices as previously described [19]. Briefly, time-mated
pregnant female CD1 mice were killed by cervical dislo-
cation and E18 embryos were harvested. Cortices were
dissected in PBS with 30 % glucose (Ca2?- and Mg2?-
free) and dissociated with a fire polished glass Pasteur
pipette. Tissue was centrifuged at 500 g for 5 min, resus-
pended in neurobasal medium supplemented with B27,
2 mM L-glutamine and 60 lg/ml penicillin and 100 lg/ml
streptomycin (12 ml medium per brain). For live imaging
experiments, cells were plated on 25 mm round glass
coverslips (thickness no. 1) coated with 20 lg/ml poly-D-
lysine, in 6-well tissue culture plates (Corning, USA). Cells
were allowed to grow for 10–14 days in vitro (DIV) at




Increases in [Ca2?]ic were measured as described previ-
ously [20]. Briefly, cells were washed twice with Tyrode’s
salt solution (TSS: 137 mM NaCl, 2.7 mM KCl, 1.0 mM
MgCl2, 1.8 mM CaCl2, 0.2 mM NaH2PO4, 12 mM
NaHCO3, 5.5 mM glucose; pH 7.4) and incubated with the
membrane-permeable, Ca2? sensitive dye fluo-3 AM
(10 lM) and 0.02 % pluronic F127 for 1 h at room tem-
perature in darkness. Cells were then washed twice with
TSS before pre-incubation (10 min) with 80 ll antagonists,
modulators or TSS. Changes in fluorescence (excitation
485 nm, emission 538 mm) were monitored using a Fluo-
roskan Ascent fluorescent plate reader (Thermo Scientific,
UK). Basal fluorescence was measured for 5 s before
agonist (20 ll) was added and fluorescence was monitored
for a further 20 s. Calibration of responses was achieved by
determining the maximum and minimum fluorescence
values of each fluo-3 AM signal, by application of 0.2 %
Triton X-100 (Fmax) followed by 40 mM MnCl2 (Fmin).
Data were calculated as a percentage of Fmax - Fmin.
Concentration response data were fitted to the Hill equation




Changes in [Ca2?]ic in individual cells ofmouse E18 cortical
cultures grown on glass coverslips weremonitored using live
cell imaging (Concord System, Perkin Elmer, UK). Cortical
cultures (10–14DIV)werewashed twicewith calciumbuffer
(140 mM NaCl, 5.0 mM KCl, 1.0 mM MgCl2, 1.8 mM
CaCl2, 10 mM glucose, 5.0 mM HEPES; pH 7.4) and
incubatedwith the ratiometricCa2?-sensitive dye fura-2AM
(5 lM) and 0.02 % pluronic F127 for 1.5 h at room tem-
perature in darkness. After another two washes with buffer,
coverslips were assembled into a temperature controlled
(37 !C) perfusion chamber (Series 20 PH2 platform with a
RC-21BR chamber, Harvard Apparatus, MA, USA) and
mounted on an inverted fluorescencemicroscope. Buffer and
drug solutions were pre-heated to 37 !C and perfused at a
rate of 5 ml/min. Fura-2 AMwas excited at 340 and 380 nm
using a SpectroMaster I and emissions at 510 nm were
detected with an intensified Ultrapix PDCI low light level
CCD camera. All experiments were carried out in the pre-
sence of 1 lM tetrodotoxin (TTX) pre-incubated for at least
1 min prior to recording. During long drug pre-incubations
perfusion was switched off to reduce drug use, and recording
was turned off to prevent photobleaching.
Data were analysed with Ultraview software (Perkin
Elmer, UK) and expressed as a ratio of F340:F380 following
subtraction of background fluorescence taken from a region
in which no cells could be seen. For successive drug treat-
ments on the same cells, initial peak F340:F380 ratio for each
individual responding region of interest (ROI) was normal-
ized to 100 % following subtraction of mean basal F340:F380
ratio recorded immediately before drug application. Sub-
sequent responses in the presence of antagonists/modulators
or after washout were calculated as a percentage of the ori-
ginal response from the same ROI. These values were then
averaged within experiments, such that n values reflect the
number of independent cultures examined.
Statistical Analysis
Statistical significance was evaluated by ANOVA with
post-hoc test, or t-test as appropriate, with details given in
figure legends.
Results
Effects of Sazetidine-A on Ca2? Responses Initiated
by Native Human nAChRs Expressed in SH-SY5Y
Cells
SH-SY5Y cells express a3, a5, a7, b2, and b4 nAChR
subunits [21–23] consistent with the formation of
functional a3* and a7 nAChRs [20]. Based on the sensi-
tivities of recombinant non-a4b2 nAChRs, sazetidine-A
was examined at 10 and 100 lM in SH-SY5Y cells loaded
with the Ca2? indicator fluo-3 AM. Both concentrations of
sazetidine-A produced a similar increase in fluorescence
and this response was abolished in the presence of 30 lM
mecamylamine (Fig. 1). The a7-selective antagonist
methyllycaconitine (MLA; 100 nM) was without effect.
This suggests that under the conditions of the assay, saz-
etidine-A activates a3-containing nAChRs but not a7
nAChRs, consistent with previous findings for other ago-
nists [24]. However, in the presence of the a7-selective
positive allosteric modulator (PAM) PNU-120596 (10 lM)
[25], sazetidine-A evoked significantly larger increases in
fluorescence that were partially blocked by both meca-
mylamine and by MLA (Fig. 1). This suggests that PNU-
120596 reveals an a7 nAChR-mediated increase in intra-
cellular Ca2?.
The response elicited by 10 lM sazetidine-A in the
presence of PNU-120596 (2.3 ± 0.7 fold increase in fluo-
rescence, Fig. 1) is comparable to that observed with the
structurally related agonist 5-iodo-A85380 (1 lM;
2.3 ± 0.2 fold increase) and with nicotine (30 lM;
4.0 ± 0.2 fold increase), both tested in the presence of the
PAM (data not shown). Increases in fluorescence in
response to sazetidine-A were concentration dependent
(Fig. 2). The concentration response curve was shifted to
the left in the presence of PNU-120596. EC50 values of 4.2
and 0.4 lM were derived for sazetidine-A in the absence
and presence of PNU-120596, respectively.
The propensity of sazetidine-A to antagonize nAChRs in
SH-SY5Y cells was assessed by preincubating cultures
with increasing concentrations of sazetidine-A for 10 min,
followed by stimulation with 100 lM nicotine (to activate
a3-containing nAChRs) or the a7-selective agonist PNU-
282987 (10 lM), in the presence of the PAM PNU-
120596. Maximally effective agonist concentrations were
deployed to elicit the optimum signal for quantitating
inhibition. In both cases sazetidine-A produced a concen-
tration-dependent inhibition of agonist-evoked responses,
with IC50 values of 522 and 476 nM respectively (Fig. 3).
Effects of Sazetidine-A on a7 nAChR-Mediated Ca2?
Signals in Mouse Cortical Neurons
Experiments were carried out on mouse E18 primary cor-
tical cultures to assess the effects of sazetidine-A on native
a7 nAChRs in cells with a more neuronal phenotype.
Cortical cultures were loaded with fura-2 AM and changes
in fluorescence indicative of changes in intracellular Ca2?
were monitored by live cell imaging. Sazetidine-A alone
(10 nM–10 lM; 20 s application) failed to evoke any
change in fluorescence, except for occasional, inconsistent
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increases at the highest concentration tested. In contrast,
40 mM KCl consistently produced robust responses from a
majority of cells (data not shown). Following preincubation
with PNU-120596, co-application of 10 lM sazetidine-A
with the PAM evoked sustained responses from 14 % of
cells (average from 6 experiments from 3 independent
cultures). Responses were completely blocked by 100 nM
MLA, with partial recovery (32.4 ± 9.4 % of initial
response) following 10 min washout (Fig. 4).
Sazetidine-A was examined for its ability to attenuate
responses from a7 nAChRs in cortical neurons by
sequential application of the a7 nAChR agonist PNU-
282987 alone (in the presence of PNU-120596) and fol-
lowing exposure to sazetidine-A for 10 min (Fig. 5).
Sazetidine-A applied at 500 nM, a concentration approx-
imating the IC50 value derived from SH-SY5Y cells
(Fig. 3), decreased the response to PNU-282987 by 59 %,
whereas preincubation with 10 lM sazetidine-A resulted
in a stronger block of 86 %. This effect was not due to
run-down of responses or exhaustion of the Ca2? indicator
as responses recovered to 57 and 60 % of control,
respectively, after 10 min washout of sazetidine-A
(Fig. 5).
Discussion
In this study we have exploited the PAM PNU-120596 to
reveal activity of native a7 nAChRs [27], in order to
examine the actions of sazetidine-A on a7 nAChRs
expressed in SH-SY5Y cells and mouse cortical cultures.
In the absence of the PAM, sazetidine-A evoked meca-
mylamine-sensitive increases in fluorescence in SH-SY5Y
cells that were insensitive to MLA. The EC50 value of
Fig. 1 Intracellular calcium elevations evoked by sazetidine-A in
SH-SY5Y cell populations. SH-SY5Y cells loaded with fluo-3 AM
were preincubated for 10 min with or without antagonist (mecamyl-
amine (Mec), 30 lM, chequered bars, or MLA, 100 nM, cross-
hatched bars) and/or PNU-120596 (PNU1, 10 lM, grey bars) before
addition of sazetidine-A (Saz, 10 lL, a, b; 100 lM, c, d) in the
presence (grey bars) or absence (white bars) of PNU-120596
(10 lM). Fluorescence at 538 nm was monitored for 20 s; represen-
tative traces are shown (b, d; some antagonist curves omitted for
clarity). The increase in fluorescence at 20 s is presented as a
percentage of the maximum fluorescence determined by addition of
0.2 % triton X-100 minus the minimum fluorescence quenched by
350 mM MnCl2 (a, c). Bars represent the mean ± SEM of at least 4
independent experiments; * P\ 0.05, ** P\ 0.01, significantly
different from sazetidine-A alone or in combination with PNU-




4 lM is consistent with the activation of human a3b4*
nAChRs in SH-SY5Y cells; at heterologously expressed
a3b4 nAChRs sazetidine-A is a relatively weak agonist,
with efficacy ranging from *0 to 100 % in different
studies, presumably reflecting differences in stoichiometry,
species and methodology [1, 7, 9].
The lack of a7 nAChR responses in the absence of the
PAM is likely to reflect the rapid kinetics of the receptor, as
other agonists were previously found to be without effect in
this assay [24]. However, sazatidine-A was recently
reported to activate rat a7 nAChRs with very low efficacy
[14] although another study using a different assay and
overexpressed human a7 nAChRs, reported 100 % efficacy
[7]. The MLA-sensitive enhancement of responses to saz-
etidine-A in the presence of the PAM PNU-120596 is
indicative of the recruitment of a7 nAChRs. The lower
EC50 determined in the presence of PNU-120596 is likely
to underestimate the true EC50 for sazetidine-A at a7
nAChRs as this PAM shifts the agonist concentration–
response relationship to the left by approximately 0.8 of a
log unit [25]. This suggests that the EC50 value for acti-
vation of a7 nAChRs in SH-SY5Y cells by sazetidine-A
would be in the low lM range, comparable with the recent
report that sazetidine-A activated recombinant a7 nAChRs
in the absence of a PAM with an EC50 value of 1.2 lM,
using a sensitive fluorescence assay to measure changes in
membrane potential [7]. A higher EC50 value of 60 lM
was found using two-electrode voltage clamp recording
from Xenopus oocytes expressing rat a7 nAChRs [14].The
ability of a brief (10 min) incubation with sazetidine-A to
ameliorate responses to subsequent stimulation of a3* or
a7 nAChRs is consistent with its propensity to desensitize
nAChRs. There was a concern that this experiment would
be compromised by the requirement for preincubation with
the PAM, alongside sazetidine-A, in order to reveal a7
nAChR-evoked responses. Although PNU-120596 pro-
longs the activation of a7 nAChRs [25], the duration of this
effect is relatively short-lived with return to baseline within
Fig. 2 Concentration dependence of sazetidine-A-evoked responses
in SH-SY5Y cells. SH-SY5Y cells loaded with fluo-3 AM were
stimulated with sazetidine-A (0.1–100 lM) in the presence (solid
black circles) or absence (open black circles) of PNU-120596 (PNU1;
10 lL). Fluorescence at 538 nm was measured for 20 s following
stimulation with sazetidine-A. The increase in fluorescence at 20 s is
presented as a percentage of the maximum fluorescence determined
by addition of 0.2 % triton X-100 minus the minimum fluorescence
quenched by 350 mM MnCl2. Points represent the mean ± SEM
from 8 independent experiments. Data were fitted to the Hill equation
and EC50 values for sazatidine-A in the absence and presence of
PNU-120596 were calculated to be 4.2 and 0.4 lM respectively
Fig. 3 Sazetidine-A inhibits responses evoked by nicotinic agonists in
SH-SY5Y cells. SH-SY5Y cells loaded with fluo-3 AM and preincu-
bated with sazetidine-A (0.01–100 lM) for 10 min before stimulation
with nicotine (100 lM; solid circles, a) or PNU-282987 (3 lM)
together with PNU-120596 (10 lM; open circles, b). The PAM was
also present during the preincubation period in b. Fluorescence at
538 nm was measured for 20 s following stimulation. Normalised
responses at 20 s are expressed as a percentage of the response to
agonist in the absence of sazetidine-A. Points represent mean ± SEM
of at least 4 independent experiments and are fitted to the Hill
equation, yielding IC50 values of 522 nM and 476 nM for sazetidine-A
versus nicotine and versus PNU-282987, respectively
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5 min [26]. The very similar inhibition curves for nicotine-
evoked responses in the absence of the PAM, attributed to
a3b4* nAChRs, and for responses evoked by the a7-
selective agonist PNU-282987 in the presence of PNU-
120596 argues that an inhibitory effect of sazetidine-A is
measured in both cases and that a3b4* and a7 nAChRs are
similarly sensitive to inhibition by sazetidine-A.
The IC50 values for this effect were *0.5 lM (Fig. 3).
This could be relevant to clinical applications of sazetidine-
A when therapeutic concentrations may approach these
levels [28] (see below). Moreover, Campling et al. [7]
recently highlighted ‘smouldering activation’ of nAChRs
resulting from the balance within a population of receptors
of sustained desensitization versus activation, such that the
impact of chronic agonist concentrations will be complex.
The sensitivity of a7 nAChRs to sazetidine-A was
reinforced by studies in primary cortical neurons. Inter-
estingly, no changes in fluorescence were detected in
response to sazetidine-A in the absence of the PAM. This
was surprising as functional a4b2 nAChRs might have
been anticipated to be present in cortical neurons. Possible
explanations are that they are only present in the LS-
a43b22 stoichiometry, or that they are absent at this
developmental stage. Although a4b2 nAChRs have been
documented on thalamocortical afferents [29], projection
neurons would not be present in the cortical cultures.
However a4b2 nAChRs may also occur on intrinsic cor-
tical neurons [30, 31]. Alternatively, a4b2 nAChRs might
not initiate detectable changes in intracellular Ca2?, due to
the presence of TTX in the perfusing buffer.
In contrast, in the presence of PNU-120596 sazetidine-A
elicited robust responses from a minority of cells, estimated
as 14 % of the total population. This proportion is con-
sistent with measurements using a selective a7 nAChR
agonist together with the PAM (Brown and Wonnacott,
unpublished observation). The almost total blockade of
these responses by 100 nM MLA confirmed that they arise
from activation of a7 nAChRs. Recovery following 3 min
washout was partial and somewhat variable, possibly
reflecting sazetidine-A’s propensity to desensitize nAChRs.
This was supported by the ability of sazetidine-A to pro-
duce a concentration-dependent-decrease in responses to
PNU-282987, with sensitivity similar to that observed in
SH-SY5Y cells.
Fig. 4 Sazetidine-A elicits intracellular calcium elevations in the
presence of PNU-120596 in mouse cortical cultures. Mouse E18
primary cortical cultures (10–14 DIV) were loaded with fura-2 AM,
perfused with 1.8 mM calcium buffer at 37 !C and imaged under a
fluorescence microscope at 510 nm. Cultures were pre-incubated with
PNU-120596 (PNU1; 10 lM; 3 min). Basal fluorescence (F340:F380)
was recorded for 30 s before stimulation with sazetidine-A (Saz;
10 lM; 20 s). Following 3 min washout, cells were pre-incubated
with MLA (100 nM; 10 min) and PNU-120596 (10 lM; 3 min) prior
to recording F340:F380 before, during and after co-stimulation with
sazetidine-A (10 lM; 20 s). Following 10 min washout, the protocol
was repeated in the absence of MLA. Panels a, b, c show
representative images of the same field of cells taken during the 3
successive stimulations with sazetidine-A before, during and after
exposure to MLA; scale bar 150 lm. Fluorescence is shown in
pseudocolour, (black/blue = low F340:F380, red/white = high
F340:F380). Two cells that responded to stimulation in a representative
experiment are indicated by the arrowheads and their individual
fluorescence profiles are shown below; fluorescence changes are
presented as a ratio of fluorescence emitted at 510 nm following
excitation at 340 and 380 nm. d Averaged data from 3 independent
cultures are presented graphically. Bars represent the mean ± SEM
peak F340:F380 increase above basal, expressed as a percentage of the
response to the initial stimulation with sazetidine-A in the presence of
PNU-120596, from the same region of interest. ****P\ 0.0001
significantly different from initial response to sazetidine-A in
combination with PNU-120596, one sample t-test
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Together these data provide evidence for the ability of
low micromolar concentrations of sazetidine-A to activate
native human and mouse a7 nAChRs, whereas an inhibi-
tory effect, likely reflecting desensitization of a7 nAChRs,
was observed at sub-micromolar concentrations of sazeti-
dine-A. Brain concentrations of sazetidine-A administered
chronically to rodents via osmotic minipump (4.7 mg/kg/
day) have been estimated to reach 32 nM, but repeated
injection achieved transient levels that were 10 times
higher [28]. This would be sufficient to elicit a degree of
desensitization and/or ‘smouldering activation’ of a7
nAChRs [7], which could either compromise or contribute
to the beneficial effects of a selective agonist such as
sazetidine-A.
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